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ABSTRACT 
Grace A. Chappell: Alterations to the epigenome represent critical mechanisms of chemically-
induced carcinogenesis 
(Under the direction of Ivan Rusyn) 
 
Environmental and occupational exposures to both natural and anthropogenic substances 
are known to play a causative role in carcinogenesis. While it is well accepted that carcinogenesis 
occurs by both genotoxic and non-genotoxic mechanisms, genotoxicity has been more thoroughly 
studied. Accumulating evidence suggests that epigenetic alterations also play an important role 
in chemically-induced carcinogenesis, and that these changes to the epigenome may be as 
important as genotoxicity. To gain a better understanding of the epigenetic alterations that occur 
as a consequence of exposure to a genotoxic chemical, we evaluated genetic and epigenetic 
alterations in two mouse models of genotoxicity. First, to determine the relative contribution of 
these molecular changes in liver tumorigenesis, we evaluated epigenetic modifications and the 
mutational profile of genes commonly altered in liver tumors in mice treated with a combination of 
a genotoxic and a pro-fibrogenic agent. Marked epigenetic changes in liver tumors and 
surrounding fibrotic liver tissue were associated with tumor incidence, while mutations in known 
cancer-related genes were not observed. Second, to better characterize the diverse molecular 
mechanisms of 1,3-butadiene (BD)-induced tumorigenicity, we evaluated DNA adducts and 
epigenetic alterations caused by exposure to BD in a set of two genetically divergent mouse 
strains (C57BL/6J and CAST/EiJ) and across both target (lung and liver) and non-target (kidney) 
tissues of BD-induced tumorigenesis. Although BD-DNA adducts were observed in all three 
tissues and both strains of BD-exposed mice, 
iv 
epigenetic alterations were clearly tissue- and strain-specific. These results suggest that 
epigenetic alterations represent a disease-relevant class of specific, and potentially 
mechanistically important, molecular features that are involved in chemically-induced 
carcinogenesis. Our findings emphasize the necessity of inclusion of epigenetic marks in 
assessment of potential and known cancer hazards. 
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CHAPTER 1: GENERAL INTRODUCTION 
 
Environmental and occupational exposures to both natural and anthropogenic substances 
are known to play a causative role in carcinogenesis (Pogribny and Rusyn, 2013; Langie et al., 
2015). While it is well accepted that carcinogenesis may occur by both genotoxic and non-
genotoxic mechanisms, genotoxicity has been more thoroughly studied. Accumulating evidence 
suggests that epigenetic alterations also play an important role in chemically-induced 
carcinogenesis, and that epigenetic mechanisms may be as important as genetic mechanisms in 
cancer development and progression (Ushijima and Asada, 2010). Epigenetic alterations 
represent non-genotoxic mechanisms of carcinogenesis that may occur independently or 
concomitantly with genotoxic aberrations. Further, the epigenomic landscape may directly 
influence the genotoxic potential of a chemical; for example, several studies have indicated 
preferential binding of reactive chemicals to regions of DNA that harbor specific histone 
modification marks and/or DNA methylation patterns (Denissenko et al., 1997; Chen et al., 1998; 
Yoon et al., 2001; Hu et al., 2003; Tretyakova et al., 2008; O'Hagan et al., 2011). 
There are several major types of epigenetic and epigenomic alterations: DNA methylation, 
alterations to histones/chromatin structure, nucleosome positioning, and expression of non-
coding RNAs. A wealth of data exists that demonstrates that alterations in DNA methylation, 
histone modifications, and expression of non-coding RNAs occur as a consequence of exposure 
to environmental chemicals, and such changes to the genome have been associated with various 
complex disease phenotypes, including cancer.   
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1.1. There is a need for better characterization of the epigenetic alterations induced by 
exposure to genotoxic chemicals 
To enable the efficacious incorporation of epigenetic endpoints in chemical hazard 
assessments, further characterization of the role of epigenetic alterations induced by 
environmental exposure is necessary (Koturbash et al., 2011a). In 2012, Richard Stein reviewed 
the current knowledge of epigenetics and environmental exposures, emphasizing that evaluating 
genotoxic factors is insufficient for the characterization of chemical hazards, and ultimately stating 
that epigenetic features do not receive adequate attention relative to genetic endpoints (Stein, 
2012). Concurrently, the appropriateness of current safety assessment paradigms that utilize a 
no observed adverse effect level (NOAEL) for epigenetic mechanisms was also considered (Alyea 
et al., 2012). Using several case studies on 1,3-butadiene, arsenic, and diethylstilbesterol, the 
authors found that epigenetic alterations largely fell within the dose-response curve for apical 
effects, but also highlighted several important gaps in the data, including dissimilar study designs 
and limited epigenetic dose-response data for only a small subset of known epigenetic marks. 
The authors concluded that current safety assessment models would be protective of various 
mechanisms that lead to adverse effects typically observed in guideline animal studies, because 
reference doses for a risk assessment are set based on an overall NOAEL that is driven by 
observed apical effects. However, additional studies are needed to characterize the relationship 
between epigenetic alterations and toxicity phenotypes, and the epigenetic-specific dose-
response.   
Exponentially growing evidence indicates that epigenetic events may be indispensable 
key mechanisms by which chemical carcinogens induce alterations in target cells. It has been 
demonstrated that these alterations occur early during exposure and may have significance as 
biomarkers of chemical exposure. However, it is not necessary that an observation of the 
epigenetic effect in response to chemical exposure, usually within hours or few days after 
exposure, has significance in the carcinogenic process. Such effects may also represent 
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transitory adaptive or non-specific cellular responses to chemical treatment. Overall, although 
there has been an increase in reporting of, and interest in, epigenetic mechanisms in the fields of 
environmental science and toxicology, the application of epigenetic endpoints in regulatory 
science is lacking. 
The US Environmental Protection Agency has held multiple workshops and State of the 
Science evaluations (http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=308271) regarding 
epigenetics and environmental chemicals, but no standard exists for how these endpoints are to 
be incorporated into chemical assessments. The International Agency for the Research of Cancer 
(IARC) recently named “Epigenetic Alterations” as one of 10 key characteristics of human 
carcinogens (Smith et al, in press). However, it is recognized that most carcinogens were 
evaluated by IARC before new data on their epigenetic effects became available (Herceg et al., 
2013).  
Research in the field of epigenetic responses to chemicals is increasing, and as additional 
information is made available regarding epigenetic mechanisms of cancer (and other toxicity 
phenotypes), such information should be utilized by regulators and governing bodies in the 
assessment of known or potentially hazardous chemicals. As the relationship between epigenetic 
alterations and toxicity phenotypes is further clarified, improved congruent guidelines for the 
application of epigenetic data in safety assessments can be accomplished.  
 
1.2. Epigenetic effects of genotoxic human carcinogens: a systematic review  
1.2.1. Methods 
To address the need for comprehensive information regarding epigenetic alterations and 
chemically-induced carcinogenesis, we conducted a systematic review of published studies 
concerning epigenetic alterations caused by known human carcinogens that have strong 
evidence of a genotoxic mechanism of carcinogenesis. We used the Health Assessment 
Workspace Collaborative (HAWC), a publically available online tool for curating published 
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literature for the assessment of chemicals or groups of chemicals (https://hawcproject.org). The 
review focused on human carcinogens as classified by IARC. IARC evaluations of carcinogenic 
risks to humans assign potential carcinogenic chemicals into one of five categories based on the 
body of evidence from epidemiological studies, animal cancer bioassays, and mechanistic and 
other relevant data (Tomatis, 1976). In 2012, re-evaluation of data on known human carcinogens 
was undertaken and published as a compendium of six monographs comprising volume 100. To 
date, there are 117 agents classified as known human carcinogens; these include chemical 
agents and related occupations, personal habits and indoor combustions, radiation, arsenic, 
metals, fibers and dusts, biological agents, and pharmaceuticals. For the purpose of this 
systematic review, we focused on environmental and occupational hazards; specifically, the 
agents and occupations listed in the IARC monograph volume 100F. Of the 31 chemicals and 
associated occupations included in this volume, 27 were included in this review because they 
were (1) classified as a known human carcinogen, and (2) the IARC Monographs working group 
concluded that there was sufficient evidence for a genotoxic mechanism of carcinogenesis. Of 
the chemicals and associated occupations included in the search, we identified publications 
relevant to epigenetic alterations for 12 (Table 1).  
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Table 1.1. Chemicals and associated occupations included in the systematic literature review. 
Chemical or associated occupation 
Original 
volume # 
Evidence of 
genotoxicity: 
animal 
Evidence of 
genotoxicity: 
human Epigenetics 
1,3-butadiene 97 yes yes yes 
2-naphthylamine 99 yes yes no 
4,4'-methylenebis(2-chlorobenzenamine) 
(MOCA) 99 yes yes yes 
4-aminobiphenyl 99 yes yes yes 
aflatoxins (naturally occurring mixtures) 82 yes yes yes 
aluminium production 92 no 
weak-to-
moderate* no 
benzene supp. 7 yes yes yes 
benzidine 99 yes yes yes 
benzo[a]pyrene 92 yes yes yes 
bis(chloromethyl)ether and chlormethyl 
methyl ether supp. 7 no 
moderate-to-
strong no 
chimney soot 92 no moderate* no 
coal gasification, occupational exposures 92 yes† no no 
coal-tar distillation, occupational 
 
92 yes# yes no 
coal-tar pitch 92 yes# moderate no 
coke production, occupational exposures 92 yes& yes* yes 
ethylene oxide 97 yes yes no 
formaldehyde 88 yes yes yes 
iron and steel founding supp. 7 no yes* no 
isopropyl alcohol manufacture  supp. 7 no plausible no 
mineral oils supp. 7 no weak no 
ortho-toluidine 99 yes moderate no 
painter (occupational exposure) 98 no yes* yes 
rubber manufacturing supp. 7 no yes* no 
shale oils supp. 7 yes no no 
strong-inorganic-acid mists containing 
sulfuric acid 54 no plausible no 
sulfur mustard supp. 7 yes yes yes 
vinyl chloride 97 yes yes yes 
*genotoxicity is attributable to the presence of known genotoxic chemicals in the exposure scenario 
†animal mechanistic data based on treatment with coal-tars or manufactured gas plant residues 
#animal mechanistic data based on treatment with coal-tars  
&animal mechanistic data based on treatment with coke-oven tar 
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Using HAWC, we queried all available literature in the PubMed database using search 
terms for both epigenetic alterations and the chemicals listed in Table 1.1. The full search terms 
are detailed in Appendix 1.1. 
The following exclusion criteria were applied: 
Not chemical of interest. The exclusion criteria “not chemical of interest” was assigned to cases 
in which no chemical in the list of Group 1 carcinogens included in the 100F IARC monographs 
(or their recognized reactive metabolites) were used in the study, or in cases in which the chemical 
was used for purposes other than exposure assessment. For example, many studies used 
formaldehyde for cross-linking of proteins or benzidine for staining of Hb, but the chemicals were 
not used for the purpose of studying cancer-relevant consequences of exposure. Such studies 
were excluded from the assessment. Similarly, studies of endogenous sources of formaldehyde 
were also excluded. 
No epigenetics. Several studies made mention of potential epigenetic mechanisms, or epigenetic 
alterations reported for a chemical that was not actually studied. Studies that investigated direct 
binding of a chemical (or metabolite) to histones, and no other epigenetic mark, were also 
excluded. 
Reviews.  Reviews were not considered. 
Unable to access full text. Articles that were not publicly available or accessible through either 
the Texas A&M Univsersity or University of North Carolina online portal were excluded.  Articles 
that were not available in English were also excluded.  
γ-H2AX. This category was created to bin all studies that measured phosphorylation of histone 
2AX (γ-H2AX) as a consequence of exposure to one of the chemicals of interest in any system. 
γ-H2AX is used as a marker for DNA double strand breaks (Rogakou et al., 1998), and studies 
that included this endpoint for that purpose alone were not included in our review if there was no 
other epigenetic analysis. The studies in this exclusion category were conducted using data 
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collected from exposures to benzo[a]pyrene, sulfur mustard, and benzene (or the 
metabolites/analogs of these chemicals). 
Other. A total of 47 studies were excluded for reasons other than those detailed above, and were 
included in this category. For example, some studies included an analysis of one of our chemicals 
of interest and of epigenetic alterations, but not of epigenetic events due to a chemical we queried. 
Methods papers also were assigned to this exclusion category. A sub-category was created for 
studies that reported specific binding of benzo[a]pyrene (BaP) to DNA at methylated vs. 
unmethylated cytosines. While these studies are pertinent to this review, and are briefly discussed 
herein (section B.3.a), they were not included with the rest of the studies because the DNA 
methylation was either assumed or definitely independent of exposure to BaP.  
A total of 919 references were returned as of the search date 10/27/2015. Of these, 148 
met the inclusion criteria and 771 were excluded (Figure 1). The publicly available assessment 
can be viewed at the following link: https://hawcproject.org/lit/assessment/185/. 
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Figure 1. 
Literature tree of the 919 studies returned by the search after assignment to appropriate 
categories. The human studies of benzene are expanded as an example. 
 
1.2.2. Evidence of genotoxic mechanisms of carcinogenesis for chemicals and associated 
occupations included in the review 
 Common routes of exposure, associated cancers, and previously reported evidence of 
genotoxicity of the 12 chemicals included in this review are briefly described below. Genotoxic 
attributes are is summarized in Table 1.2.  
1,3-butadiene 
 1,3-butadiene is a gas monomer used in the production of synthetic rubber. Exposure 
typically occurs in occupational settings in the production of 1,3-butadiene itself, as well as in 
production of rubber and plastics and petroleum refining and distribution. 1,3-butadiene is also 
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widely detected in ambient air, albeit at much lower levels than in occupational settings, from 
sources such as vehicle exhaust, cigarette smoke, and wood fires. An excess of hematopoietic 
cancers has been reported among workers occupationally exposed to 1,3-butadiene, and lung 
and bladder cancers have also been associated with 1,3-butadiene exposure. 1,3-butadiene is a 
multi-site carcinogen in experimental animals. The carcinogenicity of 1,3-butadiene is contingent 
upon the metabolism of 1,3-butadiene to reactive epoxides, which can bind with DNA and proteins 
(Huff et al., 1985; Jackson et al., 2000). bd-DNA adducts have been observed in occupationally-
exposed humans and experimental animals, and have been associated with mutations in cancer-
related genes (Ton et al., 2007; Abdel-Rahman et al., 2001; Sills et al., 2001; Lee et al., 2002; 
Abdel-Rahman et al., 2003).  
4-aminobiphenyl 
 4-aminobiphenyl is an aromatic amine used as a dye intermediate and as a rubber 
antioxidant, and human exposure predominantly occurs in occupational settings. Industrial 
production of 4-aminobiphenyl was ceased in 1955, and current exposures are due to 
contamination or metabolic release from benzidine. 4-aminobiphenyl is also a byproduct of 
tobacco combustion, and has been detected in fumes from cooking oils. Bladder carcinoma is the 
primary cancer associated with exposure to 4-aminobiphenyl, observed in human chemical plant 
workers and in experimental animal models. Multiple metabolic pathways activate aromatic 
amines, including 4-aminobiphenyl, to DNA-reactive intermediates, which are known to result in 
mutations. 4-aminobiphenyl-DNA adducts have been detected in human bladder, lung, and breast 
tissue of exposed humans (Reimann and Erdogan, 1976; Beland et al., 1983; Lin et al., 1994), 
and mutations in the HPRT locus and in the H-ras gene have been detected in human and mouse 
tissues, respectively, after exposure to 4-aminobiphenyl (IARC, 2012).  
4,4’-methylenebis(2-chlorobenzenamine) 
 4,4’-methylenebis(2-chlorobenzenamine), also referred to as MOCA, is a curing agent 
used in the manufacture of urethane rubber products. The majority of human exposures occur in 
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occupational settings, with non-occupational exposures in areas contaminated with MOCA or 
consumption of foods that were grown in contaminated soil. Limited human data is suggestive of 
an association between MOCA exposure and bladder cancer, and MOCA caused lung, liver, and 
bladder cancer in experimental animals (Stula et al., 1978). The assignment of MOCA to IARC 
“Group 1 carcinogens” was largely based on the strong evidence of genotoxic mechanism of 
action, involving metabolism of the aromatic amine to DNA-reactive intermediates, which lead to 
DNA adducts, mutations, sister chromatid exchange, and increased micronuclei (Silk et al., 1989; 
Kaderlik et al., 1993; Murray and Edwards, 1999). 
Aflatoxins 
Aflatoxins are naturally occurring potent hepatocarcinogens produced by Aspergillus 
flavus and Aspergillus parasiticus, with Aflatoxin B1 (AFB1) considered to be the most toxic type. 
Human exposure to AFB1 primarily occurs by consumption of contaminated food sources, most 
commonly stored grains, but occupational exposure also occurs during processing and handling 
of contaminated grains (inhalation and dermal). The main mode of carcinogenicity is attributed to 
the metabolic activation of AFB1 to a genotoxic epoxide, with a high prevalence of point mutations 
in the p53 gene (Tam et al., 1999; Gomaa et al., 2008). AFB1 exposure causes sister chromatid 
exchange, micronuclei, chromosomal alterations, and DNA and protein adducts (IARC, 2012).  
Benzene 
Benzene is a solvent that has historically been used in printing inks, gasoline, and 
chemical and drug production. Currently, the main use of benzene is in the manufacture of organic 
chemicals, and it is an intermediate in the production of several products that are used in drugs, 
insecticides, plastics, and dyes. Exposure to benzene is typically dermal or by inhalation in 
occupational settings, but it is present in the atmosphere, particularly in proximity to gas stations 
and in areas of high vehicular traffic. Benzene is leukemogenic, with excess cases of various 
types of leukemia (primarily acute myelogenous leukemia) reported in workers exposed to 
benzene (Infante et al., 1977; Infante, 2006). Limited studies have also associated benzene 
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exposure with increased risk of lung and kidney cancer. The carcinogenicity of benzene is 
contingent on metabolic activation, with benzoquinones in the bone marrow implicated in the 
ultimate toxicity. Benzene leads to genotoxic effects at the hematopoietic stem cell level; 
specifically, DNA double strand breaks and chromosomal aberrations that are known to be 
causative of hematopoietic cancers occur in benzene-exposed human patients (Tough and 
Brown, 1965; Zhang et al., 1999; Lau et al., 2009).  
Benzidine 
 Benzidine is, and has primarily been used as, the base for various types of dyes used in 
fabrics, as well as for visual detection of blood cells in laboratory settings. Benzidine is only 
allowed to be used in closed systems, and limited amounts are released into the environment. 
Bladder carcinoma is the primary cancer that has been associated with occupational exposure to 
benzidine, and is a multi-target carcinogen in experimental animals (primarily a hepatocarcinogen 
when administered by injection or ingestion). Like 4-aminobiphenyl, benzidine is an aromatic 
amine and can be metabolized to DNA-reactive intermediates that can lead to chromosomal 
aberrations, DNA strand breaks, micronucleation, DNA adducts, and mutations in oncogenes 
(Mirkova and Lalchev, 1990; Rothman et al., 1996; Xiang et al., 2007).  
Benzo[a]pyrene 
 Benzo[a]pyrene (BaP) is one of many polycyclic aromatic hydrocarbons (PAHs) that are 
products of incomplete combustion. BaP is a ubiquitous environmental contaminant, with major 
sources including tobacco smoke, automobile exhaust, and residential and commercial heating 
with coal or wood. Occupational exposures occur in coke production, coal gasification and 
liquefaction, roofing and paving involving coal-tar pitch, aluminum production, chimney sweeping, 
and working in power plants. BaP can be metabolized to four different diolepoxides, all of which 
are DNA-reactive. Chromosomal aberrations, DNA damage (by comet assay), sister chromatid 
exchange, DNA adducts, micronuclei and mutations have all been reported in rodents and/or 
humans exposed to BaP (Kliesch et al., 1982; Brauze et al., 1997; Kalina et al., 1998; DeMarini 
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et al., 2001). Most of the mechanistic data for BaP has been conducted in experimental mammals, 
showing that it is a multi-tissue carcinogen that primarily induces carcinomas of the lung, skin, 
liver, forestomach and mammary gland. Human cancers associated with BaP exposure include: 
lung, skin, bladder, and various oral and esophageal carcinomas specifically associated with 
tobacco smoking (IARC, 2010b).   
Coke production 
 Coke is produced by coal carbonization and is used as a fuel in iron-making blast furnaces 
and other metal-smelting processes. Coke oven workers are primarily exposed to PAHs, and may 
be exposed to a large number of other compounds, such as asbestos, silica, amines, metals, 
sulfur dioxide and sulfuric acid. An increased risk of lung cancer has been reported in coke oven 
workers, and cohort studies of bladder or skin cancer among coke oven workers have been 
conducted, although the data are inadequate for evaluation of the association with occupational 
exposures during coke production. The genotoxic effects of coke oven emissions are largely 
attributed to the presence of PAHs, several of which have been shown to be individually genotoxic 
in both in vitro and in vivo systems (benzo[a]pyrene, benzo[c]phenanthrene, 
benzo[b]fluouranthrene, (IARC, 1983). An increased frequency of sister chromatid exchange, 
DNA strand breaks (Popp et al., 1997), micronuclei frequency (Liu et al., 2006), and 
benzo[a]pyrene diol epoxide (BPDE)-DNA adducts (Pavanello et al., 2008) have been reported 
in peripheral blood lymphocytes from coke oven workers in comparison to age-matched controls. 
Further, the single major adduct detected in rats that were exposed to coke oven emissions by 
inhalation was the same (chromatographically) as the BPDE-N6-deoxyguanisine adduct that was 
characterized in calf thymus DNA incubated with BPDE.   
Formaldehyde 
 Formaldehyde is widely produced and used in the production of binders (wood production, 
pulp/paper) as well as in plastics, coatings, and textile finishing. Formaldehyde is also a commonly 
used preservative. Exposure to formaldehyde occurs both environmentally and occupationally; 
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formaldehyde is a natural product in most living systems, including fruits and other foods, and is 
even endogenously formed as a byproduct of oxidative metabolism in most mammals (including 
humans). Non-occupational exogenous sources of formaldehyde include tobacco smoke and 
automobile exhaust. Formaldehyde is associated with nasopharyngeal cancer and leukemia in 
humans, and nasal cavity, lung, leukemia and hematopoietic cancers in laboratory animals (IARC, 
2006). Occupational exposure occurs in the production of formaldehyde or the application of the 
chemical in any of the above-mentioned industrial uses. Formaldehyde can react directly with 
DNA, and increased frequency of micronuclei, DNA-protein crosslinks, DNA strand breaks, and 
sister chromatid exchange have been observed in the blood and/or nasal mucosal cells of 
exposed workers (Ying et al., 1999; Ye et al., 2005; Costa et al., 2008), as well as in various 
human and rodent in vitro systems (IARC, 2006; Schmid and Speit, 2007; Speit et al., 2007) 
Occupational exposure as a painter 
 Paint products are composed of up to thousands of chemical compounds for various 
purposes (pigment, driers, binders, corrosion inhibitors, among others) some of which are volatile 
and/or hazardous. In recent years, many hazardous chemicals, such as benzene, phthalates, 
chromium, and lead, have been reduced or removed from paint. Associations have been reported 
between bladder cancer and occupational exposure as a painter, and childhood leukemia and 
maternal exposure during painting. Chromosomal aberrations, increased micronuclei and sister 
chromatid exchange have all been reported in occupational painters (Pinto et al., 2000; Testa et 
al., 2005; IARC, 2010a); however, the genotoxic mechanisms associated with occupational 
exposure as a painter are attributed to the genotoxic effects of the individual constituents of paints, 
e.g. benzene, toluene, styrene, and PAHs. 
Sulfur mustard 
 Mustard gas is historically the most widely used chemical warfare agent.  Exposure to 
sulfur mustard occurs either in production of the chemical, or in contaminated areas where 
mustard gas was released during warfare. Exposure to sulfur mustard causes respiratory cancers 
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in humans and experimental animals (Heston, 1953b; Heston, 1953a; Nishimoto et al., 1983; 
Yamakido et al., 1996), and the carcinogenicity of sulfur mustard is attributed to its genotoxicity. 
Exposure to sulfur mustard has been shown to cause guanine-guanine DNA crosslinks, sister 
chromatid exchange, micronuclei, and mutations in humans and rodents (Roberts et al., 1971; 
IARC, 1975; Lin et al., 1996; Shahin et al., 2001). 
Vinyl chloride 
 Vinyl chloride is primarily used in polyvinyl chloride (PVC) production, and inhalational 
exposure in vinyl chloride/PVC plants is the main route of occupational exposure. Non-
occupational exposures are very low, but are higher in populations living in relatively close 
proximity to industrial emissions sources. In humans, vinyl chloride exposure is associated with 
angiosarcoma of the liver, hepatocellular carcinoma (HCC), lung cancer, and malignant 
neoplasms of connective and soft tissues. The reactive metabolites of vinyl chloride, 
chloroethylene oxide and chloroacetaldehyde, are reactive with both DNA and protein (Maltoni et 
al., 1974; Guengerich et al., 1981; Guengerich, 1992).  Vinyl chloride induces an increased 
frequency of sister chromatid exchange, micronuclei formation, and chromosomal aberrations 
(IARC, 2008). Mutations in cancer-related genes have been reported in both humans and rats 
exposed to vinyl chloride (Cheng et al., 1991; IARC, 2008).  
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Table 1.2. Evidence of genotoxicity of the chemicals and associated occupations included in the 
systematic literature review. 
  
    
DNA 
adducts DDX DPX 
strand 
breaks mutations SCE MN CA 
bacterial 
mutagenicity 
1,3-butadiene 
Human 
in vitro         + +     
yes in vivo +       +   + - 
Rodent 
in vitro         +       
in vivo + +     +   + + 
4,4’-methylenebis(2-
chlorobenzenamine) 
(MOCA) 
Human 
in vitro         +       
yes in vivo +           +   
Rodent 
in vitro           +     
in vivo +         +     
4-aminobiphenyl 
Human 
in vitro         +       
yes 
in vivo +       +       
Rodent 
in vitro                 
in vivo         +       
Aflatoxins 
Human in vitro         +       
yes 
in vivo +       + + + + 
Rodent in vitro                 
in vivo         +       
Benzene 
Human 
in vitro          -   + 
no 
in vivo       + +     + 
Rodent 
in vitro               + 
in vivo       +   + + + 
Benzidine 
Human 
in vitro             +   
yes 
in vivo +       +     + 
Rodent 
in vitro                 
in vivo +     +         
Benzo[a]pyrene 
Human 
in vitro                 
 in vivo +     + + + + + 
Rodent 
in vitro                 
in vivo +       +       
Coke production 
Human 
in vitro                 
yes 
in vivo       + + + +   
Rodent 
in vitro                 
in vivo +               
Formaldehyde 
Human 
in vitro       +     + + 
yes 
in vivo     + +   + + + 
Rodent in vitro       +     + + 
in vivo +               
Occupational 
exposure as a 
painter 
Human in vitro                 
 
in vivo +     +   + + + 
Rodent 
in vitro                 
in vivo             +   
Sulfur mustard 
Human 
in vitro + +             
yes 
in vivo   +     + +     
Rodent 
in vitro   +     +     + 
in vivo   +     +   + + 
Vinyl Chloride 
Human 
in vitro           +     
yes in vivo +           + + 
Rodent 
in vitro           +     
in vivo +           + + 
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1.2.3. Epigenetic alterations induced by chemicals and associated occupations included 
in the review 
1.2.3.1. DNA methylation 
 DNA methylation refers to the addition of methyl groups from the universal donor S-
adenosyl-L-methionine (SAM) to cytosine residues mediated by DNA methyltransferases 
(DNMTs). This epigenetic modification is an important dynamic regulator of gene expression that 
is essential during various phases of the cell cycle throughout normal developmental stages of all 
organisms (Li and Zhang, 2014). DNA methylation regulates and determines transcription, 
chromatin structure, chromosome integrity, and genomic imprinting (Meng et al., 2015). Aberrant 
DNA methylation can lead to disruption of any or all of these processes and may contribute to 
carcinogenesis. Generally, although not exclusively, hypermethylation of CpG island-containing 
promoter regions of genes (regions rich in CpG dinucleotides) is associated with their respective 
silencing, whereas promoter gene-specific CpG island hypomethylation is linked to gene 
activation, and global hypomethylation is associated with genomic instability (Watanabe and 
Maekawa, 2010; Deaton and Bird, 2011)  
1,3-Butadiene 
 Loss of global DNA methylation was observed in the liver of mice exposed to a relatively 
high concentration (625ppm) of 1,3-butadiene by inhalation for 6 hours per day, 5 days per week 
for two weeks (Koturbash et al., 2011c). This level of global DNA hypomethylation varied across 
7 different strains of mice (NOD/LtJ, CAST/EiJ, A/J, WSB/EiJ, PWK/PhJ, C57BL/6J, and 
129S1/SvImJ), and also varied across target and non-target tissues of 1,3-butadiene-induced 
carcinogenesis (Koturbash et al., 2011b; Chappell et al., 2014a). A loss of methylation within 
repetitive DNA elements was observed in the lung and liver (target tissues of carcinogenesis), but 
not in the kidney (non-target tissue of carcinogenesis) in C57BL/6J mice. These results indicate 
that dysregulation of normal DNA structure is likely associated with the carcinogenic mechanisms 
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of 1,3-butadiene, and that this epigenetic mechanism may be driven by underlying genetic 
differences.    
Aflatoxins  
A majority of studies of the effect of AFB1 exposure investigated gene-specific DNA 
methylation changes. In two studies, Zhang et al. demonstrated inactivation of the human 
RASSF1, MGMT, and p16 genes by hypermethylation in the promoter region of tumor DNA in 
human HCC patients who were exposed to AFB1 (Zhang et al., 2002; Zhang et al., 2003). Further, 
the methylation status of the promoter regions of all three of these genes was significantly 
positively associated with the level of AFB1-DNA adducts in the tumor tissues, and methylation 
of MGMT was associated with TP53 mutation status. Feng, et al. also showed that 
hypermethylation of the RASSF1 gene was associated with AFB1-DNA adducts in human HCC 
tumor tissue (Feng et al., 2012).  A significant association was observed between promoter 
hypermethylation of the glutathione S-transferase pi (GSTP1) gene and the level of AFB1-DNA 
adducts in human HCC tumor tissue, and a marginally significant association was found for 
adjacent non-tumor tissue (Zhang et al., 2005). The level of GSTP1 mRNA was inversely 
associated with promoter hypermethylation in a majority of the tumor samples, and a loss of this 
gene, which encodes a detoxifying enzyme involved in xenobiotic metabolism, may be related to 
the associated DNA damage also observed in the tumors in this study. In addition to site-specific 
gene methylation, global hypomethylation of repetitive DNA elements, a characteristic indicative 
of genomic instability, has also been reported as a result of AFB1 exposure in both HCC and 
cancer-free patients with confirmed AFB1 exposure (Zhang et al., 2012; Wu et al., 2013).   
AFB1 exposure in pregnant women was found to be associated with aberrant DNA 
methylation in blood taken from their infants at 2-8 years of age (Hernandez-Vargas et al., 2015). 
Aflatoxin-associated differential methylation was observed in growth factor genes, including 
FGF12 and IGF1, and immune-related genes, including CCL28, TLR2 and TGFB1I, exemplifying 
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pathologically important epigenetic alterations induced by exposure to a genotoxic chemical at a 
critical developmental stage.  
In mice, at least partial methylation of CpG sites was observed in 43 of 49 (88%) lung 
tumors analyzed for p19Arf promoter hypermethylation, and methylation of transcription factor 
binding sites or consensus sequences was confirmed in 21 tumors (Tam et al., 2003). There was 
a general increase in DNA methylation levels in oocytes collected from high dose mycotoxin-fed 
mice, as well as in a study of porcine oocytes exposed in vitro to AFB1, (Zhu et al., 2014; Liu et 
al., 2015b), which may be causative of decreased developmental competence of oocytes in mice 
that ingest AFB1. A study of rat AFB1-induced liver tumors demonstrated that the gamma-
glutamyl transpeptidase (GGT) gene was hypermethylated in hepatic tumors, but the correlation 
between GGT activity and methylation was not clear (Baik et al., 1991). 
In an in vitro study conducted to assess the role of cytosine methylation on mutation 
spectrum, a TP53 cDNA template and AFB1 were used to examine mutation induction (Chen et 
al., 1998; Chan et al., 2003). The mutation rate of the CpG site after DNA methylation was 
increased, and in a codon-specific manner; for example, in (Chan et al., 2003), mutations at TP53 
codon 156 were increased upon methylation, but not at other codons. This finding suggests that 
not all CpG sites have an equivalent enhancement effect on AFB1 adduct formation upon cytosine 
methylation, and differences in structural sequence contexts surrounding the CpG sites may 
contribute to these differences. 
In contrast to the above-mentioned results, alteration of DNA methylation was not a 
feature of AFB1-induced HCC in rainbow trout (Davie et al., 1987), highlighting species 
differences in the epigenetic effects of AFB1.  
Benzene 
Benzene induced global DNA hypomethylation in human lymphoblastoid TK6 cells at 
various doses. An increase was observed in the level of (PARP-1) promoter methylation, 
accompanied by a decrease in PARP-1 mRNA expression in benzene-treated lymphoblastoid 
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cells (F32 cell line, 10mM benzene for 24 hours) compared to control cells (Gao et al., 2010). In 
contrast, no significant global DNA methylation changes in studies of normal hepatic L02 cells or 
human myeloid HL-60 cells incubated with benzene for 48 hours, although cytotoxicity changes 
in gene expression levels were observed (Nishikawa et al., 2011; Hu et al., 2014). The maximum 
doses in these studies were 50 μM and 5mM, lower than that of the study conducted in TK6 cells, 
which may potentially explain the inconsistent results.  
While the in vitro studies of benzene-induced changes in DNA methylation are conflicting, 
global and repetitive element DNA hypomethylation has been reported in humans exposed to low 
levels of benzene (confirmed by personal air samplers) (Bollati et al., 2007; Fustinoni et al., 2012). 
Further, hypermethylation of the p15 promoter, which likely contributes to deregulation of cell 
proliferation and is associated with acute myelogenous leukemia, was observed in exposed 
individuals. Gene-specific DNA methylation has also been reported in individuals exposed to 
benzene. Three hypermethylated genes with concurrent mRNA down-regulation (PRKG1, 
PARD3, and EPHA8) and two hypomethylated genes with increased mRNA level (STAT3, 
IFNGR1) were identified in benzene poisoning patients (Yang et al., 2014a). Pathway analysis 
and gene ontology term enrichment identified STAT3 as a central player in several enriched 
carcinogenesis-relevant genesets and pathways, including acute myeloid leukemia and the JAK-
STAT cascade. Promoter DNA hypermethylation is the primary mechanism that leads to 
inactivation of the tumor suppressor genes p15 and p16, and promoter hypermethylation of both 
genes was observed in benzene-exposed workers, along with a decrease in the mRNA level (Xing 
et al., 2010). Down-regulation of p15 and p16 was also observed in mouse primary bone marrow 
cells incubated with 1,4-benzoquinone, but promoter methylation of these genes was not different 
between treated and control cells (Tian et al., 2012). A study of pregnant mice revealed that 
benzene exposure induced global hypomethylation, but p15 promoter methylation was 
unchanged in both fetal livers and maternal bone marrow cells (Philbrook and Winn, 2015), 
indicating that this epigenetic response to benzene exposure may be species-specific. In a study 
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using rat bone marrow cells (BMCs) (Gao et al., 2011), genes that control apoptosis (the primary 
mechanism of cytotoxicity induced by benzene) were investigated. Addition of a DNA 
methyltransferase inhibitor to the benzene-exposed cells increased the mRNA levels of Bax and 
Caspase-3 (apoptosis inhibitors), and decreased the level of cell death in benzene-exposed rat 
BMCs. This indicates that benzene-induced cytotoxicity is modulated by epigenetic regulation of 
apoptosis-inhibiting genes. A decrease in the expression of the phosphatase and tensin homolog 
gene (PTEN), a tumor suppressor, and a significant increase of PTEN methylation level was 
observed in rats exposed to benzene and in human lymphoblast cells (F32) incubated with 
benzene (Yang et al., 2014b). Both the decrease in mRNA and the increase in promoter 
methylation were observed in a dose-dependent manner. 
Hydroquinone, one of the most abundant metabolites of benzene, also led to DNA 
hypomethylation in human TK6, HEK293 and L02 cells, and caused an increase in DNA 
methylation levels at several CpG sites in erythroid-specific genes in human K562 cells (Ji et al., 
2010; Coulter et al., 2013; Li et al., 2013; Hu et al., 2014). However, this metabolic intermediate 
is not considered carcinogenic to humans and is “not classifiable as to its carcinogenicity to 
humans” (Group 3) according to IARC.  
Benzidine 
 The only report of epigenetic response after exposure to benzidine was a study of B6C3F1 
mice. The H-ras oncogene was hypomethylated (entire gene) in benzidine-induced liver tumors 
relative that of non-tumor tissue, and an increase in the expression of the gene was also detected. 
The K-ras oncogene was also hypomethylated in half of the mice. These results suggest that 
hypomethylation of oncogenes may provide an epigenetic mechanism for facilitating their aberrant 
expression. The lack of DNA methylated sites observed in the H-ras oncogene in the liver of 
B6C3F1 mice may indicate an increased potential for its expression, which could account for the 
high propensity for hepatoma development in this strain (Vorce and Goodman, 1989). 
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Benzo[a]pyrene 
Studies of DNA methylation and BaP make up the category with the most studies (33) of 
any epigenetic category/chemical combination in our review. The majority of studies on the effects 
of BaP on DNA methylation have been conducted in vitro in both human and rodent cells. BaP 
has been shown to decrease global DNA methylation levels in a dose dependent manner, as 
demonstrated in human 16HBE cells (Huang et al., 2014), oligodeoxyribonucleotides (“naked 
DNA”) (Minero et al., 2012), mouse BALB/3T3 A31 CL1-13 cells (Wilson and Jones, 1983; Wilson 
and Jones, 1984), and calf thymus and mouse liver cells (Wojciechowski and Meehan, 1984). 
This may be explained by the inhibition of enzyme-catalyzed transfer of methyl groups from SAM 
to cytosines, which is potentially caused by BaP-DNA adducts (Wojciechowski and Meehan, 
1984). In contrast, a lack of change in global DNA methylation has also been reported in BaP-
exposed mouse 3T3 (Diala and Hoffman, 1982) and C3H/10T1/2 cells (Wilson and Jones, 1983; 
Yauk et al., 2008), p53-positive and -negative human breast cancer cell lines (Sadikovic and 
Rodenhiser, 2006), and normal human fibroblast cells exposed to BPDE (Tommasi et al., 2010). 
However, sequence-specific hypo- and hyper-methylation was observed in the same p53-positive 
and -negative human breast cancer cell lines, primarily hypomethylation at DNA repetitive 
elements. Other examples of gene-specific aberrant methylation have been reported: human lung 
cells that were exposed to BPDE displayed an increase in DNA methyltransferase proteins 
relative to controls, in tandem with decreased expression of CCH1 and CDH13 genes, among 
others (Damiani et al., 2008). Promoter hypermethylation and reduced expression of the IFNγ 
was observed in Jurkat cells and two human adenocarcinoma cell lines exposed to low, non-
cytotoxic doses (0.1 and 1 nM) of BaP, as well as in cord white blood cells of women who were 
exposed to PAHs during pregnancy (Tang et al., 2012). Hypermethylation of CpG islands within 
the p16INK4α tumor suppressor gene, as well as down-regulation of expression, was observed in 
human bronchial epithelial cells exposed to BaP (Yang et al., 2012). The same trend was 
observed in the peripheral blood of PAH-exposed workers, relative to that of non-exposed control 
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subjects, and the degree of methylation was associated with the internal exposure and the level 
of DNA damage (measured by 1-hydroxypyrene concentrations in the urine and micronucleus 
frequency in the blood, respectively). HeLa cells challenged with BaP displayed DNMT1-mediated 
promoter hypomethylation, which was associated with activation of the long interspersed nuclear 
element 1 (LINE-1) retrotransposon (Teneng et al., 2011). Promoter hypermethylation and 
reduced expression of the dual specificity DUSP22, a gene that interacts with map kinases, was 
observed in Jurkat and normal human prostrate cells exposed to BaP, as well as in blood from 
both new and experienced firefighters (Ouyang et al., 2012). In the same study, IFNγ methylation 
was not altered, in contrast to the study mentioned above. Hypermethylation of the promoter 
region of p16 was evident in BaP-induced primary immortalized Syrian hamster dermal 
fibroblasts, accompanied by an overexpression of the gene (Yasaei et al., 2013). 
 In a study of newborns with potential in utero exposure to BaP, among other PAHs, the 
cord blood samples with detectable BaP-DNA adducts had higher levels of genomic methylation 
relative to the samples without adducts (Herbstman et al., 2012). The authors postulated that this 
hypermethylation may increase BaP-induced DNA damage, because reactive metabolic 
intermediates have been shown to preferentially bind to methylated CpG dinucleotides 
(Tretyakova et al., 2008), with the most data available demonstrating this characteristic in the p53 
gene (Chen et al., 1998; Weisenberger and Romano, 1999; Dong et al., 2004; Satterwhite et al., 
2013). For example, 42% of all G-to-T transversions in the p53 gene (mutations that are common 
in lung cancers in smokers) occurred at methylated CpG sites, as opposed to 23% in un-
methylated DNA (Yoon et al., 2001). The mutational frequency of BPDE-guanine adducts in the 
p53 gene was higher in cases of a methylated cytosine 5’ to the adduct, compared to instances 
of an un-methylated adjacent cytosine (Dong et al., 2004). Relatedly, the methylation of cytosines 
that are flanked by BaP-guanine DNA adducts is inhibited (Subach et al., 2006; Subach et al., 
2007) 
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 In mice administered a single dose of BaP (100 mg/kg), cytosine methylation was reduced 
in the Igf-II gene in tumors (Tao et al., 2002), and methylation of the ras association domain family 
1 (Rassf1a) gene was observed in 30% of skin tumors of mice treated with BaP (Tommasi et al., 
2005). In another study of mice, several functionally important and aberrantly methylated genes 
were down-regulated (Wnt4, Fzd3, Mapk3 (Erk1), Mapk11, Foxd3, and Nanog) (Tommasi et al., 
2014) in the BaP-treated group. Further, Dnmt3a and Dnmt3b were down-regulated in BaP-
treated mice, which may have contributed to the gene-specific aberrant methylation.   
Coke production 
 Studies have shown an association between aberrant DNA methylation patterns and 
exposure to PAHs among coke oven workers (Chao et al., 2008). Promoter methylation of the 
tumor suppressor genes p14ARK and p16INK4 was increased in peripheral blood mononuclear cells, 
along with increased urinary levels of 1-hydroxypyrene (an indicator of exposure to PAHs) in coke 
oven workers relative to water pump workers (Zhang et al., 2015). DNA damage, as evaluated by 
a comet assay, was also significantly higher in the coke oven workers. Studies have reported 
increased methylation of LINE-1 and Alu repetitive DNA elements, and gene-specific 
hypomethylation of the tumor suppressor genes p53 and HIC1 in peripheral blood (Pavanello et 
al., 2009; Pavanello et al., 2010). The changes in DNA methylation of repetitive elements were 
positively correlated with urinary biomarkers of PAH exposure and with BPDE-DNA adducts in 
the blood, while p53 promoter hypomethylation was significantly correlated with micronuclei 
formation. Another study reported LINE-1 hypomethylation, as well as hypomethylation and 
suppression of the DNA methyltransferase gene MGMT in both the blood of coke-oven workers, 
as well as in human bronchial epithelial cells (16HBE) treated with coke oven emissions (Duan et 
al., 2013). The LINE-1 methylation was inversely associated with comet tail length and 
micronucleus frequency (indicators of DNA damage) in the coke oven workers, as well as 
inversely associated with BPDE-DNA adducts in the in vitro assay. These results indicate that 
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increased genomic instability is associated not only with DNA damage caused by PAH exposure, 
but also with demethylation on the global and gene-specific (MGMT) level. 
 
Formaldehyde 
 We identified one study of DNA methylation and formaldehyde, which reported a time-
related decrease in global DNA methylation in human 16HBE cells after 24 weeks of treatment 
with 10 μM of formaldehyde for 24 hr once per week. Formaldehyde exposure also resulted in 
down-regulation of expression of DNMT3a and DNMT3b, and up-regulation of DNMT1 and MBD2 
at both the mRNA and protein level. These results indicate that loss of global DNA methylation, 
an epigenetic alteration associated with genomic instability, after long-term exposure to a low 
dose of formaldehyde may be one of the possible underlying carcinogenic mechanisms of 
formaldehyde (Liu et al., 2011).   
Occupational exposure as a painter 
A study conducted in 150 non-smoking car painters from several workshops in the 
southwest of Colombia found a significant increase in DNA methylation in the promoter region of 
GSTP1 and p16INK4a in exfoliated urothelial cells of exposed workers compared to references, and 
these gene-specific alterations were associated with an increase in micronuclei frequency 
(Hoyos-Giraldo et al., 2015). Because the exact chemical composition of the exposure is not 
reported here, the molecular findings can only be associated to the general category 
“occupational exposure as a painter,” one of the occupational exposures included in the IARC 
monograph volume 100F. 
Sulfur mustard 
 Global DNA methylation was evaluated in sulfur mustard-exposed early endothelial cells, 
as well as in human skin samples obtained from a patient 1 year after an accidental exposure to 
pure sulfur mustard. A global increase of DNA methylation was observed in both the in vitro study 
and in human skin samples, relative to unexposed control samples (Steinritz et al., 2015). 
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Vinyl chloride 
 In a study of angiosarcoma patients, the majority of whom had confirmed chronic 
occupational exposure to vinyl chloride, promoter methylation of p14ARF was confirmed in 5 of 19 
cases (26%), p16INKa showed aberrant promoter methylation in 12 of 19 cases (63%), and 
methylation of the promoter region of both of the tumor suppressor genes was observed in 3 
(16%) cases. Increased promoter methylation correlated with transcriptional down-regulation. The 
aberrant p14ARF methylation occurred independently of p53 mutation, which was detected in 6 of 
19 (32%) cases (Weihrauch et al., 2002). However, p16INKa promoter hypermethylation was 
associated with KRAS mutations in HCC patients who were occupationally exposed to vinyl 
chloride (Weihrauch et al., 2001). 
 
1.2.3.2. Histone modifications 
 Histone modifications occur post-transcriptionally and can affect the accessibility of DNA 
to transcription factors or DNA damaging agents, thus leading to changes in transcription, as well 
as influencing DNA damage and repair. There are several types of histone modifications: 
methylation, acetylation, phosphorylation, sumoylation, and ubiquitination (Weber and Henikoff, 
2014). The histone modifications that have been most commonly reported in chemical exposures 
and associated deleterious phenotypes are methylation and acetylation, with the mechanistic 
features of these alterations dependent on the nature of the change (gain or loss) and the site of 
the histone mark (Langst and Manelyte, 2015). Histone modifications are of particular interest in 
this review because histone dynamics play a role in the toxic potential of the chemicals both by 
influencing transcriptional activity, as well as potentially altering DNA accessibility to damaging 
agents.   
1,3-Butadiene 
Koturbash et al. (Koturbash et al., 2011c) conducted short-term in vivo inhalation studies 
of 1,3-butadiene (BD) in C57BL/6J mice. A loss of trimethylation at histone H3 lysine 9 
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(H3K9me3), histone H3 lysine 27 (H3K27me3), and histone H4 lysine 20 (H4K20me3) was 
observed in a dose-dependent manner in the liver of mice exposed to 1,3-butadiene for 6 hours 
a day, 5 days a week for 2 weeks. Loss of these histone marks markedly impairs chromatin 
structure, diminishes cellular maintenance and regulation of the cell cycle, disrupts the balance 
between cell proliferation and differentiation, and severely reduces cell viability (Rea et al., 2000; 
Yang and Mizzen, 2009). These 1,3-butadiene-induced histone modifications in the liver have 
also been shown to vary across several inbred mouse strains, as well as in target and non-target 
tissues of carcinogenesis (Koturbash et al., 2011b; Chappell et al., 2014a). Interestingly, an 
increase in H3K9me3, H3K27me3, and H4K20me3 was observed in the kidney, a non-target 
tissue of carcinogenesis, in C57BL/6J mice that were subjected to short-term exposure to 1,3-
butadiene. This epigenetic response may exert a protective effect, minimizing the damage caused 
by 1,3-butadiene by condensing chromatin. Interestingly, these same histone marks were 
increased in CAST/EiJ mice, which had the lowest abundance of 1,3-butadiene-DNA adducts. A 
decrease in acetylation of histones H3K56 and H4K16 in the lungs of 1,3-butadiene-exposed mice 
was observed, suggesting a critical role of H3K56ac and H4K16ac in 1,3-butadiene-induced lung 
tumorigenesis. Specifically, reduction of histone H3K56ac and H4K16ac may compromise the 
proper repair of 1,3-butadiene-induced DNA lesions (Masumoto et al., 2005; Taipale et al., 2005). 
H3K27 acetylation, an indicator of transcriptionally active (relaxed) chromatin (Szulwach et al., 
2011), was significantly increased in the liver of 1,3-butadiene-exposed mice.  
4-aminobiphenyl 
Histone H3K4 mono-methylation, which was not altered by BaP treatment alone (5µM for 
48 hours) of normal human mammary epithelial cells, was decreased when cells were treated 
with a combination of BaP, 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2-amino-1-methyl-6-
phenylimidazo[4,5b]pyridine, and 4-aminobiphenyl (Bradley et al., 2007). However, H3K4 mono-
methylation, a mark whose function is not well understood, was decreased in the human 
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mammary epithelial cells treated with 4-aminobyphenyl alone (also 5µM for 48 hours), suggesting 
that this histone modification is carcinogen-specific.  
4,4'-methylene-bis(2-chloroaniline) 
 Only one article was identified as having investigated epigenetic alterations in a study of 
4,4'-methylene-bis(2-chloroaniline) (MOCA). That study investigated histone modifications after 
exposure to MOCA, and the authors found that rat spleen cells incubated with 10 mM MOCA 
increased phosphorylation in the histone fraction of the cells after 4 hours of exposure (DeBord 
et al., 1995).  
Aflatoxins 
The levels of H3K9me3 and H4K20me3 (marks of transcriptional activation) were 
increased in oocytes from mycotoxin-fed mice, while H3K27me3 and H4K20me2 (marks of 
transcriptional repression and activation, respectively) were decreased. These alterations were 
observed along with increased global DNA hypermethylation, and may play a role in decreased 
developmental competence of oocytes in mice that ingest AFB1, although the mechanisms are 
not clear (Zhu et al., 2014). Similarly, in a study of porcine oocytes exposed in vitro to AFB1, 
H3K27me3 and H3K4me2 levels decreased, whereas the level of H3K9me3 increased (Liu et al., 
2015b).  
Benzene  
Reduced histone H4 and H3 acetylation and H3K4 methylation, and increased H3K9 
methylation were observed in the promoter region of topoisomerase IIα (Topo IIα) in patients with 
benzene exposure (Yu et al., 2011). These changes accompanied decreased Topo IIα activity, 
expression, and mRNA level assessed by DNA cleavage/relaxation assay, western blot, and 
reverse transcriptase-PCR, respectively. These findings demonstrate the involvement of histone 
modifications in the decrease of Topo IIα, a mechanism that is implicated in benzene-induced 
hemotoxicity. In the same study mentioned above (section B.3.a) that exposed rat BMCs to 
benzene (Gao et al., 2011), the inhibition of histone deacetylation and apoptosis was also 
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investigated. Inhibition of histone deacetylation increased the mRNA level of Bcl-2, an apoptosis 
inhibitor, in benzene-exposed rat BMCs, indicating that histone modification is also a mechanism 
of benzene-induced cytotoxicity. In contrast, no changes in the acetylation of histones H3, H4, 
and H3K56, nor methylation of histones H3K9 and H3K27 were observed in a study of pregnant 
mice dosed with 200 mg/kg benzene on gestational days 8, 10, 12, and 14 relative to control mice, 
in either maternal bone marrow cells or fetal livers (Philbrook and Winn, 2015). 
Benzo[a]pyrene 
 In the same study mentioned above that reported promoter hypomethylation and 
activation of LINE1 repetitive elements in BaP-exposed HeLa cells, H3K4me3 and H3K9ac, both 
marks of transcriptional activation, were also increased (Teneng et al., 2011). Together, these 
findings are suggestive of a cascade of epigenetic events that lead to reactivation of the LINE-1 
retrotransposon. 
Treatment of MCF7 breast cancer cells resulted in a global increase in acetylation of 
H3K9, and a positive correlation was identified between gene expression and gene-specific H3K9 
hyperacetylation (Sadikovic et al., 2008). Additionally, genes involved in the organization and 
remodeling of chromatin were identified among genetic pathways that were responsive to the BaP 
treatment. H3K4me2 was decreased in the promoter region of the estrogen receptor α gene (ER) 
in both a human breast cancer cell line exposed to BaP, as well as in liver tissue from mice 
exposed to BaP (Khanal et al., 2015). This histone modification, which is likely mediated by 
depletion of the orphan nuclear receptor NR2E3, causes down-regulation of ER, which is 
associated with increased BaP-induced oxidative injury. 
An increase in acetylation of H3K9 and H3K14 and trimethylation of H3K4, all marks of 
transcriptional activation, was observed in the promoter region of Cyp1a1, an aryl hydrocarbon 
hydroxylase that is highly involved in drug and xenobiotic metabolism, in BaP-exposed mouse 
hepatoma Hepa-1 cells (Schnekenburger et al., 2007; Ovesen et al., 2011). These histone 
modifications accompanied up-regulation of Cyp1a1 mRNA.  
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 In a study of neonatal rats administered BaP, the extent of acetylation of H3K14 and 
mRNA expression of steroidogenic acute regulatory protein (StAR) were both decreased several 
weeks after administration of BaP (Liang et al., 2012). This finding correlated with a decrease in 
sperm count and serum testosterone levels, and all changes persisted into adulthood.  
It has also been shown that BPDE-damaged DNA has more stable nucleosomes, which 
may interfere with nucleotide excision repair, thus leading to an increase in mutation rate (Mann 
et al., 1997).  
Formaldehyde 
In a study of human pulmonary epithelial cells, histone H3 was more highly 
phosphorylated at serine 10 and 28 after exposure to formaldehyde compared with normal human 
lung fibroblasts (Ibuki et al., 2014; Yoshida and Ibuki, 2014), particularly within the promoter 
region of the proto-oncogenes FBJ murine osteosarcoma viral oncogene homolog (FOS) and jun 
proto-oncogene (JUN), indicating a relationship between formaldehyde-inducted tumorigenesis 
and H3S10 and H3S28 phosphorylation. Another study demonstrated that binding of 
formaldehyde to lysine residues on histone 4 only occurred in the absence of post-translational 
modifications of histone 4, indicating that the balance between histone acetylation and 
deacetylation could be disturbed by the attachment of formaldehyde on lysine residues (Lu et al., 
2008). This is in contrast to a study that demonstrated no difference in the binding of BaP to 
acetylated or non-acetylated histone lysine residues (Kootstra, 1982). 
 
1.2.3.3. Non-coding RNA 
It is estimated that 66% of the genome is transcribed into non-coding RNAs (Meseure et 
al., 2015), which include any RNA molecule that is not translated into a protein. Long non-coding 
RNAs (lncRNAs) and microRNAs (miRNAs), two types of non-coding RNAs, have various 
mechanisms of post-transcriptional regulation, including direct binding to RNA, recruitment of 
chromatin modifying enzymes to target genes, and bringing together proteins to form 
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ribonucleoprotein complexes. Non-coding RNAs have been shown to  be involved in cancer 
initiation and progression, and have been reported to be dysregulated by exposure to toxic 
chemicals (Meseure et al., 2015). A vast majority (48/54, 89%) of all studies of non-coding RNAs 
in the literature included in this review reported alterations in miRNAs, a pattern that is largely 
representative of research reported on non-coding RNAs in general, in toxicological studies as 
well as in various disease and phenotypic classes. MiRNAs are short (19-25 nts) non-coding 
RNAs that regulate gene expression by binding to the 3’ untranslated region of the gene, or by 
inducing RNA degradation, with both actions inhibiting the translation of the gene (Garzon et al., 
2006). The regulatory action of miRNAs has been implicated in many human cancers, and miRNA 
expression has also been shown to be altered by exposure to environmental chemicals (Lema 
and Cunningham, 2010; Berindan-Neagoe et al., 2014).   
Aflatoxins 
In a comprehensive study of the miRNome in mouse primary hepatocytes exposed to a 
panel of both genotoxic and non-genotoxic chemicals, miRNA-mRNA interactions were identified 
for AFB1 (miR-301b-3p and Papss2), which was also found to be involved in cell cycle arrest and 
the impairment of repair mechanisms of DNA damage (Rieswijk et al., 2015). Liu et al (Liu et al., 
2015a) observed dysregulation of several miRNAs in the liver of rats that were exposed to AFB1 
for four weeks, with upregulated miR-34a-5p facilitating p53-mediated DNA damage repair. The 
level of miR34a-5p was increased in the circulating blood of the rats, preceding any significant 
increase in alanine transaminase activity (a common indicator of liver damage); thus, miR-34a-
5p may represent a sensitive biomarker of AFB1-induced DNA damage in the liver. Another study 
of rats with AFB1-induced liver cancer also reported up-regulation of miR-34a, as well a loss of 
members of the miR-17-92 cluster in tumors (Yang et al., 2014d). Members of the miR-17-92 
family, as well as miR-34a, play a tumor-suppressor role, and the loss of miR-17-92 family 
members provides insight into the underlying epigenetic mechanisms of AFB1-induced HCC.  
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Up-regulation of miR-429, which inhibits apoptosis and induces progression of tumor cell 
growth, was observed in human liver tumors in HCC patients that were confirmed to be exposed 
to AFB1, and was significantly correlated with high levels of AFB1-DNA adducts (Huang et al., 
2013). The same research group found that miR-24 was upregulated in liver tumors from patients 
who resided in regions with high AFB1 exposure (Liu et al., 2014). Further, in a large case-control 
hospital study in China that investigated polymorphisms in pre-miRNAs as potential risk and 
prognostic biomarkers of AFB1-related HCC, rs28599926 in miR-1268a was identified as one 
such candidate (Long et al., 2015).  
Additionally, the H19 gene, which encodes a lncRNA, was up-regulated in human HepG2 
cells treated with AFB1 (Lv et al., 2014). This overexpression promoted cell cycle progression in 
an E2F transcription factor 1 (E2F1)-dependent manner. 
4-aminobiphenyl 
In an in vitro study using human HepG2 cells exposed to 4-aminobiphenyl as a model of 
DNA damage, the expression of 27 miRNAs was at least 3-fold higher in the 4-ABP-treated cells 
relative to the control group. Additionally, 16 DNA repair-related genes were down-regulation in 
4-aminobiphenyl-treated cells. miRNA-513a-5p and miRNA-630 were predicted to be implicated 
in the deregulation of Fanconi Anemia, Complementation Group G (FANCG) and RAD18 E3 
Ubiquitin Protein Ligase (RAD18) genes, respectively, which are both involved in DNA damage 
repair. Overexpression and knockdown of miRNA-513a-5p and miRNA-630 reduced and 
increased the expression of FANCG and RAD18 proteins, respectively. The authors concluded 
that miRNA-513a-5p and miRNA-630 may have an inhibitory effect on DNA repair genes, 
ultimately leading to DNA damage (Huan et al., 2014). 
Benzene  
A total of 6 miRNAs were up-regulated (miR-34a, miR-205, miR-10b, let-7d, miR-185 and 
miR-423-2-5p) and 7 down-regulated (miR-133a, miR-543, miR-130a, miR-27b, miR-223, miR-
142-5p and miR-320b) in the blood of individuals with chronic benzene poisoning compared to 
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healthy controls (Bai et al., 2014a). An association between benzene and aberrant miRNA 
expression was also reported in a non-occupational setting: miR-223 expression in pregnant 
women and indoor dwelling concentrations of benzene and toluene (smoking-related volatile 
organic compounds) were positively associated and appeared to decrease the number of 
regulatory T-cells in maternal and cord blood (Herberth et al., 2014). Additionally, in a study of 
benzene-exposed workers, the expression of two lncRNAs (NR_045623 and NR_028291) was 
higher in the blood of exposed workers relative to controls (Bai et al., 2014b). These lncRNAs and 
their associated mRNAs are involved in immune response, hematopoiesis, B cell receptor 
signaling and chronic myeloid leukemia gene networks, suggesting their association with 
benzene-induced hemotoxicity. 
Benzo[a]pyrene  
 miR-29a was identified to have tumor-suppressor activity in human cells exposed to 
BPDE, by targeting Cdc7 kinase and sensitizing cells to BPDE, and thus presumably diminishing 
the accumulation of cells with DNA damage (Barkley and Santocanale, 2013). miR-29b-3p was 
also identified among BaP-mediated alterations and subsequent miRNA-mRNA interactions in 
mouse primary hepatocytes (miR-29b-3p and Col4a2, mmu-miR-24-3p and Flna), which were 
also found to be involved in cell cycle arrest and the impairment of repair mechanisms of DNA 
damage (Rieswijk et al., 2015). miR-181a-1-3p was overexpressed in HEPG cells treated with 
BaP over several timepoints. This miRNA targets the MGMT gene, which encodes a DNA repair 
enzyme, and which was decreased at the mRNA level in the same BaP-exposed cells (Caiment 
et al., 2015). BaP decreased miR-892a in human breast adenocarcinoma MCF7 cells. miR-892a 
targets CYP1A1, a gene that is induced by BaP, and repression of CYP1A1 by miR-892a 
mediated the loss of cell viability caused by BaP exposure (Choi et al., 2012). In a study using 
the human multiple myeloma cell line MM1.s, BaP exposure resulted in the upregulation of 27 
miRNAs, 7 of which (miR-25, miR-15a, miR-16, miR-92, miR-125b, miR-141, and miR-200a) have 
been reported to repress the p53 tumor suppressor gene (Gordon et al., 2015). miR-34c is also 
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associated with p53 expression, although the relationship is characterized by a positive feedback 
loop. miR-34c was increased in a correlated manner with phosphorylated p53 in human bronchial 
epithelial cells treated with BaP, and the up-regulation of miR-34c prevented BaP-induced 
malignant transformation (Han et al., 2014). miR-622 and miR-506 displayed tumor-suppressor 
properties in anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide transformed human bronchial 
epithelial cells by suppressing K-ras (protein) and N-ras (both protein and mRNA) expression, in 
the same cells (Zhao et al., 2011; Han et al., 2012). In contrast, miRs-106a, -638, -494 and -22 
were all increased and were all identified as having oncogenic properties in another experiment 
using anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide transformed human bronchial epithelial 
cells. Both miR-22 and miR-494 target the tumor suppressor PTEN, and the increase in the 
abundance of these two miRNAs was accompanied by a decrease in PTEN protein level (with no 
effect on PTEN mRNA) in the transformed cells (Liu et al., 2010a; Liu et al., 2010b). miR-106a 
inhibited the suppression of cell proliferation and cell cycle arrest and apoptosis, and promoted 
tumor growth in transfected nude mice (Li et al., 2012). miR-638 was increased both in human 
bronchial epithelial cells expressing an oncogenic H-Ras allele, and in peripheral lymphocytes 
collected from 86 workers who were exposed to PAHs (Li et al., 2012). The overexpression of 
miR-638 aggravated BaP-induced cell DNA damage, which may be the result of the associated 
suppression of the breast cancer 1 (BRCA1) gene, a target of miR-638. miR-146a was 
significantly down-regulated in a dose-dependent manner in an immortalized human placental 
cell line exposed to both nicotine and BaP, as well as in placenta samples of women who smoked 
during their pregnancy (Maccani et al., 2010).  
Three studies reported alterations in lncRNAs as a consequence of BaP exposure. 
Silencing of lncRNA-DQ786227 expression in BaP-treated human bronchial BEAS-2B cells 
inhibited cell proliferation and colony formation, and increased apoptosis. These findings were 
corroborated by the dramatic promotion of the ability of BEAS-2B-T cells to form colonies in vitro, 
and of tumor development in nude mice induced by expression of lncRNA-DQ786227 (Gao et al., 
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2013). Similarly, silencing of the lncRNAs AF118081 and LOC728228 inhibited cell growth and 
tumor invasion in BaP-treated human 16HBE cells, and downregulation of AF118081 clearly 
suppressed tumor growth in nude mice (Yang et al., 2014c; Hu et al., 2015). These three lncRNAs, 
thus, can be considered as having an oncogenic role in BaP-associated lung cancer. 
Coke production 
miRNA profiling was conducted in coke oven workers (Deng et al., 2014), and the 
association between differentially expressed miRNAs and PAH exposure, using urinary 
metabolites of PAHs as the metric of exposure, as well as DNA damage, using micronuclei 
frequency and BPDE-albumin adduct levels in the plasma and blood, respectively, was evaluated. 
Five significantly differentially expressed miRNAs that were associated with heightened levels of 
urinary PAHs and/or plasma benzo[a]pyrene-r-7,t-8,c-10-tetrahydrotetrol-albumin were identified: 
miR-24-3p, miR-27a-3p, and miR-142-5p, miR-28-5p (all down-regulated), and miR-150-5p (up-
regulated). The dysregulation of all 5 of these miRNAs was associated with increased micronuclei 
frequency. 
Formaldehyde  
miRNAs have been demonstrated to be dysregulated upon in vitro exposure to 
formaldehyde in human lung epithelial A549 cells (Rager et al., 2011), and in the olfactory bulb 
(Li et al., 2015) of mice, nasal epithelium cells of non-human primates (macaques) (Rager et al., 
2013), and in the nose and WBCs of rats (Rager et al., 2014) exposed in vivo to formaldehyde by 
inhalation. The five most differentially expressed miRNAs in the human lung cells were miR-33, 
miR-450, miR-330, miR-181a, and miR-10b (all down-regulated). The predicted mRNA targets of 
these miRNAs are associated with inflammatory response pathways; specifically, the IL-8 
pathway. An up-regulation of cytokine release in formaldehyde-exposed cells confirmed the 
involvement of miRNA expression on formaldehyde-induced inflammatory response (Rager et al., 
2011). In regard to cross-species formaldehyde-induced changes in miRNA expression, let-7a, 
let-7c, let-7f, miR-10b, miR-126, miR-21, and miR-23a were all significantly decreased in both the 
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study using human lung cells and the study of the nose of rats exposed to formaldehyde. The 
expression change in miRNAs in the blood of rats exposed to formaldehyde was calculated to 
only account for 7-35% of the alterations in transcription, and the differentially expressed miRNAs 
were postulated to be related to increased expression of inflammatory response genes in 
formaldehyde-exposed rats (Rager et al., 2014). The expression of 13 miRNAs was significantly 
dysregulated in macaques exposed to formaldehyde, with miR-125b and miR-152 being the most 
increased in expression and miR-145 and miR-142-3p being the most decreased. An up-
regulation in the expression of integrin-linked kinase-associated genes that are targets of miR-
142-3p was observed, as was a down-regulation of apoptosis-related gene targets of miR-125b, 
demonstrating the mechanistic involvement of these miRNAs in the formaldehyde-induced 
cellular disease state (Rager et al., 2013). In the olfactory bulb of mice exposed to formaldehyde 
by inhalation, the alterations in miRNA expression were more profound after 1 day of exposure 
for 6 hours relative to 7 days of 6 hours/day of exposure. The most differentially expressed 
miRNAs (after 1 day of exposure) were miR-144-5p, miR-199b-5p, miR-200-5p, and 146b-5p (Li 
et al., 2015). Functional annotation analysis of the predicted targets of all 18 miRNAs that were 
differentially expressed after exposure to formaldehyde for 1 day demonstrated enrichment for 
cancer and transcriptional regulation pathways.   
Sulfur mustard 
 One of the studies on sulfur mustard was a human in vitro study of miRNA expression 
using normal human epidermal keratinocytes, which reported dysregulation of metabolic activity, 
proliferation and keratin-1 expression as a result of up-regulation of miR-203 and miR-210 (Deppe 
et al., 2015). These two miRNAs were selected for study based on their impact on proliferation 
and differentiation in epidermal cells (miR-203) and involvement in the control of cell proliferation 
and induction by oxygen depletion in keratinocytes (miR-210). In mouse early endothelial cells 
incubated with various sub-lethal concentrations of sulfur mustard, a total of 66 miRNAs were 
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significantly differentially expressed compared to control cultures (Schmidt et al., 2015). Of those, 
up-regulation of miR-92a-3p had the strongest correlation with sulfur mustard concentration. 
In a mouse study using a VOC mixture that included formaldehyde, benzene, toluene, and 
xylene, Wang et al identified miR-1187, miR-125a-3p, miR-125b-5p miR-466c-5p miR-5105 and 
miR-3472 as the six most significantly differentially expressed miRNAs (all up-regulated except 
for miR-125b-5p) among the 69 that were found to be altered in the lung after exposure for 2 
weeks at 2 h/day 5 days/week (Wang et al., 2014). While this study is certainly informative for 
assessment of VOC exposure, we cannot delineate the significance of these miRNAs for any 
particular constituent of the mixture.  
The wide range of different miRNAs found to be differentially expressed is not surprising, 
because miRNAs are known to be tissue- and disease-specific. This also may be representative 
of the stage of current knowledge and available information regarding disease, exposure, and 
miRNAs; as more studies are conducted, consensus of “oncomiRs” and tumor suppressor 
miRNAs will likely come to light. It is notable here that miR-10b, miR-24, 125a, 125b, miR-92, and 
miR-142 were identified among the studies included in this review as some of the top-most 
differentially expressed microRNAs after exposure to at least 3 different chemicals, strengthening 
their characterization as cancer- and chemical exposure-relevant miRNAs.  
1.2.3.4. Summary  
In conclusion, there is an apparent need for additional studies of epigenetic alterations 
induced by environmental and occupational exposure to chemical carcinogens. Notably, 5 (50%) 
of the 12 chemicals (and occupational hazard) reviewed in this present study had a maximum of 
two reports of epigenetic alterations (Table 1.3). Given the state of our current scientific 
understanding of the epigenome, an epigenetic alteration cannot alone be contextualized as 
adverse in the absence of a pertinent and associated phenotype. To gain a more comprehensive 
understanding of adverse health outcomes that could be causally linked to epigenetic changes, 
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further research is needed in this area, ideally including apical end-points, functional metrics, and 
full dose-response characterization (Alyea et al., 2012; Ray et al., 2014).   
Table 1.3. Number of publications concerning epigenetics for each chemical included in the 
systematic literature review. 
 
 
 
A major challenge in the application of these epigenetic findings in regulatory sciences is 
the question of “how” to effectively include the findings. Because the functional roles of epigenetic 
mechanisms are not as extensively characterized as those of genetics, there is a lack of any static 
central dogma in regard to causality of epigenetic alterations. For example, for several years, 
there was a general consensus that genes were silenced by DNA hypermethylation in the 
promoter region (Baylin, 2005). This concept has more recently been shown to not always be 
true. There is currently not as definitive a connection from any particular epigenetic alteration to 
cancer as there currently is between genotoxicity to cancer. However, as highlighted in this 
review, some studies have indicated that epigenetic marks were more specific to tissue targets of 
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carcinogenicity than were genotoxicity endpoints (Chappell et al., 2014a; Chappell et al., 2014b), 
or were detectable before other common markers of toxicity (Liu et al., 2015a). Further, to fully 
understand the importance of epigenetic and epigenomic responses to environmental stressors, 
studies that investigate and compare both epigenetic data with functional measures (such as gene 
and protein expression) and within the same study and controlled exposure scenario are needed 
(Ray et al., 2014). 
To address this need, we conducted experiments to investigate epigenetic alterations in 
mouse models of genotoxic damage, the results of which are presented herein. We aimed to 
contribute to a better understanding of the relationship between environmental exposure-induced 
DNA damage and epigenetic events, and their respective roles in transcriptional response, toxicity 
phenotypes, and ultimate disease state. Epigenetic reprogramming is a major component of 
“genome instability,” an enabling “hallmark” of cancer cells (Hanahan and Weinberg, 2011), and 
the epigenetic state of cells is altered by many chemical carcinogens (Barrett, 1993). The 
temporal relationship of such epigenetic mechanisms and carcinogenesis is not fully understood, 
and study of both cancerous and pre-cancerous tissues is necessary to characterize the 
relevance and interaction of such mechanisms. It has also been postulated that DNA damage 
gives rise to epigenetic changes, with changes in chromatin state associated with transcription, 
DNA replication, and repair in chemically-induced DNA damage (Zhu and Wani, 2010; Khobta 
and Epe, 2012). Post-repair chromatin restoration (condensation) at sites of DNA damage has 
been demonstrated to spread over several Kb from sites of damage, capable of silencing proximal 
genes (Shanbhag et al., 2010). Additionally, mutation rates in cancer genomes have been related 
with chromatin organization, as evidenced by the correlation between variation in mutation rate 
and H3K9me3 (a histone modification associated with chromatin condensation) levels (Schuster-
Bockler and Lehner, 2012). Recent work conducted by members of our research group have 
shown that the classic genotoxic chemical 1,3-butadiene caused epigenetic alterations in addition 
to DNA damage (Koturbash et al., 2011c). The same group also demonstrated variation in 
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response to 1,3-butadiene using a multi-strain mouse model, and further demonstrated that 
differential chromatin remodeling response to 1,3-butadiene was correlated with the inter-strain 
differences in DNA damage (Koturbash et al., 2011b). Specifically, a higher prevalence of DNA 
adducts was seen in strains that had a loss of histone modifications indicative of condensed 
chromatin, after exposure to 1,3-butadiene. The opposite effect was also true (less DNA damage 
accompanied by an increase in heterochromatin-associated histone modifications). These 
findings provide evidence of the involvement of epigenetic alterations in an in vivo study of 
exposure to a known genotoxic chemical, and support the initiative of further study of the 
relationship between gene regulation by epigenetic alterations and other toxicity pathways, 
including DNA damage and repair.   
 
1.3. Filling in data gaps: studies of epigenetic alterations in complex disease phenotypes 
in mice exposed to genotoxic chemicals 
Three specific aims were created to investigate the involvement of epigenomic and 
epigenetic alterations in complex disease phenotypes induced by environmental exposure to toxic 
substances, and to address the central hypothesis that epigenetic alterations occur in a tissue- 
and/or disease state-specific manner as a result of exposure to known genotoxic chemical 
carcinogens. 
Aim 1: To investigate the role of epigenetic alterations, as well as genotoxic damage, in 
hepatocellular carcinoma (HCC) using a mouse model designed specifically to emulate 
the most common human HCC phenotype.  The molecular mechanisms leading to the 
development of HCC are complex and include both genetic and epigenetic events. To 
determine the relative contribution of these alterations in liver tumorigenesis, we evaluated 
epigenetic modifications at both the global and the gene specific level, as well as the mutational 
profile of genes commonly altered in liver tumors using a mouse model of fibrosis-associated 
liver cancer designed to emulate cirrhotic liver (Uehara et al., 2013), a prevailing disease state 
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observed in most humans with HCC (Fattovich et al., 2004; Farazi and DePinho, 2006). We 
characterized underlying molecular signatures associated with the greater-than-additive 
increase in tumor incidence that was previously observed in this mouse model of co-morbidity 
and HCC.  We hypothesized that a correlation exists between the increased tumor incidence in 
mice treated with genotoxic and pro-fibrogenic agents and epigenetic alterations, relative to 
mice treated with only one of the chemicals. 
Aim 2: To characterize the tissue specificity of epigenetic alterations and DNA damage that 
result from exposure to the genotoxic chemical 1,3-butadiene (1,3-butadiene).  1,3-
butadiene, a known human carcinogen, poses an occupational health hazard to humans due to 
its use in the synthesis of plastics and rubber (White, 2007). 1,3-butadiene is also an 
environmental pollutant because it is present in automobile exhaust and cigarette smoke (Hecht, 
1999). Although genotoxicity is an established mechanism of the carcinogenicity of 1,3-butadiene, 
epigenetic alterations have also been observed in the liver of mice exposed to 1,3-butadiene by 
inhalation (Koturbash et al., 2011b; Koturbash et al., 2011c). Further, epigenetic reprogramming 
has been proposed as an integral part of the “genome instability” enabling characteristic of cancer 
cells. Based on these findings, we aim to characterize the diverse molecular mechanisms of 1,3-
butadiene-induced tumorigenicity by evaluating both genotoxic and “epigenotoxic” effects of 1,3-
butadiene exposure in mouse tissues that are targets (lung and liver) and non-targets (kidney) of 
1,3-butadiene-induced tumorigenesis. While extensive DNA damage has been observed in the 
liver, lungs, and kidneys of mice chronically exposed to 1,3-butadiene (Goggin et al., 2009; 
Goggin et al., 2011; Swenberg et al., 2011), only the lung and liver develop tumors.  We 
hypothesized that tissue-specific epigenetic alterations may explain, at least in part, the 
differential tissue susceptibility to 1,3-butadiene-induced tumorigenesis in mice.  
Aim 3: To understand the relationship between alterations in epigenetic regulatory 
elements and transcriptional responses as a consequence of exposure to the genotoxic 
agent 1,3-butadiene. Aim 3 expanded on the findings of Aim 2 by examining mouse strain-and 
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tissue-specific transcriptional responses to 1,3-butadiene, as well as alterations to epigenetic 
regulators of gene expression. In this aim, a strain known to be susceptible to DNA damage and 
global changes to the epigenome (C57BL/6J), and a strain that has been shown to be resistant 
to the same 1,3-butadiene-responses (CAST/EiJ) (Koturbash et al., 2011b) were used to address 
the hypothesis that 1,3-butadiene-induced alterations in mRNA and miRNA vary across strains 
and tissues, and that differentially expressed miRNAs modulate the 1,3-butadiene-induced 
changes in gene expression. Measurement of differentially expressed genes and functional 
annotation enabled the identification and evaluation of genetic pathways involved in the toxicity 
of the classic genotoxic agent 1,3-butadiene. We also evaluated changes in the expression of 
microRNAs and their potential association with differential gene expression in response to 1,3-
butadiene. Alterations in miRNA expression have been implicated in many human cancers, and 
have also been shown to be influenced by exposure to toxic substances (Lema and Cunningham, 
2010; Berindan-Neagoe et al., 2014).   
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CHAPTER 2: GENETIC AND EPIGENETIC CHANGES IN FIBROSIS-ASSOCIATED 
HEPATOCARCINOGENESIS IN MICE1 
 
2.1. Introduction 
Hepatocellular carcinoma (HCC) is one of the most prevalent, life-threatening human 
cancers (Center and Jemal, 2011).  While the overall cancer incidence and death rates are 
steadily declining from their peak in 1991 (AACR Cancer Progress Report Writing Committee et 
al., 2013), the incidence of HCC continues to increase (Center and Jemal, 2011; AACR Cancer 
Progress Report Writing Committee et al., 2013).  The development and progression of HCC is a 
multistep process characterized by the progressive, sequential evolution of morphologically 
distinct pre-neoplastic lesions (formed as a result of chronic liver injury, inflammation, 
hepatocellular degeneration and necrosis, hepatocellular regeneration and small cell dysplasia, 
followed by the appearance of low- and high-grade dysplastic nodules), which eventually 
culminates in the formation of HCC (Farazi and DePinho, 2006; Aravalli et al., 2013).  In humans, 
70-90% of HCC cases are associated with advanced liver fibrosis or cirrhosis (Farazi and 
DePinho, 2006).  HCC most often arises in the presence of chronic liver inflammation and 
fibrosis/cirrhosis that may result from disturbances in metabolism, toxic insults, or viral infection 
(Fattovich et al., 2004). 
While the histopathologic features of HCC and underlying liver diseases are well 
established, the molecular mechanisms of the cancer-promoting effects of the main etiological
                                                 
1 This chapter was published in the International Journal of Cancer in 2014 (Chappell, Grace, Kristy 
Kutanzi, Takeki Uehara, Volodymyr Tryndyak, Hue‐Hua Hong, Mark Hoenerhoff, Frederick A. Beland, 
Ivan Rusyn, and Igor P. Pogribny. "Genetic and epigenetic changes in fibrosis‐associated 
hepatocarcinogenesis in mice." International Journal of Cancer 134, no. 12 (2014): 2778-2788). 
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factors, including cirrhosis, are not well understood (Zucman-Rossi, 2010; Aravalli et al., 2013).  
Elucidating the molecular mechanisms underlying the pathogenesis and progression of HCC is 
critical for prevention of this disease and development of effective therapies (Forner et al., 2012). 
Investigation of these mechanisms using human HCC samples is desirable; however, few 
epidemiological studies have established both the causality and molecular underpinnings of the 
disease. Animal models that resemble human HCC development may provide important 
additional clues regarding the molecular sequelae of etiological factors linked to HCC (Heindryckx 
et al., 2009). A commonly used mouse liver cancer model is a single low dose injection of the 
genotoxic carcinogen N-nitrosodiethylamine (DEN) into 14-day-old male mice (Vesselinovitch and 
Mihailovich, 1983). In addition, repeat dosing of the pro-fibrogenic agent carbon tetrachloride 
(CCl4) also results in development of HCC (Fujii et al., 2010).  To model key pathophysiological 
events of human cirrhosis-associated hepatocarcinogenesis, we used a combination of 
genotoxic, e.g., DEN, and non-genotoxic, e.g., CCl4, insults to study the mechanisms of the 
development of fibrosis-promoted HCC In mice (Uehara et al., 2013).  The incidence of liver 
adenomas and carcinomas was more than two-fold greater in mice treated with DEN+CCl4 as 
compared to that in mice treated with each agent alone (Uehara et al., 2013). 
The development of HCC is driven by the accumulation of genetic and epigenetic 
alterations (Nault and Zucman-Rossi, 2011; Hoenerhoff et al., 2013; Pogribny and Rusyn, 2014); 
however, a comparative analysis of the relative contribution of these aberrations is typically not 
performed in individual studies. The goal of the present study was to investigate the mechanistic 
roles and contribution of genetic and epigenetic events in fibrosis-associated liver carcinogenesis 
in mice.  We hypothesized that distinct differences in such alterations exist in the liver tissue of 
animals with fibrosis-associated cancer in comparison to liver tissue of vehicle-control animals. 
Such alterations may explain, in part, the increased incidence of hepatic tumors in fibrotic liver in 
this mouse model, and provide insight into the molecular characteristics of human HCC. 
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2.2. Materials and Methods 
Animals, treatment, and tissue preparation 
The in-life portion of this study, mouse treatments, tissue collection protocols, and the 
incidence of neoplastic liver lesions are detailed in Uehara et al. (Uehara et al., 2013).  Briefly, 
male B6C3F1/J mice were allocated randomly to one control and three experimental groups.  At 
two weeks of age, mice from two of the experimental groups were injected i.p. with DEN (1 mg/kg) 
in sterile phosphate buffered saline (PBS; 15 ml/kg).  Mice from the control group and the 
remaining experimental group were injected with sterile PBS only.  At eight weeks of age, mice 
from the control and the DEN-treated groups were injected i.p. two times per week with sterile 
olive oil (15 ml/kg).  Mice from the remaining two experimental groups were injected i.p. two times 
per week with CCl4 (0.2 ml/kg) diluted in sterile olive oil for an additional 14 weeks.  In summary, 
the groups were treated with either PBS+olive oil, DEN+olive oil, PBS+CCl4, or DEN+CCl4.  All 
mice were sacrificed at 22 weeks of age.  
Screening for mutations in H-ras and Ctnnb1 genes 
Total DNA was isolated from frozen liver tissue samples using DNeasy Mini Kits (Qiagen, 
Valencia, CA) according to the manufacturer’s instructions.  Nested PCR analysis was used to 
examine codon 61 in exon 2 of the v-Ha-ras Harvey rat sarcoma viral oncogene homolog (H-ras) 
gene and codons 5-57 in exon 2 of the catenin (cadherin associated protein) beta 1 (Ctnnb1) 
gene.  Reactions were performed on tumor and matched adjacent non-tumor liver tissue samples 
from mice treated with DEN+CCl4, as well as normal livers from control mice.  PCR products were 
purified, cycled with Terminal Ready Reaction Mix-Big Dye (Perkin Elmer, Foster City, CA), and 
sequenced. 
Immunohistochemical staining for β-catenin activation and Hnf1α inactivation  
The activity and cellular location of β-catenin (CTNNB1) was evaluated by immunostaining 
using goat polyclonal CTNNB1 (sc-1496, 1:50; Santa Cruz Biotechnology, Santa Cruz, CA) as 
described in Hoenerhoff et al. (Hoenerhoff et al., 2013).  The levels of glutamine synthetase 
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(GLUL) and liver fatty acid binding protein 1 (FABP1) were assessed by immunostaining as 
described by Jeannot et al (Jeannot et al., 2011). Sections were stained for GLUL, a target of 
Ctnnb1 activation, using a mouse anti-glutamine synthetase antibody (BD Transduction Lab, 
Franklin Lakes, NJ).  Activity of Hnf1α was assessed by immunostaining for the protein of one of 
its target genes, Fabp1, using a rabbit anti-FABP1 antibody (Abcam, Cambridge, MA). 
Global DNA methylation 
The methylation status of genomic DNA was evaluated by a methylation sensitive cytosine 
extension as described in Pogribny et al. (Pogribny et al., 1999). 
McrBC-methylation sensitive quantitative PCR 
The methylation status of long interspersed nucleotide elements (LINE) 1 and short 
interspersed nucleotide elements (SINE) B2 repetitive sequences was determined by a McrBC-
methylation sensitive quantitative PCR assay as described in Martens et al. (Martens et al., 2005). 
Methylation-specific PCR 
The methylation status of CpG sites located within the promoter/first exon region of cyclin-
dependent kinase inhibitor 2A (Cdkn2a), O6-methylguanine-DNA methyltransferase (Mgmt), 
suppressor of cytokine signaling 1 (Socs1), cadherin 1 (Cdh1), and PR domain containing 2, with 
ZNF domain (Riz1) was determined by methylation-specific PCR (MSP) as previously described 
(Herman et al., 1996). 
RNA extraction and quantitative real-time reverse transcription-PCR 
Total RNA was extracted from liver tissue using TRI Reagent (Ambion, Austin, TX) 
according to the manufacturer’s instructions. Total RNA (5 μg) was reverse transcribed using 
random primers and a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster 
City, CA) according to the manufacturer’s protocol. Gene expression was then determined by 
quantitative reverse-transcription PCR (qRT-PCR) using gene expression assays (Applied 
Biosystems).  Each sample was analyzed in duplicate.  Reactions were performed in a 96-well 
assay format using a 7900HT Fast Real-Time PCR System (Applied Biosystems).  Each plate 
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contained one experimental gene and the housekeeping gene (Gusb1 or Gapdh).  The relative 
amount of each mRNA transcript was determined using the 2−ΔΔCt method (Schmittgen and Livak, 
2008). 
Western blotting  
The level of trimethylation of histone 3 lysine 9 (H3K9), histone 3 lysine 27 (H3K27), and 
histone 4 lysine 20 (H4K20) in the livers of the mice was analyzed by Western blot analysis as 
described in Tryndyak et al. (Tryndyak et al., 2006). 
Chromatin immunoprecipitation (ChIP) assay 
Formaldehyde cross-linking and ChIP assay with primary antibodies against H3K9me3 
(Millipore Corporation) was performed by using a Chromatin Immunoprecipitation Assay Kit 
(ChIP) (Millipore Corporation).  Purified DNA from immunoprecipitates and input DNA were 
analyzed by quantitative PCR with primers for the mouse LINE1 and SINE B2 repetitive 
sequences.  The results were normalized to the amount of input DNA and presented as fold 
change for each DNA in liver of mice from experimental groups relative to control mice. 
Statistical analyses 
Results are presented as mean ± S.D. Data were analyzed by one-way analysis of 
variance with pair-wise comparisons being made by the Student-Newman-Keuls method. When 
necessary, the data were natural log transformed before conducting analysis to maintain a more 
equal variance or normal data distribution. P-values < 0.05 were considered significant. 
 
2.3. Results 
Incidence of hepatic preneoplastic and neoplastic lesions 
The mouse model of liver tumorigenesis in fibrotic liver was detailed in Uehara et al. 
(Uehara et al., 2013). Both neoplastic (adenomas and carcinomas) and pre-neoplastic (foci) 
lesions were found in mice treated with DEN+olive oil, PBS+CCl4, or DEN+CCl4. Specifically, in 
the DEN+olive oil-treated group, foci were observed in 95% (19/20) of the mice and adenomas in 
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10% (2/20). In the PBS+CCl4-treated group, the percentage of mice with foci, adenomas and 
carcinomas was 12.5% (1/8), 12.5% (1/8) and 25% (2/8), respectively.  In the DEN+CCl4-treated 
group, the percentage of mice with foci, adenomas and carcinomas was 31% (8/26), 100% 
(26/26) and 50% (13/26), respectively. Hepatocellular adenomas displayed proliferation of 
relatively uniform hepatocytes accompanied with a loss of normal lobular architecture and 
compression of the surrounding parenchyma, while the histopathological features of 
hepatocellular carcinomas consisted of a broad trabecular growth pattern of atypical hepatocytes 
with hemorrhaging and ischemic necrosis in the center of the tumors (Appendix 2.1).  Avascular 
and stromal invasions were also occasionally present in the hepatocellular carcinomas. 
Mutational profiling of H-ras, Ctnnb1, and Hnf1α in liver tumors in mice treated with DEN 
and CCl4 
 H-ras, Hnf1α, and Ctnnb1 were examined for the presence of mutations. Codon 61 of the 
H-ras gene has been identified as a hot spot for point mutations in both spontaneous and 
chemically-induced mouse hepatic tumors (Maronpot et al., 1995).  Although mutations in HRAS 
in human HCC are not common, overexpression of members of the RAS oncogene family, 
including HRAS, has been reported (Tang et al., 1998). Mutations in Ctnnb1 are a commonly 
observed event in hepatocarcinogenesis, most often found in the mouse exon 2 and in the 
corresponding human exon 3 (de La Coste et al., 1998). Human hepatocellular adenomas often 
contain inactivating mutations of the HNF1A gene (Bluteau et al., 2002); these mutations have 
been suggested to be a result of exposure to genotoxic agents (Jeannot et al., 2010). 
 Mutations in codon 61 of H-ras were rare (1/24, 8.3%) in mice treated with DEN+CCl4.  
One animal (with 13 adenomas and no carcinomas in its liver) harbored H-ras mutations, and the 
mutations were observed in both tumors and matched adjacent non-tumor liver tissue. 
Interestingly, the mutation was different in the tumor tissue (AT transversion at the second base) 
and the adjacent non-tumor tissue (CA transversion at the first base).  No significant differences 
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in gene expression of H-ras were observed between vehicle control, tumor, and adjacent non-
tumor liver tissues of DEN+CCl4-treated mice (Appendix 2.2). 
Mutations in exon 2 of Ctnnb1 were not observed in either tumor or adjacent non-tumor 
liver tissue of mice treated with DEN+CCl4.  Consistent with this finding, there were no differences 
in protein expression or cellular localization of CTNNB1 by immunohistochemistry (Figure 2.1, left 
panels).  Tumors and adjacent normal tissues from mice treated with DEN+olive oil, PBS+CCl4, 
or DEN+CCl4 were negative for GLUL (Figure 2.1, middle panels), confirming the absence of an 
activating mutation in Ctnnb1.  Because adenomas were found in all treatment groups, fatty acid 
binding protein (L-FABP1), a downstream target of Hnf1α, was used as a marker for inactivating 
mutations in Hnf1α.  Liver tissues from animals in all groups were uniformly stained for FABP1, 
indicating a normal functioning Hnf1α (Figure 2.1, right panels). 
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Figure 2.1.  Immunostaining of CTNNB1, GLUL, and FABP1 in formalin-fixed paraffin-embedded 
sections of liver tumor (T) and adjacent non-tumor (N) liver tissue.  Left panel: Liver tumors 
(pictured in all groups except vehicle control) lack immunoreactivity or nuclear accumulation of 
CTNNB1.  Minimal cytoplasmic accumulation is present in centrilobular hepatocytes in PBS+CCl4-
treated mice, primarily in non-tumor fibrotic areas and likely artifact from degeneration.  Middle 
panel: Liver tumors (pictured in all groups except vehicle control) lack immunoreactivity to GLUL.  
Positive immunoreactivity is restricted to pericentral hepatocytes in non-tumor tissue.  Pericentral 
immunoreactivity is weak in PBS+CCl4-treated mice, likely due to degeneration and loss of these 
hepatocytes. The positive staining in the PBS+CCl4 representative image is artifact due to 
necrosis.  Right panel: Uniform positive immunoreactivity is present in both tumor (pictured in all 
groups except vehicle control) and adjacent non-tumor tissue.  Original magnification: 40x. 
 
DNA methylation changes in liver tumors in mice treated with DEN and CCl4 
It is well-established that both mouse and human liver tumors exhibit substantial 
alterations in DNA methylation (Tischoff and Tannapfe, 2008).  Hence, the status of genomic and 
gene-specific DNA methylation in liver tumors induced by DEN+CCl4 treatment was examined.  
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Figure 2.2A shows that DNA was markedly hypomethylated both globally and within LINE1 and 
SINE B2 repetitive elements in tumors as compared to liver tissue from vehicle control mice.  It is 
well-established that the extent of methylation of these repetitive elements strongly corresponds 
to the level of global DNA methylation (Chalitchagorn et al., 2004). 
 
Figure 2.2.  DNA methylation and gene expression changes in liver tumors.  (A) Genomic, LINE1, 
and SINE B2 methylation.  The results are presented as an average percent change in the degree 
of DNA hypomethylation in liver tumors of mice treated DEN+CCl4 relative to that in the control 
group, which were assigned a value of 100%.  (B) Extent of Cdkn2a, Mgmt, Socs1, Cdh1 and 
Riz1 promoter methylation.  The Y-axis represents the percentage of samples that had 
methylation in the promoter region of the described gene.  (C) The expression of Cdkn2a, Mgmt, 
Socs1, Cdh,1 and Riz1 was determined by qRT-PCR as detailed in “Materials and Methods.”  The 
results are presented as an average fold change in the expression of each gene in liver tumors 
of mice treated DEN+CCl4 relative to expression in liver tissues of the control group, which were 
assigned a value of 1.  Values shown are mean±S.D., asterisks (*) denote a significant (p<0.05) 
difference from control mice. 
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Figure 2.2B shows that five tumor suppressor genes, Cdkn2a, Mgmt, Socs1, Cdh1, and 
Riz1, all known to be commonly epigenetically altered in HCC (Nishida et al., 2008; Tischoff and 
Tannapfe, 2008), were heavily methylated in liver tumors in DEN+CCl4-treated mice, while these 
genes were largely unmethylated in the livers of control mice.  One of the main cancer-associated 
epigenetic features is the silencing of aberrantly methylated genes (Jones and Baylin, 2007).  
Hence, the expression of these five genes was also evaluated.  Figure 2.2C shows that among 
the analyzed genes, only the expression of Riz1 and Mgmt was significantly decreased in 
association with promoter hypermethylation in liver tumors from mice treated with DEN+CCl4.  
Changes in the expression of Cdkn2a, Socs1, and Cdh1 did not exhibit such an association with 
the incidence of promoter methylation. 
DNA methylation changes in fibrosis-associated mouse hepatocarcinogenesis 
To determine the role of epigenetic alterations in the progression of mouse fibrosis-
associated liver carcinogenesis, the status of genomic DNA methylation in non-tumor liver tissues 
was assessed.  Figure 2.3A shows that DNA isolated from non-tumor liver tissue of mice treated 
either with PBS+CCl4 or with DEN+CCl4 was also markedly hypomethylated.  Interestingly, the 
extent of methylation of global DNA as well as of LINE1 and SINE B2 repetitive DNA sequences 
in non-tumorous liver tissue from mice treated with PBS+CCl4 or with DEN+CCl4 was similar to 
that of liver tumors in mice treated with DEN+CCl4 (Figure 2.3A).  In contrast to the results 
obtained in mice treated with PBS+CCl4 or DEN+CCl4, the level of DNA methylation in the livers 
of mice treated with DEN+olive oil was not different from that of control mice. 
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Figure 2.3.  DNA methylation and gene expression changes in non-tumor liver tissues during 
fibrosis-associated hepatocarcinogenesis in mice.  (A) Genomic, LINE1, and SINE B2 
methylation.  The results are presented as an average percent change in the degree of DNA 
hypomethylation in non-tumorous liver tissues of mice from experimental groups relative to that 
in control mice, which was assigned a value of 100%.  (B) Extent of Cdkn2a, Mgmt, Socs1, Cdh1 
and Riz1 promoter methylation.  The Y-axis represents the percentage of samples that had 
methylation in the promoter region of the described gene.  (C) The expression of Cdkn2a, Mgmt, 
Socs1, Cdh1, and Riz1 genes.  The results are presented as an average fold change in the 
expression of each gene in the livers of mice from experimental groups relative to that in control 
mice.  Values shown are mean±S.D., asterisks (*) denote a significant (p<0.05) difference from 
control mice.   
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To further evaluate the role of DNA methylation changes in fibrosis-associated mouse liver 
carcinogenesis, promoter methylation and expression of Cdkn2a, Mgmt, Socs1, Cdh1, and Riz1 
in non-tumor liver tissue were examined. Figure 2.3B shows that these tumor suppressor genes 
were methylated in the non-tumorous liver samples in DEN+CCl4-treated mice, while they were 
largely unmethylated in the livers of control mice.  However, the extent of Mgmt, Socs1, and Riz1 
methylation in non-tumor tissue was noticeably lower than in liver tumors.  Interestingly, in 
PBS+CCl4-treated mice, Cdkn2a, Socs1, Cdh1, and Riz1 were methylated in ≥ 40% of the non-
tumorous liver samples. In DEN+olive oil-treated mice, only Socs1 was methylated in ≥ 40% of 
adjacent non-tumor liver samples. 
Figure 2.3C shows that among all of the analyzed genes, only the expression of Mgmt 
and Riz1 was significantly decreased in association with promoter hypermethylation in the non-
tumor liver tissues of mice treated with DEN+CCl4. Changes in the expression of Cdkn2a, Socs1, 
and Cdh1 did not exhibit such an association with the incidence of promoter methylation.  The 
expression of these genes was similar in non-tumor and tumor tissue from the livers of mice 
treated with DEN+CCl4 (Figures 2C and 3C). 
Histone methylation during fibrosis-associated mouse hepatocarcinogenesis 
It has been previously reported that a reduction in trimethylation of H3K9, H3K27, and 
H4K20 affects genomic stability (Kouzarides, 2007; Jorgensen et al., 2013), and is an event 
observed in various human cancers.  Figure 4 shows a large decrease in H3K9 trimethylation in 
the livers of mice treated with DEN+CCl4. The levels of H3K9 trimethylation in this experimental 
group were decreased by 58% compared with control mice. In contrast to the H3K9 methylation 
changes, the levels of H3K27 and H4K20 were decreased only slightly in the livers of DEN+olive 
oil-, PBS+CCl4-, and DEN+CCl4-treated mice. 
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Figure 2.4.  H3K9, H3K279, and H4K20 trimethylation in liver tissues during fibrosis-associated 
liver carcinogenesis in mice.  Densitometry analysis of the immunostaining results is shown as 
percent change in histone modification level in the each experimental group relative to the 
corresponding values in control mice.  Values shown are mean±S.D., asterisks (*) denote a 
significant (p<0.05) difference from control mice. 
 
Expression of chromatin-modifying genes during fibrosis-associated 
hepatocarcinogenesis 
To determine the underlying mechanisms of these epigenetic aberrations, the expression 
of chromatin modifying genes involved in the proper maintenance of DNA and histone methylation 
was assessed by qRT-PCR.  The most noticeable changes that occurred during fibrosis-
associated carcinogenesis were a distinct up-regulation of the maintenance DNA 
methyltransferase 1 (Dnmt1) and de novo DNA methyltransferase 3a (Dnmt3a) genes in the livers 
of mice treated with PBS+CCl4 and DEN+CCl4.  Down-regulation of histone lysine (K)-specific 
demethylase (Kdm4a and Kdm4b) genes was observed in liver tissue of mice treated with 
DEN+CCl4 (Figure 5).  
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Figure 2.5.  Expression of chromatin-modifying genes in the liver during fibrosis-associated 
hepatocarcinogenesis in mice.  The expression of Dnmt1, Dnmt3a, Dnmt3b, Suv39h1, Ezh2, 
Suv4-30h2, Kdm4a, and Kdm4b genes was determined by qRT-PCR.  The results are presented 
as an average fold change in the expression of each gene in the livers of mice from each 
experimental group relative to that in control mice, which were assigned a value 1.  Values shown 
are mean±S.D., asterisks (*) denote a significant (p<0.05) difference from control mice. 
 
Histone H3K9 trimethylation and expression of LINE1 and SINE B2 
To investigate whether or not epigenetic changes observed in this study may be 
mechanistically related to the progression of fibrosis-associated carcinogenesis, the status of 
H3K9 methylation at LINE1 and SINE B2 repetitive sequences and their expression were 
analyzed. Figure 2.6 A shows a substantial decrease of H3K9 trimethylation (H3K9me3) at LINE1 
and SINE B2 repetitive sequences in liver tissue of mice treated with DEN+CCl4. The reduction 
of LINE1 and SINE B2 H3K9me3 was accompanied by a marked increase in the expression of 
LINE1 and, especially, SINE B2 elements (Figure 2.6 B). 
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Figure 2.6.  Level of H3K9me3 at LINE1 and SINE B2 repetitive sequences and expression of 
LINE1 and SINE B2 in the liver during fibrosis-associated liver carcinogenesis in mice.  (A) The 
level of H3K9me3 at LINE1 and SINE B2 determined by a ChIP assay as described in “Materials 
and Methods.”  The data are presented as fold change in liver of mice from experimental groups 
relative to control mice after normalization to input DNA.  (B)  Expression of LINE1 and SINE B2 
elements.  The results are presented as an average fold change in the expression of LINE1 and 
SINE B2 in the livers of mice from experimental groups relative to that in control mice, which were 
assigned a value of 1.  Values shown are mean±S.D., asterisks (*) denote a significant (p<0.05) 
difference from control mice. 
 
Expression of progenitor markers in liver tumors 
In this mouse model of hepatocarcinogenesis, markers of oncofetal liver transformation 
and cancer stem cells were found to be significantly associated with tumor incidence; whereas 
inflammation, fibrogenesis, oxidative stress, proliferation and apoptosis were not indicative of 
increased tumorigenesis (Uehara et al., 2013). Appendix 2.3 shows that the expression of alpha-
fetoprotein (Afp) was significantly up-regulated in tumor tissues of mice treated with DEN+CCl4 
when compared to control animals, a pattern similar to that reported for the non-tumor tissues 
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from the same treatment group (Uehara et al., 2013). In contrast, epithelial cell adhesion molecule 
(Epcam) was down-regulated in tumor tissues when compared to control mice, although the 
change was not statistically significant.  Interestingly, Epcam was significantly up-regulated in 
non-tumor tissues of the DEN+CCl4-tretaed mice when compared to all other treatment groups 
in the original study (Uehara et al., 2013). These findings corresponded to the hypothesis that this 
mitogenic signaling molecule is involved in tumor promotion and progression, but is less active in 
late stage tumors. 
 
2.4. Discussion 
Hepatocellular carcinogenesis is a complex process that is the consequence of multiple 
molecular events that lead to the initiation, promotion, and progression of tumor cells (Farazi and 
DePinho, 2006; Zucman-Rossi, 2010; Forner et al., 2012; Aravalli et al., 2013).  Recent reviews 
have emphasized the importance of a distinct set of events that are required for carcinogenesis 
(Laurent-Puig et al., 2001; Hanahan and Weinberg, 2011).  Specifically, distinct cellular 
capabilities that enable tumorigenesis, or “hallmarks of cancer,” are increasingly recognized as 
essential processes in carcinogenesis (Hanahan and Weinberg, 2011). Mutations in cancer-
related genes result in aberrant cellular functions, which can be characterized as specific hallmark 
capabilities. While genetic alterations have long been known to cause the development and 
progression of tumors, epigenetic events have emerged more recently as potentially equally 
important events in the process of hepatocarcinogenesis (Tischoff and Tannapfe, 2008; Pogribny 
and Rusyn, 2014). 
To better understand the role of genetic and epigenetic alterations in liver tumor 
development, the mutational profile, expression, and epigenetic alterations of several cancer-
related genes commonly involved in hepatocarcinogenesis were evaluated using a mouse model 
of fibrosis-associated hepatocellular carcinoma. Additionally, epigenetic events associated with 
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genomic instability, such as global DNA hypomethylation and histone demethylation, were 
investigated. 
Common mutations do not play a primary role in fibrosis-associated HCC in murine liver 
tumors 
We evaluated the mutational profile of genes commonly implicated in 
hepatocarcinogenesis of both mice and humans.  Alterations in the Wnt/β-catenin pathway are 
frequently involved in both human and mouse HCC, with CTNNB1 reported to be the most 
commonly activated oncogene in human HCC (de La Coste et al., 1998). Activating mutations in 
CTNNB1 lead to constitutive activation of the CTNNB1 protein and subsequent up-regulation of 
Wnt signaling (Devereux et al., 1999), the consequence of which is stimulation of cell proliferation 
and inhibition of apoptosis (Morin et al., 1997). Recent studies have reported contrasting results 
regarding the association of CTNNB1 mutations and genomic instability in hepatic tumors 
(Laurent-Puig et al., 2001; Aleksic et al., 2011). However, a general consensus has been 
established that genomic instability is an enabling characteristic in hepatic and other cancers 
(Hanahan and Weinberg, 2011). In our study, while epigenetic alterations that are associated with 
genomic instability were observed, mutations in the hot-spot region (mouse exon 2) of Ctnnb1 
were absent. These findings suggest that causative mechanisms of genomic instability may 
precede Ctnnb1 mutation, and support the theory that genomic instability and Ctnnb1 mutation 
are distinct mechanisms of hepatocarcinogenesis (Morin et al., 1997; Zucman-Rossi, 2010). 
Characterizing the frequency and type of mutations in tumor-related genes is informative 
in the determination of tumor induction and progression, especially in laboratory animals, because 
the basis of carcinogenic effects may be due to either chemical induction or spontaneous 
occurrence (Sills et al., 1999).  For example, single base substitution mutations at codon 61 of H-
ras are one of the most commonly seen mutations in spontaneously occurring liver tumors in 
B6C3F1 mice (Maronpot et al., 1995).  Mutations at this hotspot are also seen in chemically-
induced neoplasms in mice, although there is evidence that the type and frequency of mutations 
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can be chemical- and dose-dependent, with a lower incidence of codon 61 mutations associated 
with increasing doses of multiple chemicals (Devereux et al., 1994; Hoenerhoff et al., 2013), 
including DEN (Maronpot et al., 1995).  Indeed, the low frequency of H-ras mutations in our study 
suggests that CCl4 and DEN together preferentially promote cells through mechanisms 
independent of H-ras mutation. 
Epigenetic alterations are an early and important event in fibrosis-associated mouse 
hepatocarcinogenesis 
Epigenetic changes such as DNA hypomethylation at the global level and within repetitive 
sequences, promoter hypermethylation of tumor suppressor genes, and altered histone lysine 
methylation are common characteristics in many, if not all, types of cancer (Feinberg et al., 2006; 
Jones and Baylin, 2007; Kitkumthorn and Mutirangura, 2011).  In our study, the extent of global 
DNA hypomethylation was significantly greater in the livers of PBS+CCl4- and DEN+CCl4-treated 
mice than in DEN+olive oil-treated or control mice.  Similarly, demethylation of LINE1 and SINE 
2B sequences was found in PBS+CCl4- and DEN+CCl4-treated mice, although the extent of LINE1 
demethylation in the livers of PBS+CCl4-treated mice was not statistically significant.  
Furthermore, we observed a significant decrease in global H3K9me3 in the non-tumor liver tissue 
in mice treated with DEN+CCl4. Additionally, the degree of DNA methylation and H3K9me3 was 
significantly decreased in LINE1 and SINE B2 sequences in the livers of DEN+CCl4-treated mice, 
and the expression of LINE1 and SINE B2 was significantly increased.  These interspersed 
repetitive sequences, which represent nearly half of the human genome and approximately one-
third of the mouse genome (Waterston et al., 2002), play an important role in the development of 
several human cancers (Rudin and Thompson, 2001). 
Notably, the PBS+CCl4- and DEN+CCl4-treated mice had a higher incidence of liver tumors 
(37.5% and 100%, respectively) than mice treated with DEN+olive oil (10%), as reported by 
Uehara, et al. (Uehara et al., 2013). While the incidence of liver preneoplastic foci was nearly 
100% in DEN+olive oil-treated mice, few of these lesions (2/20) progressed to adenomas.  This 
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suggests that the significant increase in tumor incidence in livers of mice treated with DEN+CCl4, 
as compared to the other treatment groups, may be attributed to a significant hypomethylation of 
genomic DNA, LINE1 and SINE B2 repetitive sequences, and the decrease in global, LINE1 and 
SINE B2 H3K9me3. Importantly, these epigenetic alterations appeared to precede genetic 
aberrations commonly seen in mouse and human HCC. 
RIZ1, a member of a histone/protein methyltransferase superfamily, is associated with tumor 
suppression function (Du et al., 2001) and is frequently inactivated in HCC (Formeister et al., 
2010; Zhang et al., 2010). It has been demonstrated that the histone methyltransferase function 
of RIZ1 is an important constituent of its tumor suppressor activity (Kim et al., 2003).  Our results 
indicate that inhibition of Riz1 by promoter hypermethylation is associated with a substantial 
decrease in H3K9me3, which may be the result of lost RIZ1 histone methyltransferase function.  
A significant decrease in Riz1 expression was found in both tumor and non-tumor liver tissues of 
mice treated with DEN+CCl4, as well as in the livers of mice treated with PBS+CCl4 alone.  
Because mice in these treatment groups had a higher tumor incidence than DEN+olive oil-treated 
mice, we can infer that Riz1 plays a major role in tumorigenesis in our study. The level of 
H3K9me3 was significantly decreased only in mice treated with DEN+CCl4, suggesting a closely 
link between H3K9me3 and tumor cell promotion and/or progression.  This also suggests that 
mechanisms additional to the loss of Riz1 histone methyltransferase function play a role in H3K9 
methylation. 
RIZ1 promoter hypermethylation has been observed in both early and advanced stages 
of human HCC, with a higher incidence in early stage tumors (Piao et al., 2008). This supports 
the potential tumor-promoting role of Riz1 promoter hypermethylation found in the present study, 
and also confers the mechanistic human relevance of this mouse HCC model.  Additionally, RIZ1 
methylation has been associated with a shorter disease-free survival time in human HCC patients 
(Zhang et al., 2010). RIZ1 hypermethylation has been found to be prevalent in various human 
cancer types, particularly breast and liver, two types in which mutations in the gene have not been 
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found (Du et al., 2001). These findings indicate that this gene is likely preferably silenced by 
methylation as opposed to by mutation (Du et al., 2001).  Furthermore, there are no known cis-
acting regulators of RIZ1 expression (Gatti et al., 2007) which supports the conclusion that 
methylation is the cause for the down-regulation of the gene in many cancers. 
Not all epigenetic events may be involved in carcinogenesis 
We found that certain early epigenetic events appear to occur without effect on gene 
expression or be associated with tumor promotion.  For example, although promoter 
hypermethylation was observed in four (Cdkn2a, Mgmt, Socs1, and Cdh1) of the cancer-related 
genes examined in this study, the expression of these genes was not down-regulated. This is 
contrary to the well accepted mechanistic link between promoter hypermethylation and gene 
silencing (Chalitchagorn et al., 2004). In fact, Cdkn2a and Cdh1 were up-regulated in the livers of 
PBS+CCl4- and DEN+CCl4-treated mice a finding consistent with the hypothesis that not all DNA 
methylation changes, similar to genetic mutations, are equally important in the process of 
carcinogenesis, and that some DNA methylation changes may be purely passenger events (Kalari 
and Pfeifer, 2010). 
 
Conclusions 
Our results indicate that epigenetic alterations are an essential and early event in 
hepatocellular carcinogenesis, especially under conditions of liver fibrosis.  Based on previous 
reports, genomic instability is likely a consequence of loss of DNA methylation globally and within 
repetitive elements and decreased H3K9 methylation, all of which were associated with increased 
tumor incidence in the present study. Furthermore, loss of Riz1 expression by promoter 
hypermethylation was associated with increased tumor incidence, and therefore the tumor 
suppressor function of this gene is likely linked to its inherent histone methyltransferase activity. 
The epigenetic alterations observed in fibrosis-associated liver tumors in this mouse model 
indicate important features involved in the development of human liver tumors that arise from 
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fibrosis and cirrhosis, a common progression according to human clinico-pathological evidence.  
Additionally, these epigenetic alterations may confer a heightened risk for genomic instability, 
although additional studies are required to confirm such an association.  Our results indicate that 
H-ras, Hnf1α, and Ctnnb1 mutations are not involved in the initiation or promotion of the hepatic 
tumors in this study, and that epigenetic changes preceded or occurred independently of 
traditionally observed genetic alterations in mouse HCC.  While common HCC-related mutations 
were not detected in our study, the epigenetic alterations observed may contribute to genomic 
instability and thus represent one of the proposed hallmarks of cancer (Hanahan and Weinberg, 
2011). 
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CHAPTER 3: EPIGENETIC EVENTS DETERMINE TISSUE-SPECIFIC TOXICITY OF 
INHALATIONAL EXPOSURE TO THE GENOTOXIC CHEMICAL 1,3-BUTADIENE IN MALE 
C57BL/6J MICE2
 
3.1. Introduction 
1,3-Butadiene (BD), an industrial chemical used in the synthesis of plastics and rubber 
(White, 2007), has been classified as a “Group 1 carcinogen” (carcinogenic to humans) by the 
International Agency for Research on Cancer (IARC, 2012). BD poses an occupational health 
hazard to humans exposed in industrial settings, with BD exposure most closely associated with 
an increased cancer risk in hematolymphatic organs, including lymphosarcoma, reticulosarcoma, 
and leukemia (Delzell et al., 1996). Additionally, BD is present in automobile exhaust and cigarette 
smoke, further contributing to the ubiquity of this chemical in the environment, and further raising 
concern for human health (Pelz et al., 1990; Hecht, 1999). In rodents, in addition to the tumors in 
the hematopoietic system, BD exposure causes tumors in liver and lungs (Melnick and Sills, 
2001). Although many comprehensive reports of the carcinogenicity of BD have been presented 
(Kirman et al., 2010; Swenberg et al., 2011), the understanding of the underlying mechanisms 
associated with the variation in effects of exposure across tissues is lacking. 
The carcinogenicity of BD is mediated by DNA-reactive epoxides formed during butadiene 
metabolism (Goggin et al., 2009; Swenberg et al., 2011).  BD is metabolized by cytochrome P450 
monooxygenases to form 1,2-epoxy-3-butene, 1,2,3,4-diepoxybutane, and 1,2-epoxy-3,4-
                                                          
2 This chapter was published in Toxicological Sciences in 2014 (Chappell, Grace, Tetyana Kobets, 
Bridget O’Brien, Natalia Tretyakova, Dewakar Sangaraju, Oksana Kosyk, Kenneth G. Sexton, Wanda 
Bodnar, Igor P. Pogribny, and Ivan Rusyn. "Epigenetic events determine tissue-specific toxicity of 
inhalational exposure to the genotoxic chemical 1, 3-butadiene in male C57BL/6J mice." Toxicological 
Sciences 142, no. 2 (2014): 375-384. Permission to reprint the full article was obtained from Oxford 
University Press, license number 3721380885650. 
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butanediol (Swenberg et al., 2011).  These reactive metabolites are directly mutagenic, and the 
interaction of these intermediates with DNA is considered a key step in the mechanism of BD 
carcinogenicity (Bond and Medinsky, 2001; Kirman et al., 2010).  Point mutations and sister 
chromatid exchanges, common consequences of bulky DNA adducts, have been observed as a 
consequence of exposure to butadiene (IARC, 2008).   
In addition to the well-established and widely recognized genotoxicity of BD, other 
mechanisms have been postulated (Kirman et al., 2010).  A previous report by Koturbash et al. 
(Koturbash et al., 2011b) demonstrated that BD also causes epigenetic effects in the mouse liver.  
It has been shown that exposure to a number of chemical carcinogens may impair the cellular 
epigenome in tissues that are targets for chemical-induced tumorigenesis by altering the DNA 
methylation and histone modification patterns (Baccarelli and Bollati, 2009; Pogribny and Rusyn, 
2013; Pogribny and Beland, 2014).  Such epigenetic alterations may ultimately compromise the 
proper expression of genetic information, a feature that is considered one of the hallmarks of 
cancer (Hanahan and Weinberg, 2011). 
The tissue-specific variations in the response to DNA-damaging agents, including BD, are 
well known (Melnick and Sills, 2001); however, there is a lack of knowledge on the tissue-specific 
effects of BD exposure beyond the formation of DNA adducts and cross-links (Goggin et al., 2009; 
Swenberg et al., 2011).  Delineation of additional molecular events associated with tissue-specific 
BD damage may better characterize the underlying mechanisms of tissue-specific tumorigenicity 
and identify molecular drivers of the tumorigenic process. 
The goal of the present study was to use a male mouse sub-acute inhalational study 
design to investigate whether or not exposure to BD results in distinct genotoxic effects and 
epigenetic alterations in various solid tissues.  Such tissue-specific alterations may provide insight 
into the molecular characteristics of BD-induced tumorigenesis.  
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3.2. Materials and Methods  
Animals and experimental design 
Male C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were housed in sterilized 
cages in a temperature-controlled (24°C) room with a 12/12-hr light/dark cycle, and given ad 
libitum access to purified water and NIH-31 pelleted diet (Purina Mills, Richmond, IN, USA).  This 
strain was selected for the present study based on previously reported findings that demonstrated 
that C57BL/6J mice are highly susceptible to BD exposure, as evidenced by the greatest extent 
of both DNA damage and epigenetic alterations, relative to six other inbred mouse strains 
(Koturbash et al., 2011a). After two weeks of acclimation, the mice (9-13 weeks of age) were 
allocated randomly into a control group exposed to filtered air, or an experimental group exposed 
to 425 ppm BD. Exposures were conducted 6 hr/day, 5 days/week (Monday through Friday) for 
two consecutive weeks. Each experimental day, mice were placed in a cylindrical metal mesh 
holder for the duration of exposure and then returned to their cages. The concentration of BD in 
the exposure chambers was monitored at the beginning and at end of each exposure period using 
gas chromatography as detailed below. Following the final exposure, mice were euthanized by 
exsanguination following deep nembutal (100 mg/kg intraperitoneal injection) anesthesia.  Livers, 
lungs, and kidneys were excised and snap-frozen immediately in liquid nitrogen and stored at –
80°C for subsequent analyses. The animals were treated humanely and with regard for alleviation 
of suffering.  All procedures were approved by the Institutional Animal Care and Use Committee 
at the University of North Carolina at Chapel Hill.  
Measurement of BD chamber concentrations by gas chromatography 
The concentration of BD in the exposure chambers was monitored twice a day: an hour 
after the beginning and an hour before the end of each exposure.  An air sample was taken from 
each of the chambers and analyzed with a CP-3800 (Varian, Inc., Walnut Creek, CA) gas 
chromatograph. The gas chromatograph utilized a 10 milliliter gas sample loop injector flushed 
from a sample Teflon bag, purged with a sample of the exposure gas injected into a separation 
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column to isolate the BD from the air for integration of the response from a flame ionization 
detector.  The 30 foot long, 1/8 inch in diameter stainless steel packed column was a Supelco 
(Bellefonte, PA) part number 12809-U using 23% SP-1700 active phase on 80/100 Chromosorb 
PAW support.  Calibration of the instrument was accomplished with analysis of a commercial gas 
standard of an eight-component hydrocarbon mixture (Ref#88-104317) prepared by National 
Specialty Gases (Morrisville NC) and certified using National Institute of Standards and 
Technology traceable standards with 5% uncertainty.  
Determination of N7-guanine adduct formation 
Genomic DNA was isolated from mouse liver, lung, and kidney tissues using a Qiagen 
DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA). The analysis of N-7-(2,3,4-trihydroxybut-1-
yl)-guanine (THB-Gua) was performed following neutral thermal hydrolysis by liquid 
chromatography/positive ion electrospray ionization/tandem mass spectrometry 
(LC/ESI+MS/MS) as described in (Goggin et al., 2009) with minor modifications.  Briefly, DNA 
(100 μg) from each sample was spiked with 500 fmol stable isotope labeled THB-Gua internal 
standard (racemic [15N5]-THB-Gua), and adjusted with deionized water to a volume of 400 μL.  
Neutral thermal hydrolysis was performed at 95°C for 30 minutes, and the samples were 
centrifuged through an Amicon 10K filter (Millipore Corporation, Billerica, MA). The samples were 
then purified by off-line HPLC using a Sunfire 4.6 x 250 mm column (Waters, Milford, MA) at a 
flow rate of 1 mL/minute with 10 mM ammonium formate at a pH of 4.3 serving as mobile phase 
A, and methanol as mobile phase B. Collected fractions were dried down completely by vacuum 
centrifugation and then reconstituted in 20 µL of water before injection into the ACQUITY UPLC 
HSS T3 C18 column (2.1 x 100 mm, 1.8 um at 200 µL/min) (Waters) coupled to a TSQ Quantum 
Ultra triple quadrupole mass spectrometer (Thermo Fisher Scientific, Waltham, MA). Mobile 
Phase A was 0.1% acetic acid in water while methanol was used as mobile phase B. A gradient 
elution method from 1% B to 80% B over five minutes was used to achieve separation with a total 
cycle time of 15 minutes per injection. Quantitation of the THB-Gua analyte and internal standard 
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was performed by selected reaction monitoring using precursor to fragment ion transitions of m/z 
256.1→152.1 (THB-Gua) and m/z 261.1→157.1 ([15N5]-THB-Gua) with collision energy of 20 V 
for both.  
Determination of bis-N7-guanine cross-links formation 
The levels of 1,4-bis-(guan-7-yl)-2,3-butanediol cross-links (bis-N7G-BD) in DNA were 
evaluated using the method outlined in (Sangaraju et al., 2012).  Briefly, the aliquots were spiked 
with racemic 15N10-bis-N7G-BD internal standard, subjected to neutral thermal hydrolysis (70 °C 
for 1 h) followed by ultrafiltration through a Nanosep 10K filter (Pall Life Sciences, Ann Arbor, MI) 
and off-line HPLC purification.  Offline HPLC purification used a Zorbax Eclipse XDBC18 column 
(4.6 × 150 mm, 5 μm, from Agilent Technologies Palo Alto, CA) eluted at 1 mL/min with a gradient 
of 0.4% formic acid in Milli-Q water (mobile phase A) and HPLC grade acetonitrile (mobile phase 
B).  Bis-N7G-BD containing fractions, collected between 14-18 minutes, were dried completely 
and dissolved in 25 μL water.  For nano-HPLC-nano ESI+MS/MS analysis, a nanoAcquity UPLC 
system (Waters) was interfaced to a TSQ Quantum UltraAM mass spectrometer (Thermo Fisher 
Scientific Corp., Waltham, MA) and used for all analyses with 0.01% acetic acid in LC-MS grade 
water used as mobile phase A and methanol:acetonitrile (1:1) as mobile phase B.  Samples were 
first loaded on a trapping column (Symmetry C18 nanoAcquity, 0.18 × 20 mm, Waters) at 10 
μL/min, which was followed by chromatographic separation using nano-HPLC column (75 μm × 
200 mm) manually packed with Zorbax SB-C18, 5 μm chromatographic packing (Agilent Tech. 
Santa Clara, CA).  The column was eluted at 0.4 μL/min, and bis-N7G-BD eluted at approximately 
15 min.  Quantitation was based on the area ratios of the analyte peaks and the internal standard 
peaks on the extracted ion chromatograms corresponding to bis-N7G-BD and 15N10-bis-N7G-BD, 
respectively.  Nano-HPLC-nano ESI+-MS/MS method standard curves were constructed by 
analyzing solutions with known amounts of internal and analyte standards followed by regression 
analysis of the actual and observed amounts of bis-N7G-BD.  
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Quantitative reverse-transcription polymerase chain reaction 
Total RNA was extracted from frozen liver, lung and kidney tissues using a Qiagen 
RNeasy kit.  Complementary DNA (cDNA) was synthesized from 10 μg total RNA using a High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA).  Gene expression 
was then determined by quantitative reverse-transcription PCR (qRT-PCR) using gene 
expression assays (Applied Biosystems).  All genes and primers are listed in Appendix 3.1.  Two 
to four replicates were run for each sample. Reactions were performed in a 96-well assay format 
using a 7900HT Fast Real-Time PCR System (Applied Biosystems).  The mRNA level of the 
housekeeping gene Gusb1 was evaluated in tandem with each experimental run.  The relative 
amount of each mRNA transcript was determined using the 2−ΔΔCt method (Schmittgen and Livak, 
2008). 
DNA methylation of repetitive sequences 
The methylation status of short interspersed nucleotide elements (SINE) B1 and B2, and 
minor and major satellite repetitive sequences was determined by a McrBC-methylation sensitive 
quantitative PCR assay as described in (Martens et al., 2005). Additionally, because that assay 
does not distinguish between 5-methylcytosine (5-mC) and 5-hydroxymethycytocise (5-hmC), we 
also assessed the level of 5-hmC in repetitive sequence by hydroxymethylated DNA 
immunoprecipitation (hMeDIP) using the hMeDIP kit (Diagenode, Denville, NJ). 
Western blot analysis of histone modifications 
The level of trimethylation of histones H3 lysine 9 (H3K9me3), H3 lysine 27 (H3K27me3), 
and H4 lysine 20 (H4K20me3), as well as acetylation of histones H3 lysine 27 (H3K27ac), H3 
lysine 56 (H3K56ac), and H4 lysine 16 (H4K16ac) in the livers, lungs, and kidneys of both control 
and BD-exposed mice was analyzed by western blot analysis as described (Tryndyak et al., 
2006). 
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Statistical analyses 
 Results are presented as mean ± SD.  Differences between control and BD-exposed mice 
for each tissue and each endpoint were evaluated by Student’s t-test.  Pearson product-moment 
correlation coefficients were used to determine the relationship between levels of BD-induced 
DNA adducts and histone modifications.  Data were natural log-transformed before conducting 
analysis to ensure equal variance or normal data distribution, when necessary.  P-values < 0.05 
were considered significant.   
 
3.3. Results 
Air concentrations of BD in the exposure chambers 
 The concentration of BD was monitored by gas chromatography of an air sample taken 
from the exposure chamber an hour into and an hour before the conclusion of the six hour 
exposure each day.  Over the ten day duration of the experiment, the average concentration of 
BD in the exposure chamber was 425.8±162.0 ppm. This dose is within the range of 
concentrations that have been reported to cause tumors in the liver and the lung of BD-exposed 
B6C3F1 mice in chronic inhalation studies (6.25-1,250 ppm) (Melnick and Sills, 2001; IARC, 
2008).  Further, BD has been shown to have a supralinear exposure-response curve in mice 
exposed to BD at levels between 0 and 625ppm, (Melnick and Sills, 2001), indicating that 425ppm 
is an applicable exposure concentration for the study of potential mechanisms of BD-induced 
tumorigenicity. 
Levels of BD-DNA adducts in lung, liver, and kidney 
Several comprehensive studies of adverse health effects of BD (Goggin et al., 2009; 
Swenberg et al., 2011) demonstrated that exposure to BD resuts in the formation of BD-specific 
DNA adducts.  This was evidenced by the presence of several BD-induced DNA adducts, 
including THB-Gua adducts and bis-N7G-BD cross-links, found in both rats and mice exposed to 
BD by inhalation (Goggin et al., 2009; Swenberg et al., 2011).  Therefore, the presence of these 
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DNA adducts in the lung, liver, and kidney tissues of mice exposed to BD inhalation and control 
animals was investigated. 
Figure 1 shows that in mice exposed to BD THB-Gua adducts were present at the highest 
level in the lung tissue (8.48 adducts/106 nucleotides), followed by kidney (6.15 adducts/106 
nucleotides), and then liver (3.28 adducts/106 nucleotides).  THB-Gua adducts were undetectable 
in tissues from control (exposed to clean air) animals.  The difference in the formation of THB-
Gua adducts was statistically significant between the lung and liver (p<0.0001), but did not differ 
between kidney and either lung or liver. 
Similar to the results seen in the THB-Gua adduct analysis, bis-N7G-BD cross-links were 
undetectable in tissues from control animals, but were observed in all three of the tissues in mice 
exposed to BD, with the highest level of bis-N7G-BD cross-links, 3.07/107 nucleotides, found in 
lung tissue (Figure 1).  The number of bis-N7G-BD cross-links was significantly greater in the lung 
as compared to the liver (p<0.05), as well as compared to that of the kidney (p<0.01).   
 
 
Figure 3.1. Amount of THB-Gua-BD adducts (A) and Bis-N7G-BD crosslinks (B) in tissues from 
mice exposed to 425ppm of BD. Data are presented as mean±SD (n=3). Asterisk and pound (* 
and #) denote significant (p<0.05) differences in the amount of the same adduct between the lung 
and liver, and lung and kidney, respectively.  
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DNA methylation at repetitive sequences 
Substantial evidence exists indicating that exposure to certain chemical carcinogenic 
agents, including BD, may perturb the status of DNA methylation (Koturbash et al., 2011b).  
Furthermore, it has been suggested that the disruption of normal DNA methylation patterns may 
be responsible for tumor induction and development (Feinberg and Tycko, 2004).  In light of this, 
the methylation status of SINE B1 and B2 repetitive elements, as well as minor and major 
satellites, a sensitive indicator of global DNA methylation (Yang et al., 2004), was determined in 
BD-associated cancer target (livers and lungs) and non-target (kidneys) tissues, as have been 
established in a 2-year BD mouse carcinogenicity study (IARC, 2012).  Figure 2 shows that 
exposure to BD caused a significant decrease in the methylation of SINE B1 and B2 repetitive 
elements, and minor and major satellites in the livers, and SINE B2 and major satellites in the 
lungs.  In contrast, the methylation status did not change in the kidneys of BD-exposed mice of 
any of the evaluated repetitive sequences.  Furthermore, one of the oxidized derivatives of 5-mC, 
5-hmC, displayed a similar pattern, as shown in Figure 3.3.  The level of 5-hmC was decreased 
more noticeably in the liver and lung than in the kidney, with the exception of major satellites, in 
which 5-hmC was similar across all tissues.  However, the decrease in 5-hmC was only significant 
in SINE B2 in the lung.  
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Figure 3.2. Effects of BD exposure on the extent of DNA methylation in mouse tissues. Loss of 
methylation at SINE B1, SINE B2, major and minor satellite repetitive elements in the tissues of 
BD-exposed mice as measured by McrBC-methylation sensitive quantitative PCR. The results 
are presented as the average fold change in the degree of DNA hypomethylation relative to the 
control values of the corresponding tissues. Data are presented as mean±SD (n=3). Asterisks (*) 
denote significant (p<0.05) differences from the controls. 
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Figure 3.3. Effects of BD exposure on the extent of 5-hydroxymethylcytosine in mouse tissues. 
Loss of methylation at SINE B1, SINE B2, major and minor satellite repetitive elements in the 
tissues of BD-exposed mice as  determined by hydroxymethylated DNA immunoprecipitation 
(hMeDIP).  The results are presented as the average fold change in the degree of DNA 
hypomethylation relativee to the control values of the corresponding tissues. Data are presented 
as mean±SD (n=3). Asterisks (*) denote significant (p<0.05) differences from the controls. 
 
Tissue-specific effects of BD exposure on histone modifications 
In addition to affecting the DNA methylome, compelling data demonstrate that chemical 
carcinogens may also disturb the normal pattern of covalent histone modifications (Baccarelli and 
Bollati, 2009; Thomson et al., 2014).  Based on this evidence, several types of histone 
modifications, particularly those associated with chromatin structure, DNA damage response and 
repair, genomic stability, and gene transcription, were investigated.  Figure 4 shows that the levels 
of H3K9me3, H3K27me3, and H4K20me3, predominant histone lysine methylation marks of 
heterochromatin (Dillon, 2004; Martin and Zhang, 2005), in the livers and lungs of mice exposed 
to BD did not differ from the levels observed in control mice.  In contrast, the level of H3K9me3, 
H3K27me3, and H4K20me3 in the kidneys of BD-exposed mice was substantially greater, 2.0-, 
2.6-, and 1.4-times, respectively, than that observed in control mice. The level of H3K27ac was 
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greatly increased, 2.2-times, in the livers of mice exposed to BD, while the level of this histone 
modification was unaffected in the lungs and kidneys. 
 
 
 
Figure 3.4. Effects of BD exposure on histone modifications. H3K27me3, H4K20me3, H3K9me3, 
H3K27ac, H3K56ac, and H4K16ac levels were assessed by immunostaining using specific 
antibodies against trimethylated or acetylated histones. Equal sample loading was confirmed by 
immunostaining against total histone H3 or H4. Densitometry analysis of the immunostaining 
results is shown as change in methylation or acetylation level relative to the tissue-matched 
controls after correction for the total amount of each histone in the individual samples. Results 
are presented as the average fold change relative to the control values of the corresponding 
tissues. Data are presented as mean±SD (n=3). Asterisks (*) denote significant (p<0.05) 
differences from the controls.  
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Exposure to BD also led to a marked decrease of in acetylation of histones H3K56 and 
H4K16 in the lungs (Figure 4).  In contrast, no differences were found in the livers and kidneys 
between BD-exposed and control mice.  Interestingly, the level of histone H3K56ac was strongly 
negatively correlated with the extent of THB-Gua adducts and bis-N7G-BD cross-links (Figure 1), 
in the lungs (r=-0.89, p<0.05). 
Expression of chromatin-modifying genes 
To investigate a potential mechanism of the variation in the extent of DNA methylation and 
histone modification among tissues in BD-exposed mice, the expression of several genes that 
encode enzymes responsible for DNA methylation and relevant histone modification was 
evaluated. Figure 5 shows a significant decrease in the expression of Dnmt1 and Dnmt3a genes 
in the livers that correlated with hypomethylation of DNA observed in repetitive sequences in the 
liver.  Tet1 and Tet2 genes encode enzymes that catalyze the conversion of 5-mC to 5-hmC 
(Tahiliani et al., 2009).  The expression of these two genes was not significantly different between 
the treatment and control groups, with the exception of a decrease in Tet1 in the lungs of BD-
exposed mice.  This may explain the significant decrease in 5-hmC in SINEB2 sequences in the 
lungs.  Figure 6 shows an increase in the expression of Ezh2 gene in the lungs of mice exposed 
to BD, as well as the substantial increase, more than 2-fold, in the expression of the histone 
deacetylase gene Sirt1 in the liver, lungs, and kidneys of BD-exposed mice.  Interestingly, the 
expression of the histone acetyltransferase gene Kat8 was also increased in the livers, lungs, and 
kidneys of BD-exposed mice; however, the magnitude of this increase in the lungs was 
substantially lower (Figure 6).  A similar pattern was also observed in the expression of the histone 
acetyltranferase gene Kat2b in the livers and lungs (Figure 6).  The expression of other chromatin 
modifying genes in the livers, lungs, and kidneys was not significantly affected by BD exposure. 
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Figure 3.5. Effects of BD exposure on the expression of DNA methylation and DNA demethylation 
genes. mRNA levels of DNA methyltransferase genes (A) and methylcytosine dioxygenase genes 
(B) were evaluated by qPCR. Results are presented as the average fold change relative to the 
control values of the corresponding tissue. All experimental genes were run at least in triplicate. 
Data are presented as mean±SD (n=3). Asterisks (*) denote significant (p<0.05) differences from 
the controls. 
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Figure 4.6. Effects of BD exposure on the expression of histone modifying genes. mRNA levels 
of histone methyltransferase genes (A) and genes related to histone acetylation (B) were 
evaluated by qPCR. Results are presented as the average fold change relative to the control 
values of the corresponding tissue. All experimental genes were run at least in triplicate. Data are 
presented as mean±SD (n=3). Asterisks (*) denote significant (p<0.05) differences from the 
controls.  
 
3.4. Discussion 
Convincing evidence exists showing that chemical carcinogens affect the epigenetic state 
of cells (Baccarelli and Bollati, 2009; Pogribny and Rusyn, 2013; Pogribny and Beland, 2014). 
Such epigenetic reprogramming has been proposed to be an essential causal component of 
“genomic instability,” an enabling characteristic of cancer cells (Hanahan and Weinberg, 2011).  
Epigenetic changes have been proposed as biomarkers of exposure to carcinogens, as well as 
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markers of effect, because of the impact that epigenetic effects of chemicals have on toxicity 
phenotypes (Marlowe et al., 2009; Herceg et al., 2013).  Alterations in DNA methylation, 
histone/chromatin remodeling, and expression of non-coding RNAs represent the most frequently 
reported changes to the epigenome induced by exposure to toxic chemicals (Marlowe et al., 2009; 
Herceg et al., 2013; Pogribny and Rusyn, 2013; Pogribny and Beland, 2014).  Furthermore, the 
role of epigenetic alterations in chemical toxicity may or may not be associated with DNA damage; 
such changes to the epigenome potentially occur as a consequence of DNA damage (Khobta and 
Epe, 2012), or may represent a non-genotoxic mechanism of carcinogenesis (Herceg et al., 2013; 
Pogribny and Rusyn, 2013).  Recent studies have indicated an association between DNA damage 
responses and changes to chromatin structure as a result of chemically induced DNA damage, 
particularly histone modifications and post-repair chromatin restoration at sites of DNA damage 
(Zhu and Wani, 2010; Vempati and Haldar, 2012). 
Transcription is also affected by damage-induced chromatin alterations; localized 
chromatin condensation in response to DNA double-strand breaks can occur within regions of 
several kilobases from sites of damage, and can induce inactivation of transcription and 
epigenetic silencing of the nearby genes (Shanbhag et al., 2010).  Additionally, it has been shown 
that the methylation status of H3K9, especially of H3K9me3, is associated with mutation rate in 
cancer cells, which suggests that mutation rates in cancer genomes are closely related to 
chromatin organization state (Schuster-Bockler and Lehner, 2012).  Such modulation of the 
epigenetic status of loci with DNA damage indicates the involvement of DNA damage in the 
regulation of gene expression (Khobta and Epe, 2012).   
Recent work by our group addressed the relationship between genotoxic (e.g., formation 
of DNA adducts) and epigenetic (e.g., alterations in marks of chromatin regulation) mechanisms 
of carcinogenesis.  First, using a multi-strain mouse model to emulate the genetically diverse 
human population, we observed variation in the response to the classic genotoxic carcinogen BD, 
as well as to other chemicals (Rusyn et al., 2010; Koturbash et al., 2011a), confirming that 
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important inter-strain differences exist in both genotoxic and epigenotoxic effects of chemical 
carcinogens. Next, we confirmed that chromatin remodeling response is a mechanism that 
largely, if not completely, explains the inter-strain differences in BD-induced DNA damage 
(Koturbash et al., 2011a). 
Although profound genotoxic and non-genotoxic changes in target organs of 
tumorigenesis have been demonstrated as a consequence of exposure of experimental animals 
to certain carcinogens, including BD (Koturbash et al., 2011a; Koturbash et al., 2011b), 
information on the extent of these alterations in non-target organs of carcinogenesis is lacking.  
The results of the present study demonstrate that inhalational exposure of male C57BL/6J mice, 
a strain previously  reported to have high levels of BD-induced DNA damage and epigenetic 
alterations in the liver, to BD induced a substantial accumulation of genotoxic lesions in DNA in 
both target (liver and lungs) and non-target (kidneys) tissues. This was evidenced by the 
extensive formation of THB-Gua adducts and bis-N7G-BD cross-links in all three tissues, with the 
greatest prevalence in the lungs (Figure 1).  Interestingly, the number of BD-induced DNA adducts 
in the non-target organ (kidneys) of BD-exposed mice was comparable (bis-N7G-BD cross-links) 
or even significantly greater (THB-Gua adducts) than in the livers.  The pattern of bis-N7G-BD 
cross-links formation observed in the present study differs from previous studies.  Specifically, 
Goggin et al (Goggin et al., 2009) demonstrated that the liver had a higher prevalence of these 
adducts than the kidneys and lungs.  This discrepancy may be attributable to the use of a different 
mouse strain (B6C3F1), or the use of female mice instead of males, as previous work has shown 
that the prevalence of DNA adducts varies significantly across inbred mouse strains (Koturbash 
et al., 2011a) and between sexes (Meng et al., 2007).  Our observation of similar levels of BD-
adducts in a target (liver) and non-target (kidney) organs indicate that mechanisms other than, or 
in addition to, genotoxic lesions may play a critical role in the adverse effects of BD exposure.   
It has been previously reported that inhalational exposure to BD results in a loss of DNA 
methylation in the liver (Koturbash et al., 2011b).  In concordance with that report, in the present 
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study, we observed an increase in the level of DNA repetitive sequences hypomethylation in the 
livers and lungs, two target organs for BD-induced carcinogenesis.  In contrast, the extent of DNA 
methylation in a non-target organ (kidneys) was not affected by BD exposure.  In addition to 
carcinogen-induced changes in DNA methylation, alterations in chromatin organization, as a 
consequence of a chemical challenge, are a key component of the tumorigenic process 
(Baccarelli and Bollati, 2009; Thomson et al., 2014). The present study also demonstrated that 
exposure to BD caused tissue-specific alterations in histone modifications, including increased 
histone H3K27 acetylation in the livers, deacetylation of histones H3K56 and H4K16 in the lungs, 
and increased trimethylation of histones H3K9, H3K27, and H4K20 in the kidneys. In our previous 
study on the genotoxic effects and epigenetic alterations of BD exposure in mice (Koturbash et 
al., 2011b), we demonstrated that BD-induced DNA hypomethylation was accompanied by a 
decrease in trimethylation of histones H3K9, H3K27, and H4K20 in the livers.  It has been 
established that decreases in DNA methylation and in histone methylation at H3K9, H3K27, and 
H4K20 are associated with the formation of relaxed chromatin.  Surprisingly, we did not detect a 
reduction of these histone lysine methylation marks in response to BD exposure in the present 
study.  This may be explained, in part, by relatively lower air concentrations of BD in the exposure 
chambers as compared to those reported previously (Koturbash et al., 2011a; Koturbash et al., 
2011b), resulting in a lower cumulative dose of BD.  However, we detected a substantial increase 
in the level of hepatic histone H3K27 acetylation, which, in addition to H3K9, H3K27, and H4K20 
demethylation, is an indicator of transcriptionally active (relaxed) chromatin (Szulwach et al., 
2011). 
Another novel observation of the present study was the extensive deacetylation of H3K56 
and H4K16 in the lungs of BD-exposed mice.  It is well-accepted that H3K56ac and H4K16ac are 
critical for the organization of chromatin, genomic stability, and DNA damage response 
(Masumoto et al., 2005; Taipale et al., 2005).  Specifically, Li et al. (Li et al., 2008) have 
demonstrated that H3K56ac regulates replication-coupled nucleosome assembly, and Vempati 
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and Haldar (Vempati and Haldar, 2012) reported that increased acetylation of both histones 
H3K56 and H4K16 is associated with DNA damage induced by genotoxic chemicals, indicating 
an important role for both of these modifications in DNA damage repair.  Furthermore, it is well-
documented that loss of H3K56ac and/or H4K16ac is associated with impaired DNA repair, major 
chromosomal rearrangements, and genomic instability (Taipale et al., 2005; Yang and 
Freudenreich, 2010; Prado and Clemente-Ruiz, 2012).  These findings, in addition to our 
observation of a strong negative correlation between the formation of DNA adducts and a loss of 
acetylation of histones H3K56 and H4K16 in the lungs of BD-exposed mice, suggest a critical role 
of H3K56ac and H4K16ac in BD-induced lung tumorigenesis. Specifically, reduction of histone 
H3K56ac and H4K16ac may compromise the proper repair of BD-induced DNA lesions, leading 
to their extensive accumulation and, ultimately, genomic instability.  The loss of H3K56ac and 
H4K16ac in the lungs of BD-exposed mice may be mechanistically explained by the substantial 
up-regulation of the histone deacetylase gene Sirt1 relative to the up-regulation of the histone 
acetyltransferases genes Kat2b, the mouse homolog of yeast and human genes known to 
acetylate H3K56 (Das et al., 2009), and Kat8, which primarily acetylates H4K16 (Taylor et al., 
2013), favoring the histone deacetylation process. 
In addition, we observed the striking increase in trimethylation of histones H3K9, H3K27, 
and H4K20 in the kidneys of BD-exposed mice. It is well accepted that these epigenetic marks 
are integral in the maintenance of genomic stability and chromatin structure (Dillon, 2004; Martin 
and Zhang, 2005).  The results of our previous study on molecular determinants of mouse inter-
strain variability to BD exposure indicated a key role of these histone modifications in BD 
genotoxicity (Koturbash et al., 2011a). Specifically, CAST/EiJ mice, the strain that exhibited the 
lowest formation of hepatic BD-induced DNA adducts and no evidence for hepatotoxicity, was 
characterized by a substantial increase in the levels of H3K9me3, H3K27me3, and H4K20me3 
upon BD exposure. Similarity between the changes in the extent of H3K9, H3K27, and H4K20 
trimethylation and DNA methylation in the kidneys of C57BL/6J mice in the present study, and 
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that observed in the livers of the most resistant strain to BD exposure found in the previous study 
suggest that this epigenetic response may exert a protective effect on tissue, minimizing the 
damage caused by BD.  A summary of the most notable alterations induced by exposure to BD 
is highlighted in Figure 7. It can be clearly visualized that although all tissues sustained DNA 
damage, differing responses in DNA methylation and histone modifications existed across 
tissues, as depicted by the arrows in the chart. 
 
Figure 3.7. Summary of genotoxic and epigenetic changes in the tissues of BD-exposed 
mice. This chart highlights the significant alterations observed in each of the tissues. Arrows 
indicate an increase or decrease observed for each of the marks listed in the same box, relative 
to the same tissues in control mice. 
 
In conclusion, our results indicate that BD elicits both genotoxicity and epigenetic effects, 
but that the tissue-specific toxicity of BD may be largely due to epigenetic alterations. 
Furthermore, such interplay between genotoxic and epigenetic effects may be generalizable to 
other DNA-damaging chemicals. For example, it has been previously demonstrated that 
epigenetic alterations play a role in hepatocarcinogenesis after exposure to 2-
acetylaminofluorene, another genotoxic chemical carcinogen (Pogribny et al., 2011).  While inter-
species differences, as well as within-species tissue differences, in the carcinogenicity of BD have 
been generally attributed to differences in metabolism and DNA damage repair (Kirman et al., 
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2010), we argue that epigenetic mechanisms are equally, if not more, accountable for the tissue-
specific variation in the response to chemical exposure.  We observed prominent differences in 
both DNA methylation and histone modification response between target and non-target tissues 
of BD in the mouse: alterations in histone modifications associated with genomic instability and 
loss of DNA methylation at repetitive sequences in target organs (liver and lungs), and the 
absence of DNA methylation changes along with the formation of genome protecting chromatin 
condensation in non-target tissue (kidneys). It should be noted that assumptions regarding tissue-
specific tumorigenesis of BD were drawn based on previous studies in B6C3F1 mice (IARC, 2008) 
and to confirm the relationship between tissue-specific BD-induced epigenetic alterations and 
carcinogenesis, longer-term exposures are required in C57BL/6J mice. Additionally, while the 
present study focused on global changes in the epigenome as a result of BD exposure, evaluating 
changes in the local chromatin landscape at specific genes using techniques such as ChIP may 
enable a better understanding of the mechanisms of BD-induced genomic alterations. 
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CHAPTER 4. EXPOSURE TO THE GENOTOXIC CHEMICAL 1,3-BUTADIENE CONFERS 
TISSUE- AND STRAIN-SPECIFIC ALTERATIONS IN MRNA AND MICRORNA EXPRESSION 
 
4.1. Introduction 
The underlying mechanisms of tissue-, species-, and strain-specificity of cancer-causing 
chemicals are complex and include differences in metabolism, internal dose, and protective or 
reparative activities. Many, if not all, of these variable functional features can be attributed to 
differences in gene expression, which may be innate between tissues, species, or strains, and/or 
influenced by transcriptional regulators. We evaluated both gene expression and epigenetic post-
transcriptional regulators in 3 tissues and 2 strains of mice to investigate the potential genetic and 
epigenetic underpinnings of tissue- and strain-specificity in the response to a genotoxic chemical.  
In addition to the epigenetic alterations detailed in Chapters 2 and 3, non-coding RNAs 
(ncRNAs) represent another type of epigenetic regulator of gene expression. While studies of 
ncRNAs in environmental exposure-related disease phenotypes are not absent (Pogribny, 2009; 
Chen, 2010; Yokoi and Nakajima, 2011; Rager et al., 2014; Nicolaidou and Koufaris, 2015; 
Rieswijk et al., 2015; Vrijens et al., 2015), and are indeed increasing, they are underrepresented 
relative to the studies considering ncRNAs in diseases associated with other etiologies. 
MicroRNAs (miRNAs), one type of ncRNA, were discovered approximately 20 years ago (Morris 
and Mattick, 2014) and have since been continuously identified and characterized, with an 
increase in reports of miRNAs in recent years (Griffiths-Jones et al., 2006). miRNAs are initially 
transcribed as long primary transcripts (primary-miRNAs) that undergo several steps of 
processing that result in the formation of an approximately 70 nucleotide long precursor miRNA, 
which is cleaved by the enzyme DICER to finally result in a 18-24 nucleotide mature miRNA 
(Murchison and Hannon, 2004; Bartel, 2009). Mature miRNAs are incorporated into an RNA-
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induced silencing complex (RISC), which recognizes mRNA sequences that are complementary 
to the incorporated miRNA and then suppresses gene expression either by mRNA degradation 
or by translational repression (Bartel, 2009; Wilczynska and Bushell, 2015). Relatively high 
complementarity of the 5-8-nucleotide “seed” sequence of the miRNA with sequences within the 
3’ UTR of the gene result in mRNA degradation, while relatively lower complementarity results in 
blocked translation of the gene (Bartel, 2004) (Figure 4.1). miRNAs also appear to be capable of 
up-regulating gene expression by other mechanisms, both directly and indirectly, but this 
relationship is poorly understood (Vasudevan, 2012; Valinezhad Orang et al., 2014). Importantly, 
mammalian miRNAs have been estimated to regulate 30% of all protein-coding genes (Filipowicz 
et al., 2008; Izzotti and Pulliero, 2014).  
 
 
Figure 4.1. Mechanisms of gene silencing by miRNAs. Mature miRNAs can silence genes via 
RISC, either by mRNA degradation or by translational repression. 
 
Several studies have demonstrated the involvement of miRNAs in carcinogenesis (Lema 
and Cunningham, 2010; Berindan-Neagoe et al., 2014; Izzotti and Pulliero, 2014; Tessitore et al., 
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2014; Nicolaidou and Koufaris, 2015). While miRNAs offer mechanistic insight into chemical 
carcinogenesis, they also represent a potential tool for the detection of exposure to, or damage 
from, chemical carcinogens. To evaluate the potential role of miRNAs in the tissue-specificity of 
BD-inducted carcinogenesis, we investigated changes in miRNA expression as a result of 
exposure to the genotoxic chemical 1,3-butadiene (BD) in both target (liver and lung) and non-
target (kidney) tissues of BD-induced carcinogenesis. Additionally, the relationship between 
changes in expression of miRNAs and their target mRNAs was investigated.  
To understand if genetic heterogeneity confers differential responses to BD exposure at 
the mRNA and/or miRNA level, two inbred mouse strains that have been shown to have different 
responses to BD exposure were used: C57BL/6J, a strain known to be susceptible to DNA 
damage and global changes to the epigenome that are indicative of genomic instability, and 
Castaneous (CAST/EiJ), a strain that has been shown to be resistant to those same BD-
responses (Koturbash et al., 2011). These studies were conducted to address the hypothesis that 
BD-induced alterations in mRNA and miRNA vary across strains and tissues, and that 
differentially expressed miRNAs modulate the transcriptional responses to BD.   
Using next generation sequencing technologies to evaluate the expression profiles of both 
miRNAs and mRNAs, we observed highly tissue- and strain-specific alterations at both the gene 
and miRNA level. Specifically, a higher number of mRNAs and miRNAs were altered in the 
C57BL/6J mice (representing the strain more susceptible to BD-induced damage) relative to 
CAST/EiJ, and the most induction of either end-point was observed in the lung in both strains. In 
the lung, genes related to xenobiotic metabolism were variable between CAST/EiJ and C57BL/6J 
mice that were only exposed to clean air, suggesting that basal-level differences in gene 
expression influence the variation in response between the two strains under identical exposure 
conditions. Many of the same genes were induced in both strains by exposure to BD, resulting in 
a similar level of expression between the two strains after exposure to BD for two weeks. Further, 
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a distinct set of miRNAs were up-regulated in the lung of C57BL/6J mice that are related to DNA 
damage response, while the level of change in miRNAs in CAST/EiJ was minimal. 
 
4.2. Materials and Methods 
Animals and experimental design 
Male C57BL/6J and CAST/EiJ mice (Jackson Laboratory, Bar Harbor, ME) were housed 
in sterilized cages in a temperature-controlled (24°C) room with a 12/12-hr light/dark cycle, and 
given ad libitum access to purified water and NIH-31 pelleted diet (Purina Mills, Richmond, IN, 
USA). After two weeks of acclimation, the mice (9-13 weeks of age) were randomly allocated into 
a control group exposed to clean air or an experimental group exposed to approximately 625 ppm 
BD. Exposures were conducted 6 hr/day, 5 days/week (Monday through Friday) for two 
consecutive weeks. Each experimental day, mice were placed in a cylindrical metal mesh holder 
for the duration of exposure and then returned to their cages. The concentration of BD in the 
exposure chambers was monitored at the beginning and at end of each exposure period using 
gas chromatography as detailed below. Following the final exposure, mice were euthanized by 
exsanguination following deep nembutal (100 mg/kg intraperitoneal injection) anesthesia. Livers, 
lungs, and kidneys were excised and snap-frozen immediately in liquid nitrogen and stored at –
80°C for subsequent analyses. The animals were treated humanely and with regard for alleviation 
of suffering.  All procedures were approved by the Institutional Animal Care and Use Committee 
at the University of North Carolina at Chapel Hill.  
Measurement of BD concentration 
The concentration of BD in the exposure chamber was monitored twice a day: an hour 
after the beginning and an hour before the end of each exposure. An air sample was taken from 
the chamber and analyzed with a CP-3800 (Varian, Inc., Walnut Creek, CA) gas chromatograph. 
The gas chromatograph utilized a 10 milliliter gas sample loop injector flushed from a sample 
Teflon bag, then purged with a sample of the exposure gas injected into a separation column to 
113 
isolate the BD from the air for integration of the response with a flame ionization detector. The 
stainless steel packed column (30 ft long, 1/8 inch in diameter) was a Supelco (Bellefonte, PA) 
part number 12809-U with 23% SP-1700 active phase on 80/100 Chromosorb PAW support. The 
instrument was calibrated by analysis of eight-component hydrocarbon mixture commercial gas 
standard (chappeRef#88-104317) prepared by National Specialty Gases (Morrisville NC) and 
certified using National Institute of Standards and Technology traceable standards with 5% 
uncertainty.  
Determination of N7-guanine adduct formation 
Genomic DNA was isolated from flash-frozen mouse liver, lung, and kidney tissues using 
a Qiagen DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions. Measurement of N-7-(2,3,4-trihydroxybut-1-yl)-guanine (THB-Gua) was performed 
by liquid chromatography/positive ion electrospray ionization/tandem mass spectrometry 
(LC/ESI+MS/MS) as described in (Goggin et al., 2009) with minor modifications. Briefly, DNA (100 
μg) from each sample was spiked with 500 fmol of the internal standard: stable isotope labeled 
THB-Gua (racemic [15N5]-THB-Gua), and adjusted with deionized water to a volume of 400 μL. 
Samples first underwent neutral thermal hydrolysis at 95°C for 30 minutes to separate the purines 
from the DNA backbone, and the samples were centrifuged through an Amicon 10K filter (Millipore 
Corporation, Billerica, MA) to collect the separated purine bases (including adducted bases). The 
samples were then purified by off-line HPLC using a Sunfire 4.6 x 250 mm column (Waters, 
Milford, MA) at a flow rate of 1 mL/minute with 10 mM ammonium formate at a pH of 4.3 serving 
as mobile phase A, and methanol as mobile phase B. Collected fractions were completely dried 
by vacuum centrifugation and then reconstituted in 20 µL of water before injection into the 
ACQUITY UPLC HSS T3 C18 column (2.1 x 100 mm, 1.8 um at 200 µL/min) (Waters) coupled to 
a TSQ Quantum Ultra triple quadrupole mass spectrometer (Thermo Fisher Scientific, Waltham, 
MA). Mobile Phase A was 0.1% acetic acid in water, and mobile phase B was again methanol. A 
gradient elution method from 1% B to 80% B over five minutes was used to achieve separation 
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with a total cycle time of 15 minutes per injection. Quantitation of the THB-Gua analyte and 
internal standard was performed by selected reaction monitoring using precursor to fragment ion 
transitions of m/z 256.1→152.1 (THB-Gua) and m/z 261.1→157.1 ([15N5]-THB-Gua) with a 
collision energy of 20 V for both.  
RNA isolation 
Total RNA was isolated from flash-frozen tissues using a Qiagen miRNeasy Kit (Valencia, 
CA) that preserves both miRNA and mRNA content. RNA purity and integrity were evaluated 
using a Thermo Scientific Nanodrop 2000 (Waltham, MA) and an Agilent 2100 Bioanalyzer (Santa 
Clara, CA), respectively. A minimum RNA integrity value (RIN) of 7.0 was required for RNA 
samples to be used for library preparation and sequencing. 
Small RNA and mRNA sequencing  
Small RNA libraries were generated using an Illumina TruSeq Small RNA Sample 
Preparation Kit (San Diego, CA). A total of 14 to 20 libraries were assigned to each sequencing 
lane, and single-end (50bp) sequencing was performed using the Illumina HiSeq 2500 platform. 
miRNAs were annotated and quantified using a bioinformatics analysis pipeline as described in 
Baran-Gale, et al (Baran-Gale et al., 2013). Briefly, small RNA-seq reads were first trimmed by 
cutAdapt (parameters -O 10–e 0.1) to remove remnants of the 3′-adaptor sequence. A minimum 
of a 10 base overlap and a maximum of 1 base mismatch were allowed in the adapter sequence, 
and any reads separated by 65 nt or less were merged. A tiered mapping approach was utilized 
to first obtain exact match reads to the appropriate reference genomes (NCBI mm9 or an in-
house-created reference for C57BL/J and CAST/EiJ, respectively) using Bowtie (Langmead et 
al., 2009) (parameter set: -q -a -m 20 -n 0 -e 70), and to subsequently align remaining sequences 
aligned to appropriate reference genomes (NCBI mm9 or an in-house created reference for 
C57BL/6J and CAST/EiJ, respectively) that contained a maximum of one mismatch in the body 
or up to 3 mismatches at the 3’-end (depending on the length of the read) using SHRimP2 (David 
et al., 2011).  
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Libraries for RNA sequencing (RNA-seq) were prepared using the Illumina TruSeq Total 
RNA Sample Prep Kit (Illumina, Inc., San Diego, USA) with ribosomal depletion, according to the 
manufacturer’s instructions. Paired-end (50bp) sequencing was carried out using the Illumina 
HiSeq 2500 platform. RNA-seq reads were aligned to appropriate reference genomes (NCBI mm9 
or an in-house-created reference for C57BL/6J and CAST/EiJ, respectively) using GSNAP 
software (Wu and Nacu, 2010).  
Sequencing mapping statistics were compared across all samples for both small RNA 
sequencing and total RNA sequencing (Appendices 4.1 and 4.2).  
Identification of differentially expressed mRNAs and miRNAs 
Genes and miRNAs that were differentially expressed between BD-treated mice and 
control mice, or between CAST/EiJ and C57BL/6J, were identified using the DESeq2 R package 
(Love et al., 2014). DESeq2 employs a normalization method that accounts for compositional bias 
in sequenced libraries and individual library size. This method calculates a size factor for each 
sample as the median ratio of the read count relative to the corresponding row geometric average 
(i.e. that gene for all samples in a group), and then divides the raw counts by that associated size 
factor. The size factor is an estimate of the necessary correction factor for all read counts of the 
corresponding column, which is then applied to enable appropriate sample-to-sample 
comparisons. The adjusted counts undergo a Wald test followed by Benjamini-Hochberg 
correction for multiple testing (Benjamini and Hochberg, 1995) to identify genes or microRNAs 
that are significantly differentially expressed (q-value of <0.1). 
Geneset enrichment analysis 
 To identify functionally related sets of genes that are enriched for BD-induced differentially 
expressed genes, we employed Gene Set Association Analysis for RNA-seq (GSAASeqSP) 
(Java-based software is freely available at http://gsaa.unc.edu) (Xiong et al., 2012; Xiong et al., 
2014b) using the Preranked mode and permuting genes. The input for GSAA was the DESeq2 
output ranked by the Wald statistic, and 2,000 permutations of the genes were executed. We 
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tested enrichment of the genes in our study among a set of mouse-specific genesets curated by 
the Baderlab group at the University of Toronto (http://baderlab.org/GeneSets) based on the 
Reactome Pathway Database (http://www.reactome.org/) (Merico et al., 2010). Genesets with an 
FDR <0.05 were considered to be significantly enriched, and were then compressed into several 
geneset “themes” based on mutual inclusion of the genes not only in the geneset, but specifically 
among the “core genes” within each geneset that were responsible for the enrichment.  
Identification of miRNA regulatory hubs 
Candidate master miRNA regulators of mRNA expression among the BD-altered genes 
were identified using miRhub as described in Baran-Gale, et al (Baran-Gale et al., 2013). This 
algorithm determines if the predicted regulatory effect of any given miRNA on a set of differentially 
expressed (DE) genes is significantly greater than what is expected by chance, using a Monte 
Carlo simulation. Briefly, seed-based target predictions were used to determine the number of 
predicted conserved targets among the differentially expressed genes in each tissue and strain 
for each expressed miRNA in the same tissue/strain (target prediction, genes and corresponding 
3′-UTR sequences were downloaded from http://www.targetscan.org (Lewis et al., 2005)). Each 
predicted miRNA–gene interaction was scored based on the strength of the seed match, the level 
of conservation of the target site, and the clustering of target sites within the 3′-UTR of the target 
gene. A final targeting score was calculated for each miRNA by averaging the score of all target 
genes of that miRNA. This procedure was repeated 1,000 times with a set of randomly selected 
genes each time to generate a background distribution of the predicted targeting scores for each 
miRNA, and to derive an average score for each miRNA family based on random gene networks. 
These score distributions were then used to calculate an empirical p-value of the targeting score 
for each miRNA, which was then corrected for multiple hypothesis testing.  
The set of differentially expressed genes used for miRhub analysis were those genes that 
were significantly differentially expressed (q<0.1) in BD-treated mice relative to vehicle-control 
mice, as determined by DESeq2. To adhere to the miRhub input requirements, the mouse 
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associated gene names were converted to human associated gene names using the Ensembl 
BioMart tool (www.ensembl.org/biomart/martview), and all expressed miRNAs were converted to 
the associated TargetScan family name based on the miRNA precursor seed sequence. miRhub 
was executed using the mouse genome (taxon identifier 10090) as the species of interest; i.e. 
miRNA-gene interactions characterized for mouse.  
 
4.3. Results 
Air concentrations of BD in the exposure chambers 
 The concentration of BD was monitored by gas chromatography of air samples taken from 
the exposure chamber approximately one hour after beginning and approximately one hour before 
ending the six hour exposure each day. Over the ten day duration of the experiment, the average 
concentration of BD in the exposure chamber was 593±61ppm, slightly under the goal of 625ppm 
(Figure 4.2). This exposure concentration is within the range of concentrations that have been 
reported to cause tumors in the liver and the lung of BD-exposed B6C3F1 mice in chronic 
inhalation studies (6.25-1,250 ppm) (Melnick and Sills, 2001; IARC, 2008). Further, BD has been 
shown to have a supralinear exposure-response curve in mice exposed to BD at levels between 
0 and 625ppm, (Melnick and Sills, 2001), confirming that 594ppm is a concentration that is 
expected to cause tumorigenesis, and is therefore applicable for the study of BD-induced 
tumorigenicity. 
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Figure 4.2. Concentration of 1,3-butadiene inside the inhalation chamber. Data are presented as 
mean±SD. 
 
DNA damage varies across tissues and strains 
 The level of THB-Gua was higher in each tissue in the C57BL/6J mice exposed to BD 
compared to the corresponding tissue in the BD-exposed CAST/EiJ mice (Figure 4.3). This finding 
is consistent with what has been previously shown in the liver (Koturbash et al., 2011). We also 
observed that the highest amount of THB-Gua adducts was in the lung, followed by the kidney, 
followed by the liver, in both strains, which is consistent with the pattern of inter-tissue differences 
previously reported in C57BL/6J mice (Chappell et al., 2014). 
 
Figure 4.3. Level of N-7-(2,3,4-trihydroxybut-1-yl)-guanine (THB-Gua) adducts. Center lines 
represent the median, error bars represent SD. 
 
Day1 Day2 Day3 Day4 Day5 Day6 Day7 Day8 Day9 Day10
BD conc. 542 557 584 605 579 575 607 623 646 610
0
100
200
300
400
500
600
700
800
PP
M
 1
,3
-b
ut
ad
ie
ne
119 
Whole transcriptome analysis reveals tissue- and strain-specific enrichment of functional 
genesets 
  An average of 47,955,383 reads were obtained per sample by RNA-sequencing, of which 
an average of 70 and 69% uniquely mapped to the appropriate reference genome (C57BL/6J and 
CAST/EiJ, respectively) (Appendix 4.2). The number of differentially expressed (DE) genes varied 
across tissues and strains (Figure 4.4 A and B), and the set of DE genes in each tissue and strain 
was relatively distinct (Figure 4.4 C-E).  
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Figure 4.4. BD-induced differentially expressed genes in C57BL/6J (A) and CAST/EiJ (B) mice. 
The numbers in red indicate the number of differentially expressed genes (q<0.1). The specific 
differentially expressed genes were also different for each tissue between strains (C), as well as 
be between tissues with the same strain (D and E). All of the plotted points in C-E represent 
differentially expressed genes, and the different colors indicate if each gene is common or unique 
within each combination of tissue and strain.  
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To detect potential driver gene networks involved in BD-induced toxicity, genesets that 
were enriched with differentially expressed genes were identified using GSAASeqSP, as 
described in the Materials and Methods section. The enriched genesets were selected using a 
false discovery rate (FDR) cutoff of <0.05, and significant genesets were then grouped into 
geneset themes (when applicable) by similarity in the “core enrichment” genes within the genesets 
(Table 4.1). The core enrichment genes are those genes that contribute the most to the 
association with a phenotype or treatment, and thus drive the enrichment of that geneset.  
We found that genesets associated with phase II metabolism, specifically glutathione 
conjugation, were highly enriched among up-regulated genes in the lung of both CAST/EiJ and 
C57BL/6J mice exposed to BD (Table 4.1). Glutathione conjugation-associated genesets were 
also among the top most up-regulated genes upon exposure to BD in the liver of C57BL/6J mice, 
and the glutathione conjugation genes were significantly enriched among up-regulated genes in 
the kidney of C57BL/6J mice exposed to BD (although not as strongly as in the liver or the lung 
(higher FDR)). Interestingly, the mRNA level of phase I and II metabolism genes was significantly 
higher in lung, and phase I metabolism genes in the liver of the CAST/EiJ exposed to clean air 
relative to that of the same tissues in C57BL/6J mice exposed to clean air (Table 4.1).  
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Table 4.1. Compilation of the top enriched genesets for each strain and exposure group. 
Genesets were grouped by “theme” according to similarity in the core enrichment genes. The 
geneset themes displayed are those that included genesets with the lowest FDRs among all 
genesets, or the highest number of genesets that could be grouped into a theme, or a combination 
of the two. 
 
Inter-strain differences without 1,3-butadiene: clean air-exposed CAST vs. clean air-exposed C57BL6 
Tissue Strain Direction # genesets FDR<0.5 Top geneset “themes” 
Lung 
CAST UP 100 
TCA cycle and respiratory electron transport   
Mitochondrial translation 
Phase II conjugation, glutathione conjugation, xenobiotic metabolism 
Translation (ribosomal proteins) 
Cell signaling, mitosis (proteosomal subunits) 
C57BL6 UP 10 cell signaling 
T-cell receptor signaling 
interferon signaling 
PD-1 
Antigens activate b cell receptor 
Liver 
 
CAST UP 4 Phase I metabolism 
C57BL6 UP 0  
Kidney 
 
CAST UP 8 
Signaling by retinoic acid 
TCA cycle and respiratory electron transport chain 
Mitochondrial translation 
C57BL6 UP 6 Interferon signaling Cholesterol biosynthesis, activation of gene expression by Srebp 
 
Treatment effect: BD-exposed mice relative to control, each strain independently evaluated 
Strain Tissue Direction # genesets FDR<0.5 Top geneset “themes” 
C57BL6 
 
Lung 
UP 164 
Phase II conjugation, glutathione conjugation, xenobiotic metabolism 
DNA synthesis, DNA repair 
mitosis 
NER and BER 
 
TCA cycle and respiratory electron transport 
DOWN 73 
G-PROTEIN BETA:GAMMA SIGNALLING 
cell signaling 
T-cell signaling 
interferon signaling 
TLR signaling 
O-linked glycosylation 
Liver 
 
UP 9 
Muscle contraction 
Glucose metabolism 
Glutathione conjugation 
Platelet calcium homeostasis 
DOWN 25 
Cholesterol biosynthesis, activation of gene expression by Srebp 
Endosomal vacuolar pathway 
“immune response” 
Antigen presentation 
interferon signaling 
immunoregulatory interactions 
DNA synthesis, DNA repair 
Kidney 
 
UP 37 
Mitosis, cell cycle, (resolution of sister chromatid cohesion, double 
strand break repair) 
Kinesins 
Glutathione conjugation 
DOWN 
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Translation 
histones 
epigenetic regulation 
DNA methylation 
meiosis 
Chromatin organization 
Transcription (RNA polymerase) 
Mitochondrial translation 
Antigen processing and presentation 
Respiratory electron transport 
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Treatment effect: BD-exposed mice relative to control, each strain independently evaluated 
Strain Tissue Direction # genesets FDR<0.5 Top geneset “themes” 
Cast 
Lung 
UP 3 
Glutathione conjugation 
Iron uptake and transport 
Interleukin signaling 
DOWN 138 
TCA cycle and respiratory electron transport 
histones  
DNA methylation 
epigenetic regulation of gene 
expression 
histone methylation/acetylation 
Phase I metabolism 
Liver 
 
UP 19 
Defensins 
porphyrin metabolism 
TCA cycle and respiratory electron transport 
translation 
DOWN 7 
Interferon signaling 
Muscle contraction 
Antigen presentation 
Kidney 
 
UP 23 
Collagen biosynthesis and formation 
Laminin interactions 
PI3K cascade 
DOWN 185 
Translation 
DNA synthesis, DNA damage response 
TCA cycle and respiratory electron transport 
 
Inter-strain differences after exposure: BD-exposed CAST vs. BD-exposed C57BL6 
Tissue Strain Direction total FDR<0.05 top geneset “themes” 
Lung 
CAST UP 0  
C57BL6 UP 26 
histones DNA methylation 
meiotic recombination 
histone methylation/acetylation 
DNA damage repair 
Liver 
 
CAST UP 12 
RNA polymerase, non-coding RNA metabolism 
xenobiotic metabolism 
mitochondrial translation 
C57BL6 UP 1 muscle contraction 
Kidney 
 
CAST UP 6 
TCA cycle and respiratory electron transport 
Signaling by retinoic acid 
Amino acid synthesis 
C57BL6 UP 5 Interferon signaling Cholesterol biosynthesis, activation of gene expression by Srebp 
 
Genes related to immune response, particularly cell signaling (interferon signaling, T-cell 
signaling, and antigen presentation, among others), were down-regulated in the lung and liver of 
C57BL/6J mice exposed to BD. Some of the same gene clusters were significantly down-
regulated in the kidney of BD-exposed C57BL/6J mice as well, although less genesets and with 
lower significance (higher FDR). This trend was also observed in the lung and liver of BD-exposed 
CAST/EiJ mice, although to a much lesser degree. Interestingly, immune-related genes were 
higher in the lung of C57BL/6J mice relative to CAST/EiJ mice that were only exposed to clean 
air, and many of these same genes were down-regulated in BD-exposed C57BL/6J mice relative 
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to that of CAST/EiJ. Several DNA damage recognition and repair pathway genesets were 
enriched in the lung and lost in the liver of C57BL6 mice exposed to BD. Some of the same 
genesets were down-regulated in the kidney of BD-exposed CAST/EiJ mice, but no well-
characterized DNA repair genes were represented in the core enrichment genes; rather, 
proteosomal subunits and histone genes drove the enrichment. Additionally, several genesets 
associated with double strand break repair and resolution of sister chromatid exchange were up-
regulated in the kidney of C57BL/6J mice. In the lung of mice exposed to BD, base excision repair 
genes were more highly expressed in C57BL/6J compared to CAST/EiJ, including Pcna, Hjurp, 
and Lig3. 
Muscle contraction genesets were significantly up-regulated in the liver of C57BL/6J mice 
exposed to BD, but were among the significantly downregulated genesets in CAST/EiJ liver. 
Interestingly, genesets related to epigenetic regulation of gene expression were down-regulated 
in the kidney of C57BL/6J, and in the lung of CAST/EiJ mice exposed to BD, and were more 
highly expressed in the lung C57BL/6J mice after exposure to BD relative to that of CAST/EiJ 
after exposure to BD.  
Small RNA-sequencing reveals distinct miRNA signatures by tissue and treatment 
While both microarray and sequencing technologies offer the ability to quantitate relative 
differences in miRNA expression between samples or groups of samples, sequencing presents 
advantages over microarrays in the form of heightened sensitivity and dynamic range (Motameny 
et al., 2010). This sensitivity affords the ability to detect very lowly expressed miRNAs, as well as 
to distinguish between highly similar sequences, such as miRNA family members or isoforms of 
miRNAs (isomiRs). We obtained an average of 7,788,200 reads per sample, of which an average 
of 50 and 29% were mapped to the appropriate reference genome (C57BL/6J and CAST/EiJ, 
respectively) (Appendix 4.2). Using an adjusted p-value (q-val) of <0.1 as the criteria for 
significance, we identified 5, 142, and 88 significantly differentially expressed miRNAs in the liver, 
lung, and kidney, respectively, of BD-exposed C57BL/6J mice relative to vehicle-controls of the 
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same strain, and 0, 16, and 15 in the liver, lung, and kidney, respectively, of BD-exposed 
CAST/EiJ mice relative to controls (Appendix 4.3). Using log2(fold change) > |1.0| as an additional 
criteria to identify the miRNAs that were the most affected by BD exposure, we identified 14 
differentially expressed miRNAs in the lung of BD-exposed C57BL/6J mice, 9 in the kidney, and 
none in the liver (Figure 4.5 and Table 4.2). For CAST/EiJ, we only identified 1 miRNA that met 
these criteria: down regulation of miR-490-3p in the lung. 
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Figure 4.5. BD-induced differentially expressed miRNAs in C57BL/6J (A) and CAST/EiJ (B) mice. 
The number of miRNAs indicated in blue is the number of miRNAs that were aligned for each 
strain and tissue, and the number in red indicates the number of differentially expressed miRNAs. 
The specific differentially expressed miRNAs were also different for each tissue between strains 
(C), as well as be between tissues with the same strain (D and E). All of the plotted points in C-E 
represent differentially expressed miRNAs, and the different colors indicate if each gene is 
common or unique within each combination of tissue and strain.  
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Table 4.2. Top-most significantly differentially expressed miRNAs (q-val <0.1 and log2(fold 
change) > |1.0|). 
C57BL6 LUNG Mean expression of    BD-exposed mice 
log2(fold 
change) q-value 
mmu-mir-449c-5p 872.6 1.6 8.4E-34 
mmu-mir-150-5p 12918.5 -1.3 6.1E-08 
mmu-mir-34a-5p 572.3 1.1 1.2E-06 
mmu-mir-449a-5p 736.0 1.3 1.2E-06 
mmu-mir-24-2-3p 6591.2 1.0 3.1E-06 
mmu-mir-24-1-3p 6591.3 1.0 3.1E-06 
mmu-mir-1964-3p 71.4 -1.0 6.5E-05 
mmu-mir-296-5p 5.9 1.6 6.5E-05 
mmu-mir-501-5p 5.3 1.6 6.7E-05 
mmu-mir-342-5p 33.4 -1.0 1.1E-03 
mmu-mir-150-3p 18.8 -1.2 2.3E-03 
mmu-mir-369-5p 3.8 1.1 4.1E-03 
mmu-mir-130b-5p 33.3 -1.0 1.1E-02 
mmu-mir-31-3p 35.1 1.0 2.0E-02 
    
C57BL6 KIDNEY Mean expression of    BD-exposed mice 
log2(fold 
change) q-value 
mmu-mir-34a-5p 1286.5 1.0 1.1E-08 
mmu-mir-193b-3p 317.2 1.1 1.8E-08 
mmu-mir-128-1-3p 229.5 -1.2 1.6E-07 
mmu-mir-128-2-3p 118.7 -1.0 5.4E-06 
mmu-mir-423-5p 1979.6 -1.1 1.2E-05 
mmu-mir-92a-2-3p 3071.4 -1.0 1.9E-05 
mmu-mir-149-5p 678.6 -1.0 1.8E-04 
mmu-mir-1964-3p 40.8 -1.1 3.0E-04 
mmu-mir-146b-5p 665.1 1.2 1.1E-02 
    
CAST LUNG Mean expression of    BD-exposed mice 
log2(fold 
change) q-value 
mmu-mir-490-3p 399.8 -1.1 6.6E-09 
 
Members of the miR-34/449 family are candidate drivers of BD-induced differential gene 
expression in the lung of C57BL/6J mice 
To determine if the predicted regulatory effect of differentially expressed miRNAs on a set 
of DE genes is greater than expected by chance, we used the miRHub algorithm (Baran-Gale et 
al., 2013). Fifteen miRNA families were identified as candidate master regulators of genes that 
are downregulated in the lung of BD-exposed mice (Table 4.3), of which one (miR-34ac/34bc-
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5p/449abc/449c-5p) included miRNAs that were significantly differentially expressed (up-
regulated) in the lung of BD-exposed C57BL/6J mice.  
Table 4.3. miRNA families identified to be master regulators of mRNA expression in C57BL/6J 
lung. Actual Rank Score indicates the score for the miRNA family based on the complementarity 
between miRNA seed sequences and target mRNA sequences within the 3’ UTR of the gene, 
as well as connectivity of the genes in a designated list (in this case, differentially expressed 
genes in the lung of BD-exposed C57BL/6J mice). Average Random Score is derived using the 
same method, but using random gene networks of similar size to the actual input gene list, and 
taking an average score for the 1,000 permutations (see Materials and Methods section, or 
(Baran-Gale et al., 2013) Suppl. materials for more details). 
 
miRNA family 
Actual  
Rank Score 
Average 
Random Score 
Empirical 
p-value q-value 
miR-331/331-3p 0.38 0.30 1.0E-05 3.0E-02 
miR-185/882/3473/4306/4644 0.56 0.47 1.0E-05 3.0E-02 
miR-423a/423-5p/3184/3573-5p 0.42 0.34 1.0E-05 3.0E-02 
miR-122/122a/1352 0.26 0.22 1.0E-05 3.0E-02 
miR-339b/339-5p/3586-5p 0.32 0.28 1.0E-05 3.0E-02 
miR-342-5p/4664-5p 0.41 0.30 1.0E-05 3.0E-02 
miR-34ac/34bc-5p/449abc/449c-5p 0.41 0.35 2.0E-03 4.4E-02 
miR-744/1716 0.11 0.08 2.0E-03 4.4E-02 
miR-151-5p/151b 0.09 0.06 3.0E-03 5.3E-02 
miR-138/138ab 0.34 0.30 3.0E-03 5.3E-02 
miR-133abc 0.25 0.22 4.0E-03 6.5E-02 
miR-541 0.20 0.18 5.0E-03 6.8E-02 
miR-326/330/330-5p 0.53 0.48 5.0E-03 6.8E-02 
miR-671-5p 0.37 0.33 6.0E-03 7.1E-02 
miR-1843-5p/4802-5p 0.30 0.27 6.0E-03 7.1E-02 
 
We then used the DAVID functional annotation tool (Huang et al., 2009) to find enriched 
genesets among the down-regulated genes in the lung of BD-exposed C57BL/6J mice genes that 
are predicted targets of the miR-34ac/34bc-5p/449abc/449c-5p family, using genesets defined by 
gene ontology terms. We found clusters of genes that regulate transcription, as well as genes that 
are involved in immune cell differentiation and activation, cell adhesion, and signal transduction 
were enriched (Table 4.4).  
 There were no significantly differentially expressed miRNAs that were identified as 
candidate master regulators of genes that were differentially expressed in the concordant 
direction (up-regulated miRNA and down-regulated target mRNA, or down-regulated miRNA and 
up-regulated target mRNA) in any other tissues for either strain. 
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Table 4.4. Functional annotation clustering of mRNA targets of the miRNA 34/449 family that 
were down-regulated in the lung of C57BL/6J BD-exposed mice. Only significant genesets (FDR 
<0.05) are shown. Size refers to the number of genes included in that geneset. Annotation Cluster 
7 is missing because no genesets had an FDR <0.05. 
Annotation Cluster 1 - Enrichment Score: 7.29 
 
 
  Annotation Cluster 3 - Enrichment Score: 4.50 
 
 
Gene Ontology Term Size FDR   Gene Ontology Term Size FDR 
regulation of transcription from RNA polymerase 
  
55 2.5E-08   immune system development 30 1.5E-04 
negative regulation of transcription 36 2.0E-05   hemopoietic or lymphoid organ 
 
29 1.8E-04 
negative regulation of gene expression 38 2.3E-05   hemopoiesis 27 2.5E-04 
negative regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 
37 3.2E-05   leukocyte activation 24 1.0E-03 
negative regulation of nitrogen compound 
metabolic process 
37 4.2E-05   leukocyte differentiation 19 1.1E-03 
negative regulation of transcription, DNA-
dependent 
31 1.1E-04   lymphocyte differentiation 17 1.2E-03 
negative regulation of macromolecule 
biosynthetic process 
37 1.2E-04   cell activation 24 7.6E-03 
negative regulation of RNA metabolic process 31 1.2E-04   lymphocyte activation 20 2.2E-02 
negative regulation of transcription from RNA 
   
26 1.8E-04   Annotation Cluster 4 - Enrichment Score: 4.91 
 
 
negative regulation of macromolecule metabolic 
process 
41 2.3E-04   Gene Ontology Term Size FDR 
negative regulation of cellular biosynthetic 
process 
37 2.4E-04   regulation of Ras protein signal 
transduction 
25 6.3E-06 
negative regulation of biosynthetic process 37 3.1E-04   regulation of small GTPase mediated signal 
transduction 
28 8.2E-06 
regulation of RNA metabolic process 83 9.4E-04   GTPase regulator activity 33 2.8E-04 
regulation of transcription, DNA-dependent 82 1.0E-03   nucleoside-triphosphatase regulator 
 
33 4.0E-04 
transcription repressor activity 23 1.6E-03   small GTPase regulator activity 22 1.4E-02 
Annotation Cluster 2 - Enrichment Score: 6.17 
 
  
  
 Annotation Cluster 5 - Enrichment Score: 3.77 
 
 
Gene Ontology Term Size FDR  Gene Ontology Term Size  FDR 
regulation of transcription from RNA polymerase 
II promoter 
55 2.5E-08   cell-cell adhesion 22 4.2E-02 
regulation of transcription 120 6.1E-06   Annotation Cluster 6 - Enrichment Score: 3.75 
 
 
transcription regulator activity 76 1.9E-05   Gene Ontology Term Size FDR 
transcription 96 3.4E-04   neuron projection development 22 1.3E-02 
positive regulation of gene expression 39 7.0E-04   cell morphogenesis involved in 
 
21 2.8E-02 
regulation of RNA metabolic process 83 9.4E-04   cell motion 29 3.6E-02 
regulation of transcription, DNA-dependent 82 1.0E-03   Annotation Cluster 8 - Enrichment Score: 3.27 
 
 
positive regulation of macromolecule 
biosynthetic process 
40 2.0E-03   Gene Ontology Term Size FDR 
positive regulation of cellular biosynthetic 
 
41 2.2E-03   cell-cell adhesion 22 4.2E-02 
positive regulation of transcription 37 2.7E-03   Annotation Cluster 9 - Enrichment Score: 3.21 
 
 
positive regulation of biosynthetic process 41 2.7E-03   Gene Ontology Term Size FDR 
positive regulation of transcription, DNA-
 
34 2.8E-03   phosphate metabolic process 59 1.2E-04 
positive regulation of RNA metabolic process 34 3.2E-03   phosphorus metabolic process 59 1.2E-04 
positive regulation of macromolecule metabolic 
process 
44 4.7E-03   protein amino acid phosphorylation 47 4.2E-04 
positive regulation of nucleobase, nucleoside, 
nucleotide and nucleic acid metabolic process 
38 5.4E-03   phosphorylation 49 1.9E-03 
transcription factor activity 50 5.7E-03   Annotation Cluster 10 - Enrichment Score: 3.11 
 
 
DNA binding 91 7.5E-03   Gene Ontology Term Size FDR 
positive regulation of nitrogen compound 
metabolic process 
38 1.1E-02   cell motion 29 3.6E-02 
sequence-specific DNA binding 39 1.3E-02      
transcription activator activity 24 1.5E-02      
positive regulation of transcription from RNA 
polymerase II promoter 
29 2.3E-02      
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4.4. Discussion 
Exposure to the genotoxic chemical BD caused tissue- and strain-specific alterations in 
both mRNA and miRNA expression in mice after short-term exposure by inhalation. Several 
toxicity and biologically relevant genesets, as well as miRNAs, emerged in the analysis. These 
alterations may be associated with the tissue-specificity of tumorigenesis that has been observed 
in longer term studies of mice exposed to similar levels of BD by inhalation (Melnick and Sills, 
2001), as well as with previously reported differences in the level of DNA damage, global histone 
modifications and DNA methylation between tissues (Chappell et al., 2014) and between the two 
strains discussed herein (Koturbash et al., 2011). 
Distinct gene expression profiles were observed between strains in both BD-exposed and 
clean-air exposed mice 
The difference in the number of genes that were differentially expressed between the two 
mouse strains independent of exposure to BD was substantial (Figure 4.6), a finding that is 
expected due to the known genetic variation between different inbred mouse strains (Keane et 
al., 2011). The C57BL/6J (a Mus musculus domesticus sub-species) mice are a classical 
laboratory mouse, while CAST/EiJ (a Mus musculus castaneous sub-species) is a more wild-
derived mouse strain that has a large amount of DNA variation relative to most traditional 
laboratory inbred strains. Many more genes were differentially expressed between the two strains 
for each individual tissue, both after exposure to clean air and after exposure to BD, relative to 
the number of BD-induced differentially expressed genes for any tissue within one strain. 
We used a geneset-based approach to identify gene networks or pathways that are most 
related to the response to BD exposure. This type of approach offers advantages over 
conclusions drawn on single gene alteration by recognizing the associations that naturally exist 
within sets of biologically related genes, and thus potentially reducing the false positives and the 
uncertainty around causal genes or variants. Geneset association analysis also provides insight 
into functional links between connected genes or variants, and may enable the detection of a 
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significant biological effect distributed over multiple genes even in the event that changes in 
several genes have small individual effects (Xiong et al., 2014a). Interestingly, we observed a 
higher level of expression of genes that are pertinent to xenobiotic metabolism in the lung and the 
liver, target tissues of BD-induced carcinogenesis, in the control CAST/EiJ mice compared to 
control C57BL/6J (Table 4.1), This suggests that the CAST/EiJ basal level activity of glutathione-
s-transferase genes and cytochrome P450s leads to variation in the metabolism of BD between 
the two strains, which may contribute to the differences in DNA-BD adducts observed between 
the strains. For example, more BD intermediates may be conjugated and excreted in the urine in 
the CAST/EiJ mice, as opposed to reacting with DNA or being further metabolized to additional 
DNA-reactive intermediates, relative to C57BL/6J mice. Further, while phase II conjugation 
genesets were enriched in all three tissues of C57B/6J mice, and in the lung of CAST/EiJ mice 
upon exposure to BD, when the gene expression between the two strains for each tissue was 
compared between BD-exposed mice, these xenobiotic metabolism genes were not different. 
These findings suggest that, while the CAST/EiJ mice may be genetically better “equipped” to 
detoxify BD, the C57BL/6J eventually match their more efficient counterparts in the expression of 
these important detoxification genes. 
 
Figure 4.6. Genes that are differentially expressed in CAST/EiJ mice relative to C57BL/6J after 
exposure to clean air for 2 weeks. 
 
132 
The decrease of immune function-related genes in the lung of C57BL/6J mice exposed to 
BD was an interesting and perhaps counter-intuitive finding; a heightened inflammatory or 
immune response may be an expected response, because inhalation of BD at the relatively high 
dose used in the present study would be expected to have irritant properties to the respiratory 
tract of the mice. However, immunosuppression is a common occurrence in humans and animals 
exposed to toxicants, including cigarette smoke (Mehta et al., 2008), pesticides (Banerjee et al., 
1996), and mycotoxins (Capriotti et al., 2012), all of which have genotoxic potential. Further, 
suppression of T-lymphocyte production has been reported in B6C3F1 mice that were exposed 
to 1,250 ppm BD by inhalation for 6 hr per day, 5 days per week, for 6 weeks, but was recovered 
to the same level as controls after 12 weeks of exposure (Thurmond et al., 1986). It is also 
generally accepted that immunosuppression is, in many cases, related to carcinogenesis (Pardoll, 
2015), and down-regulation of regulatory T-cells has also been shown to be associated with 
indoor exposure to benzene (another genotoxic chemical) (Herberth et al., 2014). The decrease 
in expression of immune-related genes was profound in C57BL/6J mice, and minimal in 
CAST/EiJ, another indicator of the generally higher resistance of CAST/EiJ to the effects of BD 
relative to C57BL/6J.  
The variation in expression of DNA damage recognition and repair genes between tissues 
and strains may be related to the variation in DNA damage between tissues and strains; base 
and nucleotide excision repair genes were up-regulated in the lung of C57BL/6J mice (the 
tissue/strain with the highest level of THB-Gua adducts, Figure 4.3), while strand-break repair 
genes were up-regulated in both the kidney and lung of C57BL/6J mice. No overt changes in DNA 
damage response genesets were observed in CAST/EiJ mice exposed to BD, the strain that had 
relatively lower levels of THB-DNA adducts. Specific genes within these genesets may be 
involved in carcinogenesis or in DNA damage repair for each tissue and strain. Further functional 
experiments would aid in understanding the functional role of these DNA damage genesets in 
BD-induced toxicity. Importantly, the DNA damage-related master tumor-suppressor gene p53 
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was significantly down-regulated in the lung of C57BL/6J mice exposed to BD (q= 4.4E-4, 
log2(fold change)= -0.70), and unaltered in every other tissue evaluated in either strain. 
The up-regulation of actin- and myosin-related genes that are members of the muscle 
contraction and related genesets in the liver of BD-exposed C57BL/6J mice may indicate that the 
development of fibrosis of the liver, which is associated with carcinogenesis in the liver (Seki and 
Schwabe, 2015), is more likely than in CAST/EiJ, in which these genes were down-regulated. 
While overt inflammation and/or fibrosis has not been observed histopathologically in tissue 
collected from mice of the same strains exposed to BD under highly similar conditions, it is 
possible the that changes in the expression of these genes precede the manifestation of the 
expression alterations and actual changes in tissue architecture.  
While several genesets related to epigenetic regulation were dysregulated in the kidney 
of BD-exposed C57BL/6J mice and the lung of CAST/EiJ mice, the vast majority of the genes 
driving the enrichment of these genesets included histone family genes, as opposed to 
methyltransferases or histone acetylaces and de-acetylaces. This suggests that these changes 
are more closely related to nucleosome assembly and DNA replication than specific epigenetic 
modifications. 
Expression of miRNAs is highly variable between tissues, and in response to exposure to 
1,3-butadiene 
The BD exposure-induced alterations in miRNA expression were highly tissue-specific, 
with only one miRNA identified that was differentially expressed and had a log2(fold change) > 
1.0 or < -1.0 in more than one tissue (miR-34a-5p in the lung and the kidney of C57BL/6J mice). 
In line with other endpoints, including the level of BD-DNA adducts, gene expression, and histone 
modifications, miRNA expression also appears to be much more highly inducible by BD exposure 
in C57BL/6J mice than in CAST/EiJ (Figure 4.5). Very few miRNAs were differentially expressed 
for the same tissue in both strains, and none of those overlapping miRNAs had a fold change > 
|1.0| (Figure 4.5 C).  
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The miRNA expression profile in C57BL/6J lung is associated with DNA damage and 
carcinogenesis 
miR-449a-5p and miR-449c-5p, which have  been shown to inhibit mitosis and DNA 
synthesis and cellular proliferation (Bou Kheir et al., 2011; Zhang et al., 2014), were significantly 
up-regulated in the lung of C57BL/6J mice after exposure to BD. miR-449 is inducible by DNA 
damage, and plays a role in mediation of DNA damage by reducing proliferation and promoting 
apoptosis through a positive feedback loop with E2f1 (Lize et al., 2010). Interestingly, in our study, 
the increase in abundance of miR449a-5p and miR-449c-5p in the lung tissue of BD-exposed 
C57BL/6J mice was not accompanied by a change in E2f1 mRNA level. This indicates that the 
induction of miR-449a/c-5p, while likely related to DNA damage, occurred independently of a 
change in E2f1 expression (mRNA BD-exposed relative to clean air exposed mice: q=0.74). 
Interestingly, the expression of miR-449a-5p and miR-449c-5p was higher in the lung of clean air-
exposed CAST/EiJ mice relative to that of C57BL/6J (miR-449a-5p: q=0.02, log2(fold 
change)=0.74; miR-449c-5p: q=2.1E-4, log2(fold change)=1.12), although this particular miRNA 
was not induced by BD exposure in CAST/EiJ. Because miR-449 may play a critical role in 
mediating DNA damage induced by BD, this difference may be related to the lower abundance of 
THB-Gua adducts in the lung of the CAST/EiJ mice relative to C57BL/6J (Fig. 4.3). Further, the 
level of miR-449a-5p and miR-449c-5p were not different between the lung of C57BL/6J and 
CAST/EiJ mice after exposure to BD (miR-449a-5p: q=0.64, log2(fold change)=-0.20; miR-449c-
5p: q=0.46, log2(fold change)=0.31), indicating a similar normalizing effect between the strains 
after exposure to BD for these miRNAs as that observed for the mRNA level of phase II 
conjugation genes mentioned above. 
miR-34a-5p, which shares high sequence homology with miR-449a/c, was significantly 
up-regulated in both the lung and kidney of BD-exposed C57BL/6J mice. miR-34 has been 
reported to be up-regulated in cancers of several tissues, and has been shown to be closely 
related to DNA damage response and repair (He et al., 2007; Li et al., 2010);(He et al., 2007; 
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Hermeking, 2010). Like miR-449a/c, miR-34a-5p has been shown to inhibit proliferation (Rokavec 
et al., 2014), and dysregulation of mir-34a-5p has been observed in various tumors and models 
of exposure to genotoxic chemicals. For example, miR-34a was up-regulated in the liver of mice 
as early as 1 day after treatment with the genotoxic carcinogen N-ethyl-N-nitrosourea (Li et al., 
2010). A recent study of rats treated with aflatoxin B1 (AFB1), a known genotoxic agent, reported 
that miR-34a-5p was upregulated in tandem with an increase in p53, and was identified as a 
sensitive biomarker of AFB1-induced hepatic genotoxicity because its induction was detectable 
in the rat sera before increased alanine transaminase levels were detected (Liu et al., 2015).  
Furthermore, the up-regulation of miR-34a-5p led to cell cycle arrest and affected micronuclei 
formation induced by AFB1 exposure, indicating that that miR-34a-5p plays a role in AFB1-
induced hepatogenotoxicity.  miR-34a-5p is inducible by p53 and plays a role in the p53 gene 
network, implicating its role in many cancers (He et al., 2007; Rokavec et al., 2014). Interestingly, 
in our study, miR-34a-5p was up-regulated independent of p53 induction; in fact, Trp53 was down-
regulated in the lung of C57BL/6J BD-exposed mice (q= 4.4E-4, log2(fold change)= -0.70). These 
findings suggest that exposure to BD induces an increase in miR-34a-5p expression in a p53-
independent manner.  
In addition to their association with DNA damage, miRs-449 and -34 were identified as 
regulatory “hubs” of gene expression in the lung of BD-exposed C57BL/6J mice: the mRNA 
targets of these particular miRNAs were overrepresented among down-regulated genes in the 
lung of BD-exposed C57BL/6J mice relative to random gene networks of similar size. This 
indicates that these particular miRNAs may be regulating their mRNA targets post-
transcriptionally by mRNA degradation, and supports the potential functional role of these 
miRNAs in BD-induced toxicity. Further, among the differentially expressed mRNA targets of the 
miRNA 34/449 family, enrichment for immune response-related genes was identified by functional 
annotation clustering. This finding suggests that these miRNAs may have influenced the profound 
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loss of immune-related cell signaling genes that were identified by geneset analysis in the lung of 
C57BL/6J mice (Table 4.1).   
Up-regulation of miR-24, one of the significantly up-regulated miRNAs in BD-exposed 
C57BL/6J mouse lung tissue (Table 4.2), has been reported to promote cell proliferation in human 
non-small cell lung cancer tumors (Zhao et al., 2015), and also increased the risk of relapse and 
poor survival in acute leukemia (a cancer with excess risk among humans exposed to BD in 
industrial settings) patients (Organista-Nava et al., 2015). Further, miR-24 has been reported to 
be upregulated in the liver tumors of human HCC patients associated with AFB1 exposure (Liu et 
al., 2014). The simultaneous up-regulation of the proposed “oncomir” miR-24-3p with tumor 
suppressor miRNAs miR-34a-5p and miRs-449a/c highlight the complexity in the reactivity of the 
“miRnome” in response to a genotoxic insult. It is possible that de-regulated miRNAs may 
influence toxicity phenotypes to varying degrees, and likely that the differential expression of 
various miRNAs are temporally distinct in regard to exposure to hazardous agents and disease 
development.  
Conclusions 
Our findings reinforce previous work that has described the involvement of epigenetic 
alterations as a consequence of exposure to BD in a strain- and tissue-specific manner. We also 
expanded on previous reports of BD-induced toxicity in mouse models by conducting whole 
transcriptome analyses, revealing distinct gene expression profiles among various tissues and 
between two strains that are likely related to the deleterious effects of BD. Interestingly, 
differences in genes related to xenobiotic metabolism at the basal state appear to be suggestive 
of the susceptibility and resistance to BD-DNA adducts in C57BL/6J and CAST/EiJ mice, 
respectively. We also identified several miRNAs that are significantly differentially expressed in 
the lung of C57BL/6J mice; the most susceptible strain and tissue to BD-induced DNA damage. 
The changes in miRNAs expression observed in the present study may represent highly tissue-
specific biomarkers of exposure to BD, while perhaps not biomarkers of DNA damage, due to the 
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lack of change in miRNAs in the liver of either strain. Alternately, the changes in miRNA 
expression may be associated with tissue-specific types of DNA damage that were not evaluated 
in this study. 
The findings of this study highlight the profound differences in response to exposure to a 
genotoxic chemical between two strains at the gene and miRNA level. Further, our results identify 
several tissue-specific alterations that may influence, at least in part, the differences in 
tumorigenicity across these tissues in longer term exposures. Our results also contribute to the 
potential use of miRNAs as biomarkers of exposure to known cancer-causing chemicals. The use 
of such miRNA signatures is most relevant for those miRNAs that are known to be circulating, i.e. 
they are differentially expressed in blood and/or bone marrow in a similar or correlated manner 
as in the target tissue(s). Thus, additional studies should evaluate the relationship between 
miRNA expression in target tissues and expression level of circulating miRNAs. The results of 
this study emphasize the importance of (1) the consideration of genetic differences in model 
organisms that may influence metabolism and other underlying mechanisms of toxicity, and (2) 
the importance of the inclusion of epigenetic endpoints in hazard assessments of known and 
potential carcinogens. 
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CHAPTER 5. SUMMARY, LIMITATIONS, FUTURE DIRECTIONS, AND CONCLUSIONS 
 
Substantial recent progress has been made in the field of epigenetics across many 
disciplines and areas of research, including medicine, general biology, public health, and 
environmental sciences. The general understanding of epigenetic mechanisms and their 
involvement in various diseases continues to expand, enabling the application and incorporation 
of epigenetics data in many avenues of biomedical research. Epigenetic mechanistic data may 
also contribute to a better understanding of carcinogenicity of various chemical health hazards, 
and be valuable in the identification and characterization of potential health hazards, including 
human carcinogens (Herceg et al., 2013).  
It is now understood that epigenetic and genetic changes both occur in all cancers, and 
that crosstalk exists between the two types of molecular changes during carcinogenesis. Thus, 
evaluating both types of alterations is essential to determine the dynamics, temporality, and 
severity of various alterations in cancer microenvironments and during the progression of tumors. 
The work presented herein has broadly addressed the presence of epigenetic alterations in 
murine models of exposure to known genotoxic agents. Using chemicals that are known to be 
reactive with DNA (N-nitrosodiethylamine (DEN) and 1,3-butadiene (BD)), we evaluated various 
epigenetic marks in tandem with the assessment of genetic alterations, and demonstrated 
changes to the epigenome in two models of chemically-induced carcinogenesis.  
5.1. Summary of findings  
 In Chapter 2, we demonstrated that DNA methylation, both globally as well as gene-
specific, was related to the increased tumorigenesis observed in mice treated with a combination 
of a genotoxic (DEN) and a non-genotoxic (carbon tetrachloride, CCl4) carcinogen. 
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Also, a decrease in histone 3 lysine 9 trimethylation (H3K9me3), an indicator of genomic instability 
and chromatin relaxation, was observed both globally and within repetitive DNA elements, 
accompanied by the epigenetic silencing of the histone methyltransferase gene Riz1. These and 
other epigenetic alterations appear to be more closely associated with the DEN+CCl4 treatment 
group relative to mice treated with either chemical alone, while other common characteristics of 
hepatocellular carcinoma (HCC), including markers of inflammation, proliferation, fibrogenesis, 
and oxidative stress were not significantly different between the treatment groups. Further, we 
investigated some of the most commonly observed gene mutations in HCC and determined that 
they were not present in liver tumors of mice in our study, suggesting that epigenetic responses 
occur earlier than these mutations in fibrosis-associated mouse HCC. These findings indicate that 
a specific epigenetic signature may be an early and important event in mouse fibrosis-associated 
HCC. 
 In Chapter 3, we evaluated the tissue-specificity of several epigenetic alterations that had 
previously been shown to occur in the liver of C57BL/6J mice after short-term inhalational 
exposure to the genotoxic carcinogen 1,3-butadiene (BD). An increase in histone marks that are 
indicative of chromatin condensation were observed in the kidney, a non-target tissue of BD-
induced carcinogenesis, but not in the lung and liver, which are tumor sites in mice after long-
term exposure to BD. Further, histone alterations that are associated with DNA damage were 
observed in the lungs, which was the tissue that also had the highest level of DNA adducts.  Our 
results indicate that, while DNA adducts appear to be ubiquitous in tissues of mice exposed to 
BD, epigenetic alterations are tissue-specific, indicating that such alterations may play an 
important role in the variation in tumor occurrence across tissues in BD-exposed mice.  
In Chapter 4, we expanded upon our findings from Chapter 3 and conducted whole 
transcriptome analyses, evaluated changes in the expression of microRNAs (another type of 
epigenetic mechanism), and measured BD-DNA adducts. For this study, we included another 
strain of mouse that is known to be highly genetically variable from the C57BL/6J strain, 
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CAST/EiJ, to enable the identification of strain-specific as well as tissue-specific epigenetic 
alterations induced by exposure to BD. We found that C57BL/6J had an overall higher induction 
of gene expression changes relative to CAST/EiJ, as well as a higher level of BD-DNA adducts 
after exposure to BD, which corroborates a previous study conducted by our research group that 
showed a higher level of BD-DNA adducts liver tissue of C57BL/6J mice compared to CAST/EiJ 
under similar exposure conditions (Koturbash et al., 2011). Genes that are involved in xenobiotic 
metabolism and inflammation were identified as being differentially expressed between the two 
strains among control mice, and many of these genes were differentially expressed after exposure 
to BD in a strain- and tissue-specific manner. Differences in metabolism genes likely contribute 
to the differences in BD-DNA adducts between the two strains.  Further, we found a set of 
differentially expressed miRNAs in the lung of C57BL/6J mice that are associated with DNA 
damage, and may represent a tissue-specific biomarker of DNA damage caused by BD. miRNAs 
were nearly unchanged in all tissues of CAST/EiJ, and the liver in both strains did not harbor 
substantial changes in microRNAs, demonstrating another epigenetic mark that is tissue-, 
condition-, and strain-specific. 
 
5.2. General discussion 
DNA damage and mutagenesis that occur as a consequence of the metabolism of 
environmental chemicals to DNA-damaging intermediates are critical initiating events that can 
lead to cancer. In addition to genotoxicity, many chemical carcinogens alter the epigenetic state 
of cells, and epigenetic reprogramming has been proposed as an integral component of genome 
instability, an enabling characteristic of cancer cells (Hanahan and Weinberg, 2011). Changes to 
the epigenome, which is a link between the genome and responses to exogenous stimuli, can 
serve as either (or both) a representation of a temporally specific response to various 
environmental exposures, or as a potential predictor of disease development and/or outcome. To 
fully understand the relationship between epigenetic and genetic mechanisms and responses, it 
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is necessary that studies evaluate and compare epigenetic data with functional measures, such 
as gene or protein expression, DNA damage, or other toxicity phenotypes within the same study 
and controlled exposure scenario (Ray et al., 2014). Our studies are unique in the comprehensive 
approach taken to address that necessity; while the major focus was on the identification of 
epigenetic responses, we also studied genetic alterations, including mutations, DNA adducts, and 
gene expression in the same tissues. By doing so, we are able to associate our epigenetic findings 
with other molecular events, some of which have known consequences and associations with 
disease. The results presented herein have highlighted several types of epigenetic mechanisms 
in two different models of chemically-induced carcinogenesis using genotoxic chemicals. We 
evaluated three of the main types of epigenetic alterations: DNA methylation, histone 
modifications, and changes in the expression of non-coding RNA. Trends in the treatment-
induced changes to various histone modifications emerged among our findings, with specific 
histone modifications relating best to specific phenotypes. Changes in microRNA expression were 
also specific to a particular strain, treatment, and tissue, and are likely associated with DNA 
damage. The epigenetic alterations in our studies appear to be more specific to particular cancer 
or pre-cancerous states relative to that of genotoxicity, emphasizing the importance of further 
characterization of epigenetic endpoints, and their inclusion in the evaluation of chemical hazards. 
The studies presented herein offer insight into the involvement of epigenetic alterations in 
chemically-induced carcinogenesis and demonstrate the relevance of epigenetic endpoints in the 
evaluation of the toxic effects of chemical exposures, thus providing a foundation to be built upon 
in future toxicology studies. 
 
5.3. Limitations 
Several limitations exist in the experiments discussed herein. The study of epigenetic 
alterations in fibrosis-associated HCC in Chapter 2 addressed a major gap in animal models of 
human HCC by modeling a co-morbidity etiology of the disease; however, HCC is known to be 
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an especially heterogeneous type of tumor, and both intra- and inter-tumoral heterogeneity can 
exist within a single HCC patient (or mouse). Because of this, there may be differences in the 
molecular profile of different tumors from the same liver. Tissue samples were taken from tumors 
grossly isolated from the liver at the time of sacrifice, and one tumor per liver (and thus per animal) 
was used for the molecular assays described herein. An alternate strategy to address the issue 
of tumor heterogeneity would be to take samples from multiple tumors, either at sacrifice or by 
laser dissection from FFPE samples, to evaluate the epigenetic profile for each individual tumor.  
Alternately, all tumors could be pulverized and homogenized so that the tissue sample would 
represent the potentially variable tumor genomes present in a single mouse with HCC. 
Regarding Chapter 3, while global changes to the epigenome are informative to the 
underlying mechanisms of BD-induced carcinogenesis, determining the site-specific alterations 
in chromatin state would provide more targeted information regarding the functional relationship 
between DNA damage, epigenetic and epigenomic alterations, and transcription. This limitation 
has been addressed by members of our research group who are performing analyses of 
chromatin structure in the tissues of the mice utilized in Chapter 4 using the assay for 
transposase-accessible chromatin (ATAC) and next generation sequencing. The results of such 
analyses will be evaluated with the transcriptomic data presented in Chapter 4 to enable a better 
understanding of the regulation of gene expression related to site-specific chromatin structure, in 
regard to inter-strain and inter-tissue variation, as well as the effect of exposure to BD on such 
associations. Furthermore, within the same collaborative effort, chromatin immunoprecipitation 
will also be performed to evaluate the sequence-specific level of two histone modifications that 
were measured at the global level in Chapter 3 (trimethylation and acetylation of H3K27).  
In Chapter 4, we discussed the relationship between changes in miRNA and mRNA 
expression. However, the relationship between the genes and miRNAs would only reflect those 
that resulted in mRNA degradation, because we did not evaluate the level of translation of any of 
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the miRNA targets. Additional experiments, such as immunoblotting or immunohistochemical 
staining, could further characterize the potential effects of miRNAs on protein expression.  
Another limitation of the short-term inhalation studies of BD that should be addressed is 
the lack of tumorigenesis in the mice; the duration of exposure selected is not long enough for 
tumor development, requiring assumptions to be drawn regarding tissue-specific tumor 
susceptibility based on previous studies (Melnick and Huff, 1992; Melnick et al., 1992; Melnick 
and Huff, 1993). To fully confirm the relationship between BD-induced epigenetic alterations and 
carcinogenesis, longer-term exposures of the mice from the stains used herein are required.  
Alternately, evaluation of the same epigenetic endpoints discussed in the previous chapter could 
be conducted under the same short-term BD exposure conditions, but using B6C3F1 mice, the 
strain for which long-term carcinogenicity studies have been conducted and data are available. 
We have exposed B6C3F1 mice to BD for 10 days and collected lung, liver and kidney tissues, 
so that chromatin dynamics, sequence-specific histone modifications, and transcriptional 
response may be evaluated in the same manner as was done for C57BL/6J and CAST/EiJ in 
future studies. A challenge in conducting the sequencing-based analysis in the B6C3F1 strain is 
the lack of a fully annotated reference genome. In future studies, an appropriate reference 
genome will be created for B6C3F1 to enable these analyses, as was achieved for CAST/EiJ 
mice for the analyses described in Chapter 4.  
 
5.4. Future directions 
Due to the increasing recognition that epigenetic events are drivers of disease, there has 
been a rise in interest in monitoring epigenetic perturbations in various models of disease 
phenotypes. However, when the target tissue of oncogenesis is an internal organ, biomarkers in 
accessible surrogate tissues are required for evaluation of molecular changes in human 
subjects and patients. For example, because miRNAs are detectable in biological fluids, 
including blood and urine, they represent a potentially easily accessible and informative class of 
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biomarkers of both exposure as well as effect (Siddeek et al., 2014). An important future 
direction is to determine whether changes in the epigenome and transcriptome, as well as level 
of DNA damage, of easily accessible tissues (e.g. peripheral blood, skin) can inform the same 
responses of target tissues, and can thus act as surrogates. While the same molecular changes 
may not be observed within surrogate tissues and target tissues, a reproducible and clearly 
defined relationship between a signal in a surrogate tissue and epigenetic alterations in target 
tissues would enable the identification of a marker of change. Regarding microRNAs, the 
correspondence between the expression signatures of circulating microRNA and that of target 
tissues is essential for their use as biomarkers in humans, a relationship that continues to be 
characterized and requires further study across specific types of disease. 
Additionally, incorporation of several time points in the exposure studies would facilitate 
a better understanding of the evolution and persistence of epigenetic and transcriptional 
alterations during and after cessation of exposure to environmental toxicants, respectively. 
There are few reports of persistence of various epigenetic effects of chemical exposures, and 
the studies that have been conducted primarily demonstrated reversibility of most effects after 
cessation of an exogenous stimulus, while a few have shown that some epigenetic marks 
(particularly histone lysine acetylation) persist for weeks and even months. An additional time-
course study of BD exposure would afford further characterization of various aspects of the 
epigenetic responses that we observed, including the temporal relationship of alterations in 
miRNAs and transcriptional response, as well as with DNA damage. Time-course studies would 
also allow us to end the exposure and include a “wash out” period during which mice were not 
exposed to the chemical, allowing for the evaluation of the static or dynamic nature of the 
changes to miRNA and mRNA expression, as well as changes in chromatin. For example, our 
results revealed an up-regulation of the miR-34a-5p, which is considered a potential tumor 
suppressor miRNA. Both up- and down-regulation of this miRNA have been previously reported 
in cancers and/or after exposure to cancer-causing agents; however, the majority of cancer 
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studies have shown its down-regulation. This miRNA may be induced after 2 weeks as a 
reparative post-damage response, but after a longer duration, the expression of miR-34a-5p 
may be lost and bear a higher resemblance to the expression profiles of other cancer studies.  
Another future direction that is actively being pursued is in relation to the findings 
reported in Chapter 4 regarding the variation in genes included in phase II conjugation pathways 
between strains and as induced by exposure to BD. While it is likely that induction of glutathione 
conjugation is a detoxifying event, previous studies have shown that 1,3-butadiene-glutathione 
(BD-GSH) conjugates can react with DNA, and that those conjugates are indeed mutagenic in 
bacterial assays (Cho et al., 2010; Cho and Guengerich, 2012). To investigate if there is a 
difference in the level of such adducts between the two strains, we have engaged in a 
collaboration with the authors of the above-mentioned studies to measure the levels of these 
BD- GSH-DNA adducts in all three tissues of the two strains of mice used in our BD exposure 
studies.  
Importantly, future studies are needed to address the mechanistic relationship between 
specific epigenetic alterations and DNA damage, and how this relationship is associated with 
carcinogenesis.  For example, in vitro assays may be conducted to evaluate the supposed 
potentiation effect(s) of certain epigenetic alterations in tandem with, or preceding, genotoxicity. 
Further, genomic analysis of site-specific DNA damage in association with epigenetic marks of 
condensed or relaxed chromatin will offer insight into the relationship between chromatin 
dynamics genotoxicity. 
Finally, to truly evaluate the human relevance of our findings, similar molecular assays 
and evaluations should be conducted using tissue samples from humans. Specifically relevant to 
the findings discussed herein, examples of appropriate samples include tumor and cirrhotic non-
tumor tissues from HCC patients and samples from individuals who have been occupationally 
exposed to BD. 
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5.5 Conclusions 
 In conclusion, the results of this dissertation project have demonstrated the importance of 
the integration of epigenetic studies in analyses of both known and potential cancer-causing 
agents. Amounting evidence confirms that epigenetic alterations are an important response to 
exposure to many chemicals for which the carcinogenic potential has previously been nearly or 
entirely attributed to reactivity with DNA. The results presented herein support this supposition, 
demonstrating that epigenetic alterations not only exist in models of exposure to genotoxic 
chemicals, but that such epigenetic alterations appear to be more specific to tissues with tumors 
(as in Chapter 2) or to target tissues of tumorigenesis (as in Chapters 3 and 4) than measures of 
genotoxicity. The results of each study not only contribute to a better understanding of the 
molecular events that are associated with the carcinogenicity of specific chemicals and/or 
conditions, but also encourage the inclusion of this class of molecular marker in the evaluation of 
safety or hazard of various environmental and occupational chemicals. Studies such as those 
presented herein that include both genetic and epigenetic endpoints will ultimately contribute to 
efficacious prioritization and standardized incorporation of epigenetic endpoints in various types 
of chemical assessments and public health initiatives. 
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APPENDIX 1.1: FULL SEARCH TERMS USED IN HAWC FOR THE SYSTEMATIC 
LITERATURE REVIEW 
 
 Exact search terms 
Epigenetics terms ("epigenetic"[All Fields] OR "microRNA"[All Fields] OR "miRNA"[All 
Fields] OR "lncRNA"[All Fields] OR "non-coding RNA"[All Fields] OR 
"non coding RNA"[All Fields] OR "ncRNA"[All Fields] OR "small 
RNA"[All Fields] OR "smallRNA"[All Fields] OR "DNA methylation"[All 
Fields] OR "methylated DNA"[All Fields] OR "chromatin 
modification"[All Fields] OR "open chromatin"[All Fields] OR 
"histone"[All Fields] OR "histone positioning"[All Fields] OR "histone 
methylation"[All Fields] OR "histone acetylation"[All Fields] OR 
“histone mark”[All Fields] OR “histone modification”[All Fields]) 
Chemical identifiers ("benzidine"[All Fields] OR “92-87-5"[All Fields] OR "4-
aminobiphenyl"[All Fields] OR “92-67-1”[All Fields] OR "MOCA"[All 
Fields] OR "4,4’-methylenebis(2-chlorobenzenamine)"[All Fields] OR 
"4,4’-methylenebis(2-chloroaniline)"[All Fields] OR “101-14-4” OR "2-
naphthylamine"[All Fields] OR “91-59-8”[All Fields]  OR "ortho-
toluidine"[All Fields] OR “95-53-4”[All Fields] 
OR  "benzo[a]pyrene"[All Fields] OR "benzo-a-pyrene"[All Fields] OR 
“50-32-8”[All Fields] OR "coal-tar"[All Fields] OR “8007-45-2”[All 
Fields] OR "coal-tar pitch"[All Fields] OR “65996-93-2”[All Fields] OR 
"coal gasification"[All Fields] OR "coke production"[All Fields] OR 
"coke oven"[All Fields] OR "aflatoxin"[All Fields] OR “1402-68-2” OR 
"mineral oil"[All Fields] OR "benzene"[All Fields] OR “71-43-2”[All 
Fields] OR "1,3-butadiene"[All Fields] OR “106-99-0” OR "ethylene 
oxide"[All Fields] OR “75-21-8”[All Fields] OR "formaldehyde"[All 
Fields] OR “50-00-0“[All Fields] OR "sulfur mustard"[All Fields] OR 
“505-60-2”[All Fields] OR "vinyl chloride"[All Fields] OR “75-01-4”[All 
Fields] OR "rubber manufacture"[All Fields] OR "rubber 
manufacturing"[All Fields] OR "chimney sweep"[All Fields] OR 
"painter"[All Fields] OR "iron founding"[All Fields] OR "steel 
founding"[All Fields] OR "bis(chloromethyl) ether"[All Fields] OR 
"542-88-1"[All Fields] OR "chloromethyl methyl ether"[All Fields] OR 
"107-30-2"[All Fields] OR "isopropyl alcohol manufacture"[All Fields] 
OR "manufacture of isopropyl alcohol"[All Fields] OR "strong 
inorganic acid mist"[All Fields] OR "aluminum production"[All Fields] 
OR "production of aluminum"[All Fields]) 
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APPENDIX 2.1: LIVER TUMOR HISTOLOGY OF DEN+CCL4-TREATED MICE 
 
Tumor histology as evaluated by H&E staining of paraffin-embedded formalin fixed liver sections. 
Original magnification 100x. (A) Fibrosis in a CCl4 treated mouse liver. Prominent fibrosis with 
degenerative/necrotic hepatocytes is present in the centrilobular area. Cellular infiltration is 
accompanied. (B) Hepatocellular adenoma in the liver of a DEN+CCl4 treated mouse. The 
adenoma is sharply demarcated with compression of the adjacent normal parenchyma. Normal 
parenchyma is present on the upper right of the figure. (C) Hepatocellular carcinoma in the liver 
of a DEN+CCl4 treated mouse. Characteristic trabecular growth pattern with necrosis and 
hemorrhage is observed in hepatocellular carcinoma.  Normal parenchyma is present on the 
upper right of the image.  
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APPENDIX 2.2: H-RAS GENE EXPRESSION 
 
Expression of the H-ras gene in the liver during fibrosis-associated hepatocarcinogenesis in mice. 
The expression of the H-ras gene in livers of mice treated with DEN+CCl4 was determined by 
qRT-PCR as detailed in “Materials and Methods.”  The results are presented as an average fold 
change in the expression of the gene in tumor and non-tumorous liver of mice from the 
experimental group relative to liver tissues from the control group, which were assigned a value 
1.  Values shown are mean±S.D. 
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APPENDIX 2.3: EXPRESSION OF CANCER STEM CELL MARKERS IN FIBROSIS-
ASSOCIATED HCC 
 
 
The expression of Afp and Epcam genes was determined by qRT-PCR as detailed in “Materials 
and Methods.”  The results are presented as an average fold change in the expression of each 
gene in the livers of mice from experimental groups relative to that in the control group, which 
were assigned a value 1.  Values shown are mean±S.D., asterisks (*) denote a significant 
(p<0.05) difference from the vehicle-treated control mice.   
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APPENDIX 3.1: QPCR PRIMERS USED FOR GENE EXPRESSION ANALYSES DISCUSSED 
IN CHAPTER 3 
 
 
  
Applied Biosystems 
Assay ID 
Gene Symbol Gene Name Function 
Mm00599763_m1 Dnmt1 DNA methyltransferase 1 DNA methyltransferase 
Mm00432881_m1 Dnmt3a DNA methyltransferase 3A DNA methyltransferase 
Mm00468464_m1 Ezh2 enhancer of zeste homolog 2 Histone methyltransferase 
Mm00451387_m1 Kat2B K(lysine) acetyltransferase 2b Histone acetyltransferase 
Mm00458911_m1 Myst1 K(lysine) acetyltransferase 8 Histone acetyltransferase 
Mm00490758_m1 Sirt1 Sirtuin 1 Proteine/histone deacetylase 
Mm00468952_m1 Suv39h1 suppressor of variegation 3-9 homolog 1 Histone methyltransferase 
Mm00525366_m1 Suv420h1 suppressor of variegation 4-20 homolog 1 Histone methyltransferase 
Mm01169087_m1 Tet1 tet methylcytosine dioxygenase 1 5-methylcytosine hydroxylation 
Mm00524395_m1 Tet2 tet methylcytosine dioxygenase 2 5-methylcytosine hydroxylation 
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APPENDIX 4.1: NUMBER OF SEQUENCES READ AND ALIGNED FOR TOTAL RNA 
SEQUENCING DISCUSSED IN CHAPTER 4 
Mouse ID Total Reads Aligned Reads % aligned 
Liver1 48015993 11345345 23.63 
Liver2 44450804 11410344 25.67 
Liver3 93510645 31234712 33.40 
Liver4 75841349 26180978 34.52 
Liver5 32128690 24269003 75.54 
Liver6 40187457 32224991 80.19 
Liver7 112674371 19172726 17.02 
Liver8 59000142 23021391 39.02 
Liver9 44869863 19634945 43.76 
Liver10 51430044 38058817 74.00 
Liver11 51603989 38204031 74.03 
Liver12 51272257 39890078 77.80 
Liver13 50747795 24285190 47.85 
Liver14 72507356 31271847 43.13 
Liver15 91274724 38630209 42.32 
Liver16 41809195 32262710 77.17 
Liver17 33006976 25815772 78.21 
Liver18 30910322 25056543 81.06 
Liver101 30545440 18829805 61.65 
Liver102 23492629 14304651 60.89 
Liver104 90860938 50736692 55.84 
Liver105 30498863 19992281 65.55 
Liver106 36533362 25715883 70.39 
Lung1 44917676 34361302 76.50 
Lung2 32290479 27613273 85.52 
Lung3 35747848 28840105 80.68 
Lung4 28687033 24046680 83.82 
Lung5 60263099 38297779 63.55 
Lung6 53622673 46859964 87.39 
Lung7 23548923 19967611 84.79 
Lung8 49486649 37182887 75.14 
Lung9 39447354 29646224 75.15 
Lung10 39781848 34405631 86.49 
Lung11 57295124 48337865 84.37 
Lung12 107956830 93976290 87.05 
Lung13 59993190 53337061 88.91 
Lung14 61316294 53973732 88.03 
Lung15 35524371 26782243 75.39 
Lung16 74389901 62389820 83.87 
Lung17 40951913 36011840 87.94 
Lung18 25010471 21844668 87.34 
Lung101 24759795 17670969 71.37 
Lung102 60312010 51158451 84.82 
Lung103 37120500 30693113 82.69 
Lung104 40377084 34820110 86.24 
Lung105 25955594 20717715 79.82 
Lung106 78233900 63640163 81.35 
Kidney1 27433939 24239546 88.36 
Kidney2 33019148 15824063 47.92 
Kidney3 50687687 40594840 80.09 
Kidney4 24702618 9586291 38.81 
Kidney5 29320368 23960472 81.72 
Kidney6 39875406 32270657 80.93 
Kidney7 22222896 15585530 70.13 
Kidney8 44894374 32466828 72.32 
158 
Kidney9 34292430 24718753 72.08 
Kidney10 34683484 27763087 80.05 
Kidney11 28385861 22726763 80.06 
Kidney12 52240519 42258132 80.89 
Kidney13 21114996 16947331 80.26 
Kidney14 56398837 43958120 77.94 
Kidney15 70504410 19861722 28.17 
Kidney16 38365009 21863994 56.99 
Kidney17 57764243 38708543 67.01 
Kidney18 44473663 31107465 69.95 
Kidney101 80494476 56549913 70.25 
Kidney102 47058260 32047743 68.10 
Kidney103 41830481 26834570 64.15 
Kidney104 54709705 37923924 69.32 
Kidney105 51880066 33089612 63.78 
Kidney106 44315534 33575245 75.76 
AVERAGE: 47955383 31867431 69.24 
average overall 
C57BL/6J: 49385495 32891108 69.99 
average overall 
CAST/EiJ: 46713443 30978448 68.58 
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APPENDIX 4.2: NUMBER OF SEQUENCES READ AND ALIGNED FOR SMALL RNA 
SEQUENCING DISCUSSED IN CHAPTER 4 
Mouse ID Total Reads miRMapped %miR mapped 
Liver1 8499224 2463474 28.98 
Liver2 13032577 5228802 40.12 
Liver3 7299281 5434218 74.45 
Liver4 5926131 3736847 63.06 
Liver5 7847816 5919342 75.43 
Liver6 8021601 6143225 76.58 
Liver7 10092010 3714723 36.81 
Liver8 7492299 2569231 34.29 
Liver9 9181955 3063143 33.36 
Liver10 8046498 2404829 29.89 
Liver11 4697632 987142 21.01 
Liver12 6204301 492028 7.93 
Liver13 7430055 5192261 69.88 
Liver14 7128122 5268793 73.92 
Liver15 7820325 7339802 93.86 
Liver16 6633630 3942078 59.43 
Liver17 6333734 5780382 91.26 
Liver18 6348839 4530586 71.36 
Liver101 11423734 739576 6.47 
Liver102 6528651 506194 7.75 
Liver103 10950459 794331 7.25 
Liver104 9112844 678402 7.44 
Liver105 8037906 623183 7.75 
Liver106 4738125 728064 15.37 
Lung1 7229312 2816526 38.96 
Lung2 9456306 3497460 36.99 
Lung3 7184431 3239655 45.09 
Lung4 7454361 2920579 39.18 
Lung5 9519402 3536062 37.15 
Lung6 7469945 3588456 48.04 
Lung7 8076004 3318591 41.09 
Lung8 7552940 3420376 45.29 
Lung9 6789917 2850277 41.98 
Lung10 5704187 2649965 46.46 
Lung15 17760855 8407589 47.34 
Lung16 17301588 8986405 51.94 
Lung17 15540194 8072648 51.95 
Lung18 7943315 3306597 41.63 
Lung101 10095636 4401088 43.59 
Lung102 9080744 3581737 39.44 
Lung103 8915000 3009419 33.76 
Lung104 8310125 3263065 39.27 
Lung105 8181473 3825163 46.75 
Lung106 4517205 2166923 47.97 
Kidney1 12839827 3544301 27.60 
Kidney2 12259943 4220048 34.42 
Kidney3 10474355 5085292 48.55 
Kidney4 12708843 5938056 46.72 
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Kidney5 9959628 4560102 45.79 
Kidney6 12535983 6331404 50.51 
Kidney7 14671510 4568454 31.14 
Kidney8 10370691 4475610 43.16 
Kidney9 7610745 3037888 39.92 
Kidney10 10238445 3985918 38.93 
Kidney11 10936003 4917583 44.97 
Kidney12 8920240 3908496 43.82 
Kidney13 16948407 10596570 62.52 
Kidney14 16557547 8601638 51.95 
Kidney16 14120270 3917842 27.75 
Kidney17 25516951 6850659 26.85 
Kidney18 14173221 3983459 28.11 
Kidney101 16302336 2104949 12.91 
Kidney102 12192981 2311683 18.96 
Kidney103 18257262 2874051 15.74 
Kidney104 9888040 1584016 16.02 
Kidney105 9116424 1487545 16.32 
Kidney106 13763013 3089522 22.45 
AVERAGE: 10048856 3897229 40.19 
average overall 
C57B/6J: 
10565906 5239835 49.59 
average overall 
CAST/EiJ: 
9629627 2808629 29.17 
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APPENDIX 4.3: DIFFERENTIALLY EXPRESSED (q<0.1) MIRNAS IN BD-EXPOSED MICE 
RELATIVE TO CLEAN AIR-EXPOSED MICE 
C57BL6 Liver Mean expression in    BD-exposed 
log2 Fold 
Change Wald Stat p-value q-value 
mmu-let-7f-1-5p 14102.60 -0.22 -3.46 5.43E-04 5.08E-02 
mmu-mir-181b-1-5p 178.02 0.37 3.59 3.26E-04 5.08E-02 
mmu-mir-181b-2-5p 195.49 0.37 3.48 4.95E-04 5.08E-02 
mmu-mir-802-5p 3302.44 0.62 3.60 3.21E-04 5.08E-02 
mmu-let-7f-2-5p 17251.40 -0.22 -3.22 1.28E-03 9.55E-02 
C57BL6 Lung Mean expression in    BD-exposed 
log2 Fold 
Change Wald Stat p-value q-value 
mmu-mir-449c-5p 872.56 1.57 12.61 1.88E-36 8.36E-34 
mmu-mir-142-5p 11418.16 -0.81 -7.53 5.27E-14 1.17E-11 
mmu-mir-92a-2-3p 3646.26 -0.93 -7.10 1.27E-12 1.88E-10 
mmu-mir-150-5p 12918.49 -1.26 -6.20 5.52E-10 6.14E-08 
mmu-mir-130a-3p 7101.92 0.31 6.13 8.64E-10 7.69E-08 
mmu-mir-142-3p 2947.46 -0.92 -5.78 7.69E-09 5.70E-07 
mmu-mir-200b-3p 28471.05 -0.49 -5.72 1.04E-08 6.60E-07 
mmu-mir-128-1-3p 480.08 -0.93 -5.56 2.66E-08 1.24E-06 
mmu-mir-34a-5p 572.31 1.07 5.55 2.78E-08 1.24E-06 
mmu-mir-449a-5p 735.98 1.27 5.59 2.28E-08 1.24E-06 
mmu-mir-99a-3p 474.76 0.55 5.39 7.05E-08 2.85E-06 
mmu-mir-125b-2-5p 20225.51 -0.58 -5.31 1.12E-07 3.12E-06 
mmu-mir-149-5p 866.75 -0.82 -5.33 9.90E-08 3.12E-06 
mmu-mir-181c-5p 11169.64 0.45 5.35 8.83E-08 3.12E-06 
mmu-mir-24-1-3p 6591.27 0.95 5.32 1.06E-07 3.12E-06 
mmu-mir-24-2-3p 6591.19 0.95 5.32 1.06E-07 3.12E-06 
mmu-mir-125b-1-5p 20782.25 -0.58 -5.27 1.40E-07 3.65E-06 
mmu-mir-128-2-3p 225.46 -0.84 -5.20 2.04E-07 4.87E-06 
mmu-mir-144-3p 1840.85 0.78 5.19 2.08E-07 4.87E-06 
mmu-mir-92a-1-3p 57478.37 -0.76 -5.15 2.55E-07 5.67E-06 
mmu-mir-200a-3p 8343.08 0.80 4.82 1.47E-06 3.12E-05 
mmu-mir-1964-3p 71.38 -1.02 -4.66 3.19E-06 6.46E-05 
mmu-mir-296-5p 5.92 1.62 4.65 3.38E-06 6.55E-05 
mmu-mir-29b-1-3p 737.22 0.80 4.63 3.74E-06 6.65E-05 
mmu-mir-29b-2-3p 763.82 0.82 4.63 3.59E-06 6.65E-05 
mmu-mir-125a-5p 93056.75 -0.63 -4.61 4.09E-06 6.74E-05 
mmu-mir-501-5p 5.32 1.61 4.61 4.01E-06 6.74E-05 
mmu-let-7d-3p 2494.82 -0.43 -4.43 9.38E-06 1.49E-04 
mmu-mir-22-5p 250.62 0.77 4.40 1.10E-05 1.69E-04 
mmu-mir-34b-5p 3588.35 0.43 4.26 2.04E-05 3.03E-04 
mmu-mir-106b-5p 800.44 0.54 4.14 3.52E-05 4.59E-04 
mmu-mir-30c-1-5p 46773.75 -0.48 -4.15 3.34E-05 4.59E-04 
mmu-mir-30c-2-5p 46776.32 -0.48 -4.15 3.34E-05 4.59E-04 
mmu-mir-582-3p 588.57 0.53 4.13 3.61E-05 4.59E-04 
mmu-mir-582-5p 145.34 0.90 4.14 3.46E-05 4.59E-04 
mmu-mir-29c-3p 6361.50 0.59 4.11 3.92E-05 4.84E-04 
mmu-mir-328-3p 1876.24 -0.57 -4.05 5.03E-05 5.97E-04 
mmu-mir-92b-3p 19772.44 -0.56 -4.05 5.09E-05 5.97E-04 
mmu-mir-32-5p 364.92 0.70 4.04 5.25E-05 5.99E-04 
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mmu-mir-497-5p 4282.37 -0.89 -4.01 6.12E-05 6.81E-04 
mmu-mir-33-5p 94.95 0.80 3.97 7.16E-05 7.77E-04 
mmu-mir-500-3p 89.62 0.81 3.94 8.20E-05 8.69E-04 
mmu-mir-455-5p 244.03 0.62 3.92 8.96E-05 9.27E-04 
mmu-mir-15a-5p 3316.89 0.39 3.90 9.81E-05 9.92E-04 
mmu-mir-342-5p 33.44 -1.04 -3.86 1.12E-04 1.10E-03 
mmu-mir-30a-5p 353783.38 0.36 3.75 1.77E-04 1.71E-03 
mmu-mir-30e-5p 59468.80 0.29 3.71 2.04E-04 1.93E-03 
mmu-mir-19b-1-3p 1832.13 0.54 3.69 2.26E-04 2.10E-03 
mmu-mir-19b-2-3p 1867.22 0.53 3.68 2.32E-04 2.10E-03 
mmu-mir-150-3p 18.83 -1.18 -3.65 2.62E-04 2.33E-03 
mmu-mir-218-1-5p 281.76 0.52 3.56 3.70E-04 3.23E-03 
mmu-mir-3096b-5p 145.59 -0.89 -3.55 3.88E-04 3.26E-03 
mmu-mir-326-3p 834.32 0.47 3.55 3.84E-04 3.26E-03 
mmu-let-7i-3p 185.20 0.69 3.53 4.15E-04 3.42E-03 
mmu-mir-1298-5p 800.72 0.40 3.50 4.61E-04 3.73E-03 
mmu-mir-676-3p 629.65 -0.68 -3.49 4.88E-04 3.88E-03 
mmu-mir-200c-3p 2138.59 0.44 3.47 5.25E-04 4.08E-03 
mmu-mir-369-5p 3.81 1.13 3.46 5.41E-04 4.08E-03 
mmu-mir-451 24307.43 0.75 3.46 5.33E-04 4.08E-03 
mmu-mir-218-2-5p 262.14 0.53 3.41 6.45E-04 4.78E-03 
mmu-mir-136-5p 180.37 0.65 3.39 6.87E-04 5.01E-03 
mmu-mir-125b-1-3p 178.63 -0.58 -3.29 9.95E-04 7.14E-03 
mmu-mir-3057-5p 27.92 -0.90 -3.27 1.09E-03 7.73E-03 
mmu-mir-21-5p 65438.80 0.33 3.25 1.15E-03 8.02E-03 
mmu-mir-130b-5p 33.32 -0.96 -3.15 1.62E-03 1.11E-02 
mmu-mir-29a-3p 33460.42 0.26 3.15 1.66E-03 1.12E-02 
mmu-mir-141-3p 12254.60 0.53 3.12 1.81E-03 1.20E-02 
mmu-mir-423-3p 2835.41 -0.56 -3.10 1.92E-03 1.26E-02 
mmu-mir-222-3p 3605.68 -0.60 -3.07 2.16E-03 1.39E-02 
mmu-mir-1198-5p 114.01 -0.61 -3.05 2.31E-03 1.45E-02 
mmu-mir-126-5p 103013.52 -0.34 -3.05 2.31E-03 1.45E-02 
mmu-mir-200b-5p 99.09 -0.60 -3.04 2.36E-03 1.46E-02 
mmu-mir-425-3p 31.86 0.82 3.04 2.40E-03 1.46E-02 
mmu-mir-31-3p 35.07 0.98 2.94 3.33E-03 2.00E-02 
mmu-mir-362-3p 174.57 0.45 2.89 3.83E-03 2.27E-02 
mmu-mir-29c-5p 40.63 0.78 2.86 4.20E-03 2.46E-02 
mmu-mir-542-3p 384.70 0.32 2.85 4.32E-03 2.50E-02 
mmu-mir-103-1-3p 6098.47 0.27 2.79 5.23E-03 2.98E-02 
mmu-mir-338-3p 1148.40 0.36 2.79 5.34E-03 3.01E-02 
mmu-mir-146b-5p 2325.13 0.52 2.78 5.44E-03 3.03E-02 
mmu-mir-139-5p 132.77 -0.46 -2.75 5.95E-03 3.27E-02 
mmu-mir-652-5p 5.21 0.79 2.74 6.19E-03 3.36E-02 
mmu-mir-138-1-5p 125.93 -0.46 -2.73 6.34E-03 3.40E-02 
mmu-mir-103-2-3p 6278.14 0.26 2.72 6.58E-03 3.49E-02 
mmu-mir-375-3p 3464.03 -0.30 -2.71 6.71E-03 3.51E-02 
mmu-mir-106b-3p 192.66 -0.43 -2.69 7.19E-03 3.59E-02 
mmu-mir-18a-5p 111.67 0.64 2.69 7.19E-03 3.59E-02 
mmu-mir-193b-3p 120.97 0.65 2.69 7.09E-03 3.59E-02 
mmu-mir-363-3p 18.87 -0.83 -2.69 7.05E-03 3.59E-02 
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mmu-mir-143-3p 513373.93 0.29 2.68 7.44E-03 3.64E-02 
mmu-mir-30e-3p 752.13 -0.42 -2.68 7.38E-03 3.64E-02 
mmu-mir-23a-3p 9641.63 0.34 2.67 7.63E-03 3.69E-02 
mmu-mir-19a-3p 503.07 0.45 2.66 7.86E-03 3.72E-02 
mmu-mir-27a-3p 25661.93 0.28 2.66 7.83E-03 3.72E-02 
mmu-mir-199b-5p 2483.96 0.25 2.63 8.52E-03 3.93E-02 
mmu-mir-27b-5p 259.98 -0.51 -2.63 8.56E-03 3.93E-02 
mmu-mir-342-3p 1268.91 -0.41 -2.63 8.54E-03 3.93E-02 
mmu-mir-3068-5p 35.95 0.81 2.61 9.18E-03 4.17E-02 
mmu-mir-1839-3p 81.48 0.57 2.60 9.30E-03 4.18E-02 
mmu-mir-155-5p 374.22 -0.55 -2.60 9.43E-03 4.20E-02 
mmu-mir-700-5p 59.62 0.64 2.56 1.05E-02 4.62E-02 
mmu-let-7f-2-5p 52345.75 -0.44 -2.55 1.07E-02 4.68E-02 
mmu-mir-30c-1-3p 49.90 -0.68 -2.55 1.08E-02 4.68E-02 
mmu-mir-301a-5p 4.28 0.71 2.54 1.12E-02 4.77E-02 
mmu-let-7f-1-5p 44490.73 -0.41 -2.53 1.14E-02 4.84E-02 
mmu-mir-351-5p 12376.84 -0.41 -2.52 1.18E-02 4.96E-02 
mmu-mir-181b-1-5p 3790.47 -0.34 -2.51 1.21E-02 5.03E-02 
mmu-mir-26b-5p 30004.37 -0.28 -2.51 1.22E-02 5.03E-02 
mmu-mir-494-3p 4.46 0.70 2.50 1.24E-02 5.05E-02 
mmu-mir-138-2-5p 113.29 -0.43 -2.46 1.41E-02 5.69E-02 
mmu-mir-219-2-5p 3.72 0.68 2.45 1.42E-02 5.70E-02 
mmu-mir-376b-3p 3.66 0.68 2.44 1.46E-02 5.80E-02 
mmu-mir-193-3p 1671.96 0.45 2.42 1.53E-02 6.03E-02 
mmu-mir-5709 3.64 0.67 2.42 1.54E-02 6.03E-02 
mmu-mir-5109 3.47 0.66 2.41 1.60E-02 6.18E-02 
mmu-mir-224-5p 1469.05 -0.33 -2.40 1.63E-02 6.24E-02 
mmu-mir-299-3p 3.36 0.66 2.39 1.69E-02 6.43E-02 
mmu-mir-874-5p 3.37 0.66 2.38 1.71E-02 6.44E-02 
mmu-mir-551b-3p 3.30 0.65 2.37 1.76E-02 6.59E-02 
mmu-mir-448-3p 49.76 0.53 2.37 1.79E-02 6.62E-02 
mmu-mir-329-3p 3.30 0.65 2.36 1.83E-02 6.71E-02 
mmu-mir-200c-5p 3.25 0.64 2.34 1.93E-02 7.05E-02 
mmu-mir-421-3p 357.73 -0.38 -2.32 2.01E-02 7.29E-02 
mmu-mir-331-3p 375.52 0.62 2.32 2.06E-02 7.36E-02 
mmu-mir-700-3p 19.98 0.73 2.31 2.07E-02 7.36E-02 
mmu-mir-1981-3p 94.69 -0.47 -2.31 2.10E-02 7.41E-02 
mmu-mir-130b-3p 125.88 -0.49 -2.30 2.13E-02 7.47E-02 
mmu-mir-193-5p 3.14 0.62 2.30 2.16E-02 7.50E-02 
mmu-mir-467c-5p 2.96 0.61 2.28 2.27E-02 7.82E-02 
mmu-mir-136-3p 36.49 0.63 2.27 2.30E-02 7.87E-02 
mmu-mir-450b-3p 2.90 0.61 2.27 2.34E-02 7.96E-02 
mmu-mir-143-5p 689.65 -0.29 -2.25 2.46E-02 8.28E-02 
mmu-mir-671-3p 150.91 -0.48 -2.25 2.48E-02 8.28E-02 
mmu-mir-211-5p 16.27 -0.79 -2.23 2.55E-02 8.39E-02 
mmu-mir-32-3p 2.78 0.60 2.24 2.54E-02 8.39E-02 
mmu-mir-146b-3p 3.75 0.58 2.22 2.67E-02 8.73E-02 
mmu-mir-345-5p 34.09 0.72 2.21 2.69E-02 8.73E-02 
mmu-mir-10b-5p 10373.96 0.38 2.20 2.77E-02 8.92E-02 
mmu-mir-126-3p 95534.16 -0.18 -2.18 2.94E-02 9.42E-02 
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mmu-mir-221-5p 1050.64 -0.48 -2.15 3.12E-02 9.93E-02 
mmu-mir-1a-1-3p 159.62 0.67 2.15 3.18E-02 9.96E-02 
mmu-mir-1a-2-3p 159.62 0.67 2.15 3.18E-02 9.96E-02 
C57BL6 Kidney Mean expression in    BD-exposed 
log2 Fold 
Change Wald Stat p-value q-value 
mmu-mir-328-3p 1098.98 -0.61 -6.64 3.20E-11 1.03E-08 
mmu-mir-34a-5p 1286.46 0.98 6.53 6.56E-11 1.06E-08 
mmu-mir-193b-3p 317.18 1.12 6.38 1.72E-10 1.85E-08 
mmu-mir-128-1-3p 229.52 -1.15 -5.99 2.05E-09 1.65E-07 
mmu-let-7d-3p 1342.36 -0.62 -5.69 1.24E-08 7.95E-07 
mmu-mir-23a-3p 2542.16 0.57 5.58 2.36E-08 1.27E-06 
mmu-mir-128-2-3p 118.67 -1.02 -5.27 1.34E-07 5.41E-06 
mmu-mir-141-3p 3591.75 0.77 5.27 1.33E-07 5.41E-06 
mmu-mir-423-5p 1979.63 -1.06 -5.11 3.25E-07 1.16E-05 
mmu-mir-92a-2-3p 3071.42 -0.95 -5.00 5.80E-07 1.87E-05 
mmu-mir-222-3p 4409.57 -0.73 -4.87 1.10E-06 3.21E-05 
mmu-mir-200b-3p 42167.98 -0.73 -4.78 1.72E-06 4.61E-05 
mmu-mir-125a-5p 33153.77 -0.74 -4.70 2.56E-06 6.34E-05 
mmu-mir-24-1-3p 3421.40 0.82 4.61 4.04E-06 8.68E-05 
mmu-mir-24-2-3p 3421.23 0.82 4.61 4.04E-06 8.68E-05 
mmu-mir-149-5p 678.63 -1.05 -4.44 8.81E-06 1.77E-04 
mmu-mir-24-2-5p 668.57 0.33 4.37 1.22E-05 2.32E-04 
mmu-mir-1964-3p 40.82 -1.08 -4.31 1.66E-05 2.98E-04 
mmu-mir-451 12081.98 0.80 4.10 4.16E-05 7.06E-04 
mmu-mir-140-5p 630.00 0.41 4.07 4.70E-05 7.57E-04 
mmu-mir-125b-2-5p 5135.27 -0.89 -3.86 1.14E-04 1.74E-03 
mmu-mir-29b-1-3p 780.09 0.67 3.84 1.21E-04 1.77E-03 
mmu-mir-125b-1-5p 5322.99 -0.89 -3.81 1.38E-04 1.93E-03 
mmu-mir-200c-3p 978.12 0.40 3.72 2.00E-04 2.62E-03 
mmu-mir-29b-2-3p 809.31 0.66 3.72 2.03E-04 2.62E-03 
mmu-let-7e-3p 49.05 -0.69 -3.35 7.98E-04 9.88E-03 
mmu-mir-497-5p 951.55 -0.81 -3.33 8.83E-04 1.03E-02 
mmu-mir-92b-3p 604.32 -0.45 -3.32 8.95E-04 1.03E-02 
mmu-mir-146b-5p 665.10 1.18 3.29 1.01E-03 1.12E-02 
mmu-mir-671-3p 216.70 -0.68 -3.27 1.07E-03 1.15E-02 
mmu-mir-30c-1-3p 220.12 -0.67 -3.24 1.20E-03 1.21E-02 
mmu-mir-345-5p 30.83 0.87 3.24 1.18E-03 1.21E-02 
mmu-mir-145-5p 6822.20 0.53 3.22 1.28E-03 1.25E-02 
mmu-mir-224-5p 167.98 -0.83 -3.20 1.38E-03 1.27E-02 
mmu-mir-27a-3p 4904.02 0.50 3.21 1.35E-03 1.27E-02 
mmu-mir-92a-1-3p 45061.89 -0.48 -3.19 1.43E-03 1.28E-02 
mmu-mir-32-5p 279.20 0.82 3.17 1.52E-03 1.33E-02 
mmu-mir-15b-5p 291.77 0.48 3.15 1.62E-03 1.36E-02 
mmu-mir-19b-1-3p 1730.79 0.52 3.13 1.75E-03 1.36E-02 
mmu-mir-19b-2-3p 1757.29 0.52 3.13 1.74E-03 1.36E-02 
mmu-mir-30c-1-5p 80081.71 -0.55 -3.13 1.77E-03 1.36E-02 
mmu-mir-30c-2-5p 80085.52 -0.55 -3.13 1.78E-03 1.36E-02 
mmu-mir-34c-5p 923.49 -0.40 -3.06 2.22E-03 1.63E-02 
mmu-mir-98-3p 76.06 -0.61 -3.06 2.20E-03 1.63E-02 
mmu-let-7i-3p 56.64 0.79 3.03 2.48E-03 1.71E-02 
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mmu-mir-210-3p 287.44 0.36 3.02 2.49E-03 1.71E-02 
mmu-mir-331-3p 308.74 0.70 3.03 2.45E-03 1.71E-02 
mmu-mir-361-3p 222.70 -0.40 -3.01 2.61E-03 1.75E-02 
mmu-mir-1981-3p 135.42 -0.67 -2.98 2.89E-03 1.90E-02 
mmu-mir-190-5p 1554.14 0.53 2.93 3.36E-03 2.12E-02 
mmu-mir-200b-5p 146.35 -0.55 -2.93 3.35E-03 2.12E-02 
mmu-mir-7a-1-5p 34.79 0.87 2.88 4.02E-03 2.49E-02 
mmu-mir-143-3p 284993.80 0.54 2.85 4.42E-03 2.68E-02 
mmu-mir-365-2-3p 456.91 0.33 2.84 4.56E-03 2.72E-02 
mmu-mir-20a-5p 1563.70 0.77 2.81 4.96E-03 2.89E-02 
mmu-mir-365-1-3p 456.47 0.33 2.81 5.03E-03 2.89E-02 
mmu-mir-423-3p 2496.23 -0.66 -2.77 5.64E-03 3.19E-02 
mmu-mir-7a-2-5p 33.64 0.83 2.75 6.05E-03 3.36E-02 
mmu-mir-802-5p 250.13 -0.56 -2.67 7.69E-03 4.20E-02 
mmu-mir-30d-3p 381.92 -0.38 -2.66 7.87E-03 4.22E-02 
mmu-mir-429-3p 10511.53 -0.33 -2.60 9.21E-03 4.78E-02 
mmu-mir-700-5p 69.68 0.56 2.61 9.06E-03 4.78E-02 
mmu-mir-19a-3p 375.86 0.50 2.59 9.70E-03 4.96E-02 
mmu-mir-674-3p 140.77 -0.71 -2.58 9.90E-03 4.98E-02 
mmu-mir-150-5p 1306.14 -0.50 -2.56 1.04E-02 5.11E-02 
mmu-mir-28-5p 778.69 -0.41 -2.56 1.05E-02 5.11E-02 
mmu-mir-144-3p 557.06 0.77 2.55 1.07E-02 5.15E-02 
mmu-mir-33-5p 69.12 0.66 2.52 1.16E-02 5.48E-02 
mmu-mir-744-5p 970.30 -0.37 -2.51 1.21E-02 5.65E-02 
mmu-mir-18a-5p 83.73 0.63 2.49 1.27E-02 5.77E-02 
mmu-mir-3068-5p 69.05 0.63 2.49 1.27E-02 5.77E-02 
mmu-mir-146a-5p 1683.74 0.58 2.48 1.33E-02 5.95E-02 
mmu-mir-421-3p 369.29 -0.35 -2.42 1.55E-02 6.82E-02 
mmu-mir-144-5p 768.58 -0.46 -2.40 1.62E-02 7.06E-02 
mmu-mir-542-3p 208.74 0.42 2.40 1.64E-02 7.06E-02 
mmu-mir-3096-5p 31.16 0.78 2.39 1.70E-02 7.21E-02 
mmu-mir-10b-5p 991773.02 0.71 2.38 1.74E-02 7.27E-02 
mmu-mir-23b-3p 7118.89 0.24 2.37 1.76E-02 7.27E-02 
mmu-mir-22-5p 315.63 0.41 2.36 1.84E-02 7.52E-02 
mmu-mir-877-5p 37.18 -0.65 -2.34 1.95E-02 7.86E-02 
mmu-mir-29c-5p 53.77 0.55 2.30 2.13E-02 8.48E-02 
mmu-mir-30a-5p 491343.67 0.36 2.28 2.25E-02 8.85E-02 
mmu-mir-130a-3p 4196.03 0.14 2.27 2.30E-02 8.94E-02 
mmu-mir-27b-5p 114.65 -0.48 -2.27 2.33E-02 8.95E-02 
mmu-mir-99a-5p 3758.93 -0.58 -2.26 2.39E-02 9.05E-02 
mmu-mir-17-5p 950.76 0.35 2.25 2.44E-02 9.14E-02 
mmu-mir-200a-3p 14004.21 0.45 2.23 2.61E-02 9.54E-02 
mmu-mir-24-1-5p 32.87 0.66 2.23 2.59E-02 9.54E-02 
CAST/EiJ Lung Mean expression in    BD-exposed 
log2 Fold 
Change stat p-value q-value 
mmu-mir-490-3p 399.84 -1.11 -7.29 3.13E-13 7.42E-11 
mmu-mir-143-5p 650.83 -0.88 -6.97 3.27E-12 3.88E-10 
mmu-mir-145-5p 7059.33 -0.64 -5.33 9.86E-08 7.79E-06 
mmu-mir-143-3p 465615.25 -0.61 -5.17 2.31E-07 1.37E-05 
mmu-mir-335-5p 1125.51 0.49 4.66 3.21E-06 1.52E-04 
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mmu-mir-335-3p 375.07 0.60 4.19 2.81E-05 1.11E-03 
mmu-mir-195-5p 2299.86 0.45 3.82 1.32E-04 4.47E-03 
mmu-mir-140-3p 3392.82 -0.57 -3.64 2.77E-04 8.19E-03 
mmu-mir-204-5p 157.55 -0.74 -3.31 9.20E-04 2.22E-02 
mmu-mir-381-3p 193.73 -0.46 -3.31 9.37E-04 2.22E-02 
mmu-mir-140-5p 426.73 -0.54 -3.03 2.47E-03 5.33E-02 
mmu-mir-434-3p 629.38 -0.42 -2.92 3.55E-03 7.01E-02 
mmu-mir-22-3p 247242.00 0.20 2.85 4.38E-03 7.98E-02 
mmu-mir-10b-5p 12733.78 -0.39 -2.75 6.04E-03 9.54E-02 
mmu-mir-300-3p 226.89 -0.48 -2.75 6.03E-03 9.54E-02 
mmu-mir-411-5p 476.89 -0.41 -2.72 6.55E-03 9.71E-02 
      
CAST/EiJ Kidney Mean expression in    BD-exposed 
log2 Fold 
Change Wald Stat p-value q-value 
mmu-mir-200b-5p 108.90 -0.93 -5.37 7.98E-08 1.92E-05 
mmu-mir-140-3p 1722.78 -0.40 -3.74 1.85E-04 1.46E-02 
mmu-mir-200b-3p 31587.34 -0.68 -3.67 2.42E-04 1.46E-02 
mmu-mir-96-5p 110.65 -0.83 -3.78 1.54E-04 1.46E-02 
mmu-mir-130a-3p 1899.76 0.29 3.47 5.19E-04 2.48E-02 
mmu-mir-22-3p 294544.52 0.23 3.42 6.18E-04 2.48E-02 
mmu-mir-125b-1-5p 3790.99 -0.84 -3.33 8.61E-04 2.59E-02 
mmu-mir-125b-2-5p 3699.59 -0.84 -3.36 7.82E-04 2.59E-02 
mmu-mir-421-3p 180.72 0.44 3.26 1.10E-03 2.95E-02 
mmu-mir-92a-2-3p 1653.93 -0.43 -3.21 1.31E-03 3.16E-02 
mmu-mir-221-5p 443.17 -0.72 -3.05 2.32E-03 5.08E-02 
mmu-mir-224-5p 143.70 -0.69 -3.02 2.56E-03 5.14E-02 
mmu-mir-99a-5p 2317.43 -0.73 -2.80 5.13E-03 9.52E-02 
mmu-mir-532-5p 883.66 -0.32 -2.76 5.71E-03 9.80E-02 
mmu-mir-99b-5p 13512.03 -0.71 -2.74 6.10E-03 9.80E-02 
 
 
